
<html lang="en"     class="pb-page"  data-request-id="45fba9d7-cdd1-4be9-81dc-ba22ebca0f3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2015.58.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm500784e"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Novel Imidazo[1,2-a][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity" /></meta><meta name="dc.Creator" content="Pascal  Dao" /></meta><meta name="dc.Creator" content="Nikaia  Smith" /></meta><meta name="dc.Creator" content="Céline  Tomkiewicz-Raulet" /></meta><meta name="dc.Creator" content="Expédite  Yen-Pon" /></meta><meta name="dc.Creator" content="Marta  Camacho-Artacho" /></meta><meta name="dc.Creator" content="Daniel  Lietha" /></meta><meta name="dc.Creator" content="Jean-Phillipe  Herbeuval" /></meta><meta name="dc.Creator" content="Xavier  Coumoul" /></meta><meta name="dc.Creator" content="Christiane  Garbay" /></meta><meta name="dc.Creator" content="Huixiong  Chen" /></meta><meta name="dc.Description" content="A series of triazinic inhibitors of focal adhesion kinase (FAK) have been recently shown to exert antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancer cell lin..." /></meta><meta name="Description" content="A series of triazinic inhibitors of focal adhesion kinase (FAK) have been recently shown to exert antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancer cell lin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 11, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500784e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500784e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500784e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500784e" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Novel Imidazo[1,2-a][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500784e" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Novel Imidazo[1,2-a][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0011.jpeg" /></meta><meta property="og:description" content="A series of triazinic inhibitors of focal adhesion kinase (FAK) have been recently shown to exert antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancer cell lines. We report herein that we further explored the heterocyclic core of these inhibitors by a fused imidazole ring with the triazine to provide imidazo[1,2-a][1,3,5]triazines. Importantly, these new compounds displayed 10–7–10–8 M IC50 values, and the best inhibitor showed IC50 value of 50 nM against FAK enzymatic activity. Several inhibitors potently inhibited the proliferation of a panel of cancer cell lines expressing high levels of FAK. Apoptosis analysis in U87-MG and HCT-116 cell lines suggested that these compounds delayed cell cycle progression by arresting cells in the G2/M phase of the cell cycle, retarding cell growth. Further investigation demonstrated that these compounds strongly inhibited cell-matrix adhesion, migration, and invasion of U87-MG cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500784e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500784e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500784e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500784e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500784e&amp;href=/doi/10.1021/jm500784e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 237-251</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500669m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5009264" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Novel Imidazo[1,2-<i>a</i>][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Dao">Pascal Dao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikaia++Smith">Nikaia Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Tomkiewicz-Raulet">Céline Tomkiewicz-Raulet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Exp%C3%A9dite++Yen-Pon">Expédite Yen-Pon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Camacho-Artacho">Marta Camacho-Artacho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Lietha">Daniel Lietha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Phillipe++Herbeuval">Jean-Phillipe Herbeuval</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Coumoul">Xavier Coumoul</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christiane++Garbay">Christiane Garbay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huixiong++Chen">Huixiong Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemistry & Biology, Nucleo(s)tides & Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité, UFR Biomédicale, 45 rue des Saints-Pères, 75270 Cedex 06 Paris, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Toxicologie, Pharmacologie et Signalisation Cellulaire, INSERM, UMR S 1124, Université Paris Descartes, PRES Sorbonne Paris Cité, UFR Biomédicale, 45 rue des Saints-Pères, 75270 Cedex 06 Paris, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernández Almagro 3, Madrid 28029, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">School of Chemical Engineering and Light Industry, Guangdong University of Technology, no. 100 Waihuan Xi road, Education Mega Center, Guangzhou, 510006, China</span></div><div class="corresp-info"><strong>*</strong>Tel: +331-428-640-85. Fax: +331-428-640-82. E-mail: <a href="/cdn-cgi/l/email-protection#e68e938f9e8f898881c8858e8388a69687948f95828395858794928395c88094"><span class="__cf_email__" data-cfemail="cca4b9a5b4a5a3a2abe2afa4a9a28cbcadbea5bfa8a9bfafadbeb8a9bfe2aabe">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500784e&amp;href=/doi/10.1021%2Fjm500784e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 237–251</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 2, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 May 2014</li><li><span class="item_label"><b>Published</b> online</span>11 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 January 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500784e" title="DOI URL">https://doi.org/10.1021/jm500784e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D237%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPascal%2BDao%252C%2BNikaia%2BSmith%252C%2BC%25C3%25A9line%2BTomkiewicz-Raulet%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D1%26contentID%3Djm500784e%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BNovel%2BImidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2Band%2BTheir%2BDerivatives%2Bas%2BFocal%2BAdhesion%2BKinase%2BInhibitors%2Bwith%2BAntitumor%2BActivity%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D251%26publicationDate%3DJanuary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500784e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2706</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500784e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Novel Imidazo[1,2-a][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Dao&quot;},{&quot;first_name&quot;:&quot;Nikaia&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Tomkiewicz-Raulet&quot;},{&quot;first_name&quot;:&quot;Expédite&quot;,&quot;last_name&quot;:&quot;Yen-Pon&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Camacho-Artacho&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Lietha&quot;},{&quot;first_name&quot;:&quot;Jean-Phillipe&quot;,&quot;last_name&quot;:&quot;Herbeuval&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Coumoul&quot;},{&quot;first_name&quot;:&quot;Christiane&quot;,&quot;last_name&quot;:&quot;Garbay&quot;},{&quot;first_name&quot;:&quot;Huixiong&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;237-251&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500784e&quot;},&quot;abstract&quot;:&quot;A series of triazinic inhibitors of focal adhesion kinase (FAK) have been recently shown to exert antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancer cell lines. We report herein that we further explored the heterocyclic core of these inhibitors by a fused imidazole ring with the triazine to provide imidazo[1,2-a][1,3,5]triazines. Importantly, these new compounds displayed 10–7–10–8 M IC50 values, and the best inhibitor showed IC50 value of 50 nM against FAK enzymatic activity. Several inhibitors potently inhibited the proliferation of a panel of cancer cell lines expressing high levels of FAK. Apoptosis analysis in U87-MG and HCT-116 cell lines suggested that these compounds delayed cell cycle progression by arresting cells in the G2/M phase of the cell cycle, retarding cell growth. Further investigation demonstrated that these compounds strongly inhibited cell-matrix adhesion, migration, and invasion of U87-MG cells.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500784e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500784e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500784e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500784e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500784e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500784e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500784e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500784e&amp;href=/doi/10.1021/jm500784e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500784e" /></input><a href="/doi/pdf/10.1021/jm500784e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500784e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500784e%26sid%3Dliteratum%253Aachs%26pmid%3D25180654%26genre%3Darticle%26aulast%3DDao%26date%3D2015%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BNovel%2BImidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2Band%2BTheir%2BDerivatives%2Bas%2BFocal%2BAdhesion%2BKinase%2BInhibitors%2Bwith%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D1%26spage%3D237%26epage%3D251%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jmcmar.2015.58.issue-1/20150108/jmcmar.2015.58.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of triazinic inhibitors of focal adhesion kinase (FAK) have been recently shown to exert antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancer cell lines. We report herein that we further explored the heterocyclic core of these inhibitors by a fused imidazole ring with the triazine to provide imidazo[1,2-<i>a</i>][1,3,5]triazines. Importantly, these new compounds displayed 10<sup>–7</sup>–10<sup>–8</sup> M IC<sub>50</sub> values, and the best inhibitor showed IC<sub>50</sub> value of 50 nM against FAK enzymatic activity. Several inhibitors potently inhibited the proliferation of a panel of cancer cell lines expressing high levels of FAK. Apoptosis analysis in U87-MG and HCT-116 cell lines suggested that these compounds delayed cell cycle progression by arresting cells in the G2/M phase of the cell cycle, retarding cell growth. Further investigation demonstrated that these compounds strongly inhibited cell-matrix adhesion, migration, and invasion of U87-MG cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/58/1"><issue-title>New Frontiers in Kinases</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase and scaffold protein localized to focal adhesions, is uniquely positioned at the convergence point of integrins and receptor tyrosine kinase signal transduction pathways, which transmit signals from the extracellular matrix (ECM) to the cell cytoskeleton. FAK has been identified as a key pathogenic mediator of a variety of diseases. The most widely studied disease in this regard is cancer. This protein is emerging as a promising therapeutic target because it is highly expressed at both the transcriptional and translational level in various cancers. Ample evidence has indicated that FAK signaling pathways can stimulate tumor progression and metastasis through their regulation of cell migration, invasion, ECM, and angiogenesis (for a recent review of FAK, refer to refs <a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">1−4</a>). The initial attempts at inhibition focused upon down-regulation of FAK expression, demonstrating that silencing FAK by transfection of dominant-negative C-terminal FAK-CD decreased adhesion, colonization, and tumor growth in breast cancer cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Similarly, the inhibition of FAK expression with antisense oligonucleotides and siRNA to FAK led to cell rounding, detachment, reduction of invasion, increased apoptosis, and finally induced <i>in vivo</i> tumorigenesis.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(-6, 7)</a> It was also observed that in two transgenic mouse models there is a strong correlation between FAK expression and late-stage tumorigenesis, indicating that FAK is required for progression of early tumors to late-stage adenocarcinoma.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> These studies confirmed scientific rationale for further development of FAK inhibitors as anticancer agents.</div><div class="NLM_p">FAK has also been involved in angiogenesis as an important modulator during development, as evidenced by the early embryonic lethality of mice engineered to harbor an endothelial specific deletion of this protein.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> FAK signaling pathway was connected to increased production of vascular endothelial growth factor (VEGF) and urokinase plasminogen activator, known factors involved in tumor progression.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> It was reported that FAK expression in endothelial cells is necessary for the formation of new blood vessels, for the stability of the vascular network, and for the survival of endothelial cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Overexpression of FAK in vascular endothelial cells directly promotes angiogenesis in transgenic mice.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> On the other hand, endothelial FAK deletion in adult mice inhibited tumor growth and reduced tumor angiogenesis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A correlation between microvessel density on tumor specimen and FAK expression was found in a clinical study with breast cancer patients.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Therefore, several FAK inhibitors have been successfully developed,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> and two of them were extensively examined in preclinical or clinical studies.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Their efficacy in tumor models may be a result of their ability to potently inhibit both tumor growth and tumor-associated angiogenesis.</div><div class="NLM_p">Previously, we have described the generation of a series of triazinic inhibitors of FAK, which show antiangiogenic activity against HUVEC cells and anticancer efficacy against several cancers in cell culture studies (glioblastoma U-87MG, colon cancer HCT-116, breast cancer MDA-MB-231, and prostate cancer PC-3).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> X-ray crystallographic analysis of the cocrystal structure of these compounds in the FAK kinase domain revealed that the mode of interaction is highly similar to that observed in the complex of TAE-226,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> a potent ATP-competitive inhibitor of FAK designed by Novartis Pharma AG that stabilizes an unusual helical conformation of the DFG motif in which the φ torsion angle of Asp564 is rotated by 113° compared with the active kinase domain. This compound has shown potent antiproliferative and antitumor effects <i>in vitro</i> and <i>in vivo</i> in several types of malignancies including brain tumors,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> esophageal cancer,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> breast cancer,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> ovarian cancer,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and gastrointestinal stroma tumor.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, TAE-226 never entered clinical trials, because this compound also inhibited the insulin receptor with an IC<sub>50</sub> of 40 nM and showed important side effects in animal studies including severely affected glucose metabolism and glucose blood levels.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Interestingly our triazinic compounds did not inhibit the insulin receptor (IR) kinase at 1 μM. Compared with TAE-226, our compounds showed similar antiangiogenic and anticancer activities but a poorer affinity for FAK with IC<sub>50</sub> values in the range of 10<sup>–7</sup> M, which could be worthy of further development.</div><div class="NLM_p">In an attempt to design compounds with inhibitory potency enhancement toward FAK kinase activity, we decided to explore the heterocyclic core by the fused imidazole ring with the triazine to give an imidazo[1,2-<i>a</i>][1,3,5]triazine (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), which we hoped to have potentially an interaction with a gate-keeper residue Met499 in the kinase domain, and we also expected to retain the functional selectivity against the IR because the poorer affinity of 1,3,5-triazinic inhibitors for FAK might be attributed to the missing chlorine atom, which in TAE226 makes van der Waals interactions with this residue and significantly contributes to binding capacity.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Molecular docking is an application where the lowest energy binding mode of a small molecule bound to a protein target is predicted based on computationally calculated ligand–protein interactions. We first docked one imidazotriazinic compound into FAK based on the cocrystal structure of PHM16 with the FAK kinase domain (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4c7t">4c7t</a>, see Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). This compound could bind to the ATP-binding site in a very similar way to PHM16 and fits well in the nucleotide binding pocket with the imidazotriazine ring located in the adenine pocket and the imidazole ring oriented toward residue Met499 (3.1 Å). We hypothesized that the imidazotriazine cycle could be used as a good scaffold to develop novel FAK inhibitors. Recently, 1<i>H</i>-pyrrolo[2,3-<i>b</i>]- and 3<i>H</i>-imidazolo[4,5-<i>b</i>]pyridine scaffolds were also used to prepare FAK inhibitors with good affinity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">This paper describes the design, the synthesis, the biological evaluation, and the docking study of imidazotriazinic compounds as novel FAK inhibitors. The compounds potently suppressed the enzymatic activities of FAK with IC<sub>50</sub> values in the 10<sup>–7</sup>–10<sup>–8</sup> M range. The best inhibitor of this series of compounds showed an IC<sub>50</sub> value of 50 nM. These compounds also strongly suppressed the proliferation of human cancer cells in which FAK expression was at high levels. Furthermore, the representative compounds potently suppressed cancer cell adhesion, migration, and invasion, indicating their potential to serve as new lead compounds for further anticancer drug discovery.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of imidazo[1,2-<i>a</i>][1,3,5]triazine scaffold is described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Starting from cyanuric chloride (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), the first chlorine was displaced by nucleophilic substitution with arylamines at −10 °C to produce the mono-substituted intermediates. Intermediates <b>1</b>–<b>4</b> were synthesized from cyanuric chloride (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) by nucleophilic substitution with arylamines at −10 °C followed by reaction with ammonia in a one-pot procedure. The displacement of the last chlorine by the corresponding arylamines was accomplished by a Pd-catalyzed arylamination procedure, affording compounds <b>5</b>–<b>10</b> in good yields. Next, compounds <b>11</b>, <b>13</b>, <b>14</b>, and <b>16</b>–<b>18</b> were obtained in the form of two regioisomers by the condensation of compounds <b>5</b>–<b>10</b> with 4.2-fold excess of 2-chloroacetaldehyde. These two regioisomers were isolated by column chromatography, and their respective structures were confirmed by NOE experiments. In theory, it was possible from this cyclocondensation to obtain a pair of isomeric products that differ in the position of the imidazole ring, because the starting compounds <b>5</b>–<b>10</b> are differently substituted in the 4 and 6 positions. In general, the minor product is identified as the regioisomer B. Aminolysis of esters <b>11</b>, <b>14</b>, and <b>18</b> was accomplished using methylamine and CaCl<sub>2</sub> under MW irradiation to afford compounds <b>12</b>, <b>15</b>, and <b>19</b>. Finally, the protecting N-Alloc groups of compounds <b>18</b> and <b>19</b> were removed using a palladium catalyzed reductive deprotection procedure to produce the desired products <b>20</b> and <b>21</b>, respectively, in good yields.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Arylamine/THF/DIEA, −20°C, and NH<sub>3</sub>/THF, TA; (b) arylamine/dioxane/Pd(OAc)<sub>2</sub>/rac-BINAP/Cs<sub>2</sub>CO<sub>3</sub>/MW, 100 °C, 10 min; (c) 2-chloroacetaldehyde/EtOH/reflux; (d) CH<sub>3</sub>NH<sub>2</sub>/CaCl<sub>2</sub>/MW, 100 °C, 20 min; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaBH<sub>4</sub>, THF, TA.</p></p></figure><div class="NLM_p">The second series of imidazo[1,2-<i>a</i>][1,3,5]triazine derivatives (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were synthesized from compound <b>22</b>, which was prepared according to a previously published method.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Subsequent cyclization of compound <b>22</b> with methyl 2-nitrophenylacetate or methyl 2-(2-methoxy-2-oxoethyl)benzoate was performed in methanolic sodium methoxide to afford trisubstituted triazines <b>23</b> and <b>24</b>. Next, compounds <b>25</b> and <b>26</b> were obtained in the form of two regioisomers by the condensation of compounds <b>23</b> and <b>24</b> with 2-chloroacetaldehyde as described in the first series. Aminolysis of ester <b>26a</b> led to the corresponding amide derivative <b>27a</b>. Finally, the synthesis of compounds <b>30a</b> and <b>31a</b> was accomplished by either chemical reduction using Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> or catalytic hydrogenation using PtO<sub>2</sub> and further substitution by methanesulfonyl chloride as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3,4,5-Trimethoxyaniline/dioxane/MW, 90 °C, 15 min; (b) phenylacetate derivatives/MeONa/THF/reflux; (c) 2-chloroacetaldehyde/EtOH, 120 °C; (d) Al(CH<sub>3</sub>)<sub>3</sub>/NH<sub>4</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>, RT, 12 h; (e) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>/NaHCO<sub>3</sub>/THF/EtOH/H<sub>2</sub>O, RT; (f) H<sub>2</sub>/PtO<sub>2</sub>/MeOH/THF; (g) CH<sub>3</sub>SO<sub>2</sub>Cl/pyridine, 50 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro Activity against FAK Kinase</h3><div class="NLM_p">The <i>in vitro</i> inhibition of FAK kinase activity of the newly synthesized compounds was evaluated using a TR-FRET based kinase assay as described previously.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> One reported inhibitor of FAK, TAE-226, was included to validate the screening conditions. Under the experimental conditions, TAE-226 inhibited the activity of FAK with IC<sub>50</sub> value of 7 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which was similar to previously reported data.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Enzymatic Activities of Novel Imidazo[1,2-<i>a</i>][1,3,5]triazines Compared with TAE-226</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">regioisomer</th><th class="colsep0 rowsep0" align="center" char=".">FRET IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">3,4,5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.28 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.57 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.87 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">1.20 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.23 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.31 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub>-4-morpholino</td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.37 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.57 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.33 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.51 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.71 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">1.12 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-NHSO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.92 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-NHSO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">1.73 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>NHAlloc</td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.50 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">1.05 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.05 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.88 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.24 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.28 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.12 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">0.22 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26a</b></td><td class="colsep0 rowsep0" align="left">3,4,5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.37 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.18 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-NHSO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">0.84 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2-NHSO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">8.91 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>TAE226</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.007 ± 0.002</td></tr></tbody></table></div></div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, comparison of regioisomers A and B of imidazo[1,2-<i>a</i>][1,3,5]triazines revealed that, in general, the first one is slightly more active as FAK inhibitor, especially for <b>19a</b>, which showed higher potency affinity to FAK (17.6-fold) than <b>19b</b>. It is interesting to note that the introduction of the 3,4,5-trimethoxyphenylamino group (ring B) at the position 2 of the imidazo[1,2-<i>a</i>][1,3,5]triazine ring and the phenylamino moiety (ring A) bearing an ester function at the position 4 of the same ring (compounds <b>11a</b>) resulted in a large increase in inhibitory potency on FAK kinase activity (IC<sub>50</sub> 280 nM), compared with the corresponding 1,3,5-triazinic FAK inhibitor (IC<sub>50</sub> 2.3 μM),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> showing specific contributions of the heterocyclic core of imidazo[1,2-<i>a</i>][1,3,5]triazine. The displacement of the ester group from ortho (compound <b>11a</b>) to meta position in the arylamine on the imidazo[1,2-<i>a</i>][1,3,5]triazine ring A (compound <b>13a</b>) was not well tolerated and led to a decreased affinity toward FAK. This is consistent with what was observed for related 1,3,5-triazinic inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, replacing the ester group on the arylamine (ring A for compound <b>11a</b>) with an amide moiety (compound <b>12a</b>) displayed only a marginal improvement in inhibitory activity.</div><div class="NLM_p last">Then, we investigated the replacement of 3,4,5-trimethoxy groups on the phenyl ring (ring B) by different groups. When the 3,4,5-trimethoxyphenyl group (compound <b>12a</b>) is replaced by 2-methoxy-4-morpholinophenyl moiety, the corresponding compounds <b>15a</b> and <b>16a</b> did not display any relevant inhibitory activity changes. In contrast, increased inhibitory potencies are observed when the phenyl ring (ring B) is substituted by a CH<sub>2</sub>NH<sub>2</sub> group or CH<sub>2</sub>NHAlloc group in the para position (<b>19a</b> and <b>21a</b> compared with <b>12a</b>), which led to a potent inhibitor of FAK (IC<sub>50</sub> 50 nM for compound <b>19a</b>). This may be attributed to an additional interaction with the Glu506 residue of the enzymatic site, which could further enhance the binding capacity. The replacement of NH moiety between the phenyl group and the triazine moiety in the first series of imidazo[1,2-<i>a</i>][1,3,5]triazines by a CH<sub>2</sub> group leading to <b>26</b>, <b>27</b>, and <b>30</b> did not demonstrate an improved affinity for FAK (<b>26a</b> compared with <b>11a</b> and <b>27a</b> compared with <b>12a</b>), suggesting that the NH group did not play an important role for the inhibitory activity of FAK. Finally, a dihydroimidazo[1,2-<i>a</i>][1,3,5]triazine scaffold, a novel heterocyclic core, was not well tolerated and led to a decreased binding affinity toward FAK (<b>31a</b> compared with <b>30a</b>), showing that this scaffold is not favorable for the enzymatic site probably due to the dihydrotriazine ring, which is not planar.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Molecular Docking Study of Compound <b>19a</b></h3><div class="NLM_p">In an attempt to gain insight into the putative binding mode of the potent inhibitor <b>19a</b> with the FAK kinase, compared with its regioisomer <b>19b</b>, molecular docking of these compounds into the ATP binding site of the apo-FAK kinase (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4c7t">4c7t</a>) was performed. The resulting 3D binding modes of compounds <b>19a</b>,<b>b</b> to FAK are depicted in Figure S1, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p">For compound <b>19a</b>, the triazine ring, the two aniline rings (A and B), and the carboxamide moiety take very similar positions as observed for PHM16<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> bound to FAK. The two hydrogen bonds to the kinase hinge region made by PHM16 with its [1,3,5]triazine ring and the aniline moiety (ring B) are conserved in <b>19a</b>; however, additional interactions are made by the imidazo[1,2-<i>a</i>] ring in <b>19a</b>, most notably with Met499 (Figure S1A, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The CO of the carboxamide group of <b>19a</b> is located near the DFG (D564-F565-G566) motif of the activation loop of the kinase domain and forms a hydrogen bond with the backbone nitrogen of Asp564 of the DFG motif. This hydrogen bond together with hydrophobic contacts between ring A and Leu567 stabilize the short helical conformation of residues 565–568 and the typical DFG conformation also seen in PHM16 and TAE226 bound structures, with the side chain of Asp564 pointing up toward the kinase N-lobe. The CH<sub>2</sub>NH on the phenyl ring B forms a hydrogen bond with Ile-428, and the CO of the alloc group in <b>19a</b> has an additional interaction with Glu506. These interactions together with the interactions made by the imidazo[1,2-<i>a</i>] ring may be responsible for the increased binding affinity to FAK for <b>19a</b> compared with PHM16.</div><div class="NLM_p last">In contrast, <b>19b</b> cannot bind in the same mode as <b>19a</b>, because the imidazole ring is too close to Glu-500 in the hinge region, leading to steric clashes with this residue (Figure S1F, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). As a result, the imidazo and triazine rings are pushed further out of the pocket, preventing hydrogen bonds between <b>19b</b> and the kinase hinge and the hydrogen bonds that are formed are much more solvent exposed and provide lower binding energy, likely explaining the lower affinity of <b>19b</b> compared with <b>19a</b>. As shown in Figure S1C,F, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, <b>19a</b> but not <b>19b</b> fits well into the pocket as observed from a slice through the kinase just above the binding site.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Kinase Selectivity Profile of Compound <b>19a</b></h3><div class="NLM_p last">We further profiled the best inhibitor, <b>19a</b>, <i>in vitro</i> against a panel of more than 30 kinases (ABL1, AKT1, ALK, CDK1, CDK2, CDK3, CDK4, CDK5, CHK1, EGFR, ERBB2, ERK1, ERK2, FGFR-1, FGFR-2, FGFR-3, FYN, GSK3β, IGF1R, IR, JAK3, c-Kit, LCK, c-Met, PDGFRA, Pyk2, RAF1, c-Src, mTOR/FRAP1, FLT1/VEGFR1, KDR/VEGFR2, and FLT4/VEGFR3) determined by Reaction Biology Corporation, Malvern, PA, USA to investigate its selectivity (Table S1, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). A radioactive in vitro kinase assay was performed using [γ<sup>33</sup>P]ATP and human recombinant protein in the presence of 1 μM of compound <b>19a</b>. The results revealed that compound <b>19a</b> displays an excellent selectivity profile against the tested kinases. As expected, this compound did not inhibit the IR (insulin receptor) kinase at 1 μM in contrast to TAE-226.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It is also interesting to note that at 1 μM <b>19a</b> did not inhibit Pyk2, which shares a highly similar structural organization and a high sequence homology with approximately 60% identity in the central catalytic domain and 40% identity in both the N- and C-terminal domains with FAK.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This high affinity binding to FAK but not Pyk2 was also observed for the compound PF-573,228 reported by Pfizer.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibition of FAK Autophosphorylation and Growth Inhibitory Activity on Cancer Cell Lines</h3><div class="NLM_p">The antiproliferative effects of several compounds, compared with TAE-226, were investigated on human glioblastoma (U-87MG), human colon carcinoma (HCT-116), human metastatic breast cancer (MDA-MB-231), and human prostate cancer (PC-3), which express high levels of FAK.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">The inhibition of FAK autophosphorylation was first tested in these cancer cell lines, using FACEFAK ELISA kit (Active Motif Europe, Belgium). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, FAK autophosphorylation was significantly inhibited by treatment with the best inhibitor, <b>19a</b>, compared with TAE-226. Consistent with its inhibitory activity shown against the FAK kinase, compound <b>19a</b> blocked tyrosine 397 phosphorylation in a dose-dependent manner in these cancer cell lines, suggesting that these inhibitors are able to effectively inhibit cellular FAK autophosphorylation and phosphorylation of kinase targets at low concentrations.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cells (U-87MG, HCT-116, MDA-MB-231, and PC-3) were treated for 48 h with 0.1, 1, and 10 μM of compound <b>19a</b> or TAE-226 as control. Data obtained by the Face method are expressed as the fold decrease relative to the control and represent mean of triplicate readings of three independent experiments. A decrease of FAK tyrosine 397 phosphorylation in a dose-dependent manner is shown for <b>19a</b> and for TAE-226.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Then, we investigated the inhibition of cancer cell growth with several imidazo[1,2-<i>a</i>][1,3,5]triazine compounds using the WST-1 assay. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the IC<sub>50</sub> values of these compounds against different tumor cells ranged between 0.27 and 4.2 μM except for compounds <b>12a</b> and <b>15a</b> to which MDA-MB-231 cells are not sensitive in terms of decrease in cell survival. Among them, U-87MG cells were the most sensitive to <b>21a</b> with an IC<sub>50</sub> value of 0.37 μM, significantly lower than that of TAE-226. HCT-116 cells were as sensitive to these compounds as to TAE-226, except for <b>12a</b>, which exhibited less cytotoxicity. PC-3 cells are more sensitive to these compounds than to TAE-226. MDA-MB-231 cells showed more sensitivity to compounds <b>19a</b> and <b>21a</b> than to TAE-226.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferation Activity, IC<sub>50</sub> (μM)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char=".">U-87MG</th><th class="colsep0 rowsep0" align="center" char=".">HCT-116</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char=".">PC-3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=".">4.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.95 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.35 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.31 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.34 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.27 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.89 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.52 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.80 ± 0.27</td><td class="colsep0 rowsep0" align="char" char=".">0.29 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.37 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.31 ± 0.18</td><td class="colsep0 rowsep0" align="char" char=".">1.08 ± 0.45</td><td class="colsep0 rowsep0" align="char" char=".">1.27 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>TAE-226</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">2.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">1.6 ± 0.2</td></tr></tbody></table></div></div><div class="NLM_p">The effects of these compounds and TAE-226 on the tumorigenicity of these cancer cell lines were also examined using an <i>in vitro</i> colony formation assay. These compounds inhibited colony formation of the four cancer cell lines in a dose-dependent manner. In general, these compounds, like TAE-226, showed less cytotoxic effects but had stronger antitumorigenic effects on the cancer cell lines. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, these compounds showed a similar effect on U-87MG cells as TAE-226, except for <b>15a</b>. Similar results were also observed for HCT-116 cells, except for <b>15a</b>, which demonstrated a stronger antitumorigenic effect with an IC<sub>50</sub> value of 20 nM, compared with TAE-226. The different cellular properties (cell permeability, intracellular stability, and distribution) or off-target effects might account for this strong inhibition of <b>15a</b> on HCT-116 cancer cells. Concerning MDA-MB-231 cancer cells, compounds <b>19a</b> and <b>21a</b> exhibited more potent anticancer activity than TAE-226. However, these compounds showed slightly weaker effects on PC-3 cells than TAE-226.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Colony Formation, IC<sub>50</sub> (μM)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center" char=".">U-87MG</th><th class="colsep0 rowsep0" align="center" char=".">HCT-116</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char=".">PC-3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.76 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">3.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.99 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="char" char=".">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.63 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.42 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.13 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.14 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.63 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.52 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">1.4 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>TAE-226</b></td><td class="colsep0 rowsep0" align="char" char=".">0.19 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.23 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.26 ± 0.1</td></tr></tbody></table></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Effects of Compounds <b>19a</b> and <b>21a</b> on Apoptosis and on Cell Cycle in U-87MG and HCT-116 Cell Lines</h3><div class="NLM_p">To further investigate the mechanism underlying the antiproliferative effect of these compounds, we first examined whether the inhibitory effects of two good FAK inhibitors, <b>19a</b> and <b>21a</b>, on U-87MG and HCT-116 cell lines were due to apoptosis by examining the expression of annexin V using FACS analysis.</div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, we tested apoptosis caused by these two compounds and compared them with TAE-226. In U-87MG cells, 3 μM <b>19a</b> and 0.3 μM <b>21a</b> did not induce significant apoptosis. This finding is similar to that reported in the literature<a onclick="showRef(event, 'ref19 ref27'); return false;" href="javascript:void(0);" class="ref ref19 ref27">(19, 27)</a> and suggests that these two compounds may disrupt cell cycle progression. Interestingly, when the HCT-116 cell line was exposed to <b>19a</b> at 3 μM, it resulted in a significant increase in apoptosis. Indeed, cell apoptosis was increased by 25.9% for <b>19a</b> compared with control. This effect is less potent than that observed with TAE-226 (41.8%). Low concentrations of <b>19a</b> and TAE-226 were also able to induce significant apoptosis in HCT-116 cell lines (Figure S2, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In contrast, <b>21a</b> did not induce significant apoptosis.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two cancer cell lines (U87-MG and HCT-116) were plated at 10<sup>5</sup> cells per well in a 6-well culture dish, incubated overnight, and then cultured with <b>19a</b>, <b>21a</b>, or TAE-226 for 24 h. Cells were stained with annexin V and 7AAD and analyzed by FACS calibur. Cells were then classified as alive with no apoptosis (i.e., 7AAD negative, annexin V negative), dead (i.e., 7AAD positive), or apoptotic (i.e., annexin V positive). (A) U87-MG cells were treated with 3 μM <b>19a</b>, 0.3 μM <b>21a</b>, or 1 μM TAE-226; (B) HCT-116 cells were treated with 0.5 μM <b>19a</b>, 0.4 μM <b>21a</b>, or 0.3 μM TAE-226. One representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we wished to determine whether <b>19a</b>- or <b>21a</b>-induced decrease of FAK phosphorylation would result in cell cycle arrest in U-87MG and HCT-116 cell lines, compared with TAE-226. Cell cycle analysis was performed using flow cytometry (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Cell lines were treated with <b>19a</b> at 3 μM, <b>21a</b> at 0.4 μM, or TAE-226 at 1 μM. When the U-87MG cell line was exposed to <b>19a</b> or <b>21a</b> for 24 h, the DNA contents of the live population were 61.7%, 16.0%, and 20.0% for untreated cells, 34.3%, 5.1%, and 58.8% for <b>19a</b>-treated cells, and 47.6%, 9.8%, and 40.7% for <b>21a</b>-treated cells, respectively, for G0/G1, S, and G2/M phase. This finding is similar to that observed with TAE-226. Indeed, treatment with 3 μM <b>19a</b> or 0.4 μM <b>21a</b> resulted in a 2.9-fold and 2-fold, respectively increase in the fraction of cells arrested at G2. Similar results were also observed for the HCT-116 cell line. When these cells were treated with <b>19a</b> at 3 μM or <b>21a</b> at 0.4 μM, the number of cells in G2–M phase increased from 14.6% to 54.7% and 61.0%, whereas cells in G0/G1 phase decreased from 63.8% to 29.9% and 24.4%, respectively, compared with the controls. Low concentrations of <b>19a</b>, <b>21a</b>, and TAE-226 were also able to induce significant cell cycle arrest in U-87MG and HCT-116 cell lines (Figure S3, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Taken together, these results suggest that these compounds delayed cell cycle progression by arresting cells in the G2/M phase of the cell cycle, retarding U-87MG and HCT-116 cell growth.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell cycle distribution was studied by flow cytometry: cells (U87-MG and HCT-116) were plated at 10<sup>5</sup> per well in a 6-well culture dish, incubated overnight, and then exposed to <b>19a</b>, <b>21a</b>, or TAE-226 along with a vehicle treatment control for 24 h. Cell cycle distribution was represented by histograms. Asterisks denote statistically significant differences (*<i>p</i> < 0.01; **<i>p</i> < 0.001) as determined by unpaired Student’s <i>t</i> test. (A) U87-MG cells were treated with 3 μM <b>19a</b>, 0.3 μM <b>21a</b>, or 1 μM TAE-226; (B) HCT-116 cells were treated with 0.5 μM <b>19a</b>, 0.4 μM <b>21a</b>, or 0.3 μM TAE-226. One representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effects of Compounds <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> on the Adherence, Migration, and Invasion of U-87MG and HCT-116 Cell Lines</h3><div class="NLM_p">Metastasis is multistep process that results from the convergence of a variety of cellular processes. Some of these processes include cell migration, invasion, adhesion into the surrounding stroma and through vessel walls, and survival in a foreign environment. Furthermore, the ability of tumor cells to migrate, invade, and metastasize is associated with increased FAK expression.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Indeed, a role for FAK in cell migration was first suggested by observations of its increased expression or activation in the migrating keratinocytes in epidermal wound healing or ECs migrating into the wounded monolayer in vitro, respectively.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> Interference with FAK function via antisense oligonucleotides or by FRNK expression inhibits the motility of various cell types.<a onclick="showRef(event, 'ref7 ref36'); return false;" href="javascript:void(0);" class="ref ref7 ref36">(7, 36)</a> FAK–/– fibroblasts derived from FAK KO mouse embryo showed a significant decrease in cell migration compared with the cells from wild-type mice.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Because FAK is critical for cell attachment, migration, and invasion, we fist treated the U-87MG cells with different doses of our best inhibitors of FAK (<b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b>) for the adhesion assay. We observed that these compounds caused dose-dependent decrease of attachment (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Among them, <b>21a</b> and <b>19a</b> showed strong potencies for adhesion inhibition. Indeed, at low dose of 0.5 μM <b>21a</b> or 3 μM <b>19a</b>, the attachment decreased about 50%, compared with that treated with TAE-226, which only decreased 36% of attachment at 1 μM (Figure S4, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">Next, we performed measurements of U-87MG cell migration and invasion using modified 16-well plates on the xCELLigence DP device form Roche Diagnostics. This assay is based on real time monitoring of cell migration or invasion, which captures cell responses during the entire course of an experiment. The cell index (CI) reflects the electrical impedance across the interdigitated microelectrodes integrated on the lower side of the 8 μm pore membrane, caused by the cells invading through the Matrigel or collagen, across the membrane and spreading on the lower side of the membrane. As shown in Figure 5B, treatment with 4 μM <b>12a</b>, 2 μM <b>15a</b>, 3 μM <b>19a</b>, and 0.4 μM <b>21a</b> significantly decreased the number of cells migrating through the collagen-coated Transwell membrane chambers after 12 h. Interestingly, these compounds were even more potent for the cell mobility reduction than TAE-226. Among them, <b>19a</b> and <b>21a</b> showed strong inhibition of U87-MG cell migration. Indeed, as shown by the slopes (1/<i>h</i>), representing the cell migration ability, the migration of U87-MG cells across collagen-coated Transwell membrane was reduced by 66.4% in the presence of 0.4 μM <b>21a</b> and 69.5% in the presence of 3 μM <b>19a</b> compared with the reduction of only 25.5% in the presence of 1 μM TAE-226. This result is consistent with that observed in the adhesion inhibition and also confirmed by Boyden chamber assay, which showed that our compounds inhibited cell migration in a dose-dependent manner (Figure S5A, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compounds <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> on the cell attachment, migration, and invasion in U-87MG cell lines. (A) Cells were treated for 30 min in the presence of <b>12a</b>, <b>15a</b>, <b>19a</b>, <b>21a</b>, or TAE226. The attached cells were removed and counted. (B) Comparative xCELLigence analysis of the effect of different treatments on the migration of U87-MG human cancer cell lines. CI values are plotted on the graph. The slopes (1/<i>h</i>), representing the cell migrating ability, were calculated based on CI values in the time interval indicated on the plots by the boxes. The mean slopes calculated with DMSO (control) were set to 100. The experiment was repeated two times and was consistent. (C) Comparative xCELLigence analysis of the effect of different treatment on the invasion of U87-MG human cancer cell lines. CI values are plotted on the graph. The slopes (1/<i>h</i>), representing the cell invasion ability, were calculated based on CI values in the time interval indicated on the plots by the boxes. The mean slopes calculated with DMSO (control) were set to 100. The experiment was repeated two times and was consistent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cell invasion is a prerequisite for establishment of metastases at secondary sites requiring movement through basement membranes.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> To allow for measurement of cellular invasion, the membrane separating the upper and lower compartment of the CIM-plate 16 was coated with a layer of Matrigel, forcing the cell to digest the Matrigel prior to moving the bottom side of the membrane. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C, these compounds significantly reduced the invasive propensity of U87-MG cells compared with the vehicle control. Quantification of these results showed that compounds <b>19a</b> and <b>21a</b> could inhibit U87-MG cell invasion by at least 50% of untreated control, supporting their potent anti-invasion activity. As observed in the inhibition of cell migration, these compounds were more potent than TAE-226 in inhibiting cell invasion, except for compound <b>15a</b>, which showed the similar result as TAE-226. This result is consistent with that observed in the cellular migration and also confirmed by Boyden chamber assay, which showed that these compounds inhibited cell invasion in a dose-dependent manner (Figure S5B, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Taken together, these compounds can prevent cell adhesion, migration, and invasion of human U87-MG cells in vitro, which suggest that inhibition of FAK may uncouple adhesions from the substrate while still allowing them to be connected to the mobile actin network in the cell and this uncoupling would lead to defects in the generation or maintenance of tension at sites of adhesion, affecting thus cell migration, invasion, and tumor metastasis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a series of novel imidazo[1,2-<i>a</i>][1,3,5]triazines and their derivatives were found to be selective FAK inhibitors against the tested kinases. These compounds displayed IC<sub>50</sub> values in the range of 10<sup>–7</sup>–10<sup>–8</sup> M and the best inhibitor showed IC<sub>50</sub> values of 50 nM against FAK. Several inhibitors potently inhibited the proliferation of a panel of cancer cell lines expressing high levels of FAK, including U87-MG, HCT-116, MDA-MB-231, and PC-3. Apoptosis analysis in U87-MG and HCT-116 cell lines suggested that these compounds (<b>19a</b> and <b>21a</b>) may disrupt cell cycle progression but do not induce apoptosis as measured by 7AAD and annexin V, except for <b>19a</b> in the HCT-116 cell line. Indeed, using flow cytometry analysis, when the U-87MG and HCT-116 cell lines were exposed to these two compounds, the number of cells in G2–M phase increased and those in G0/G1 phase decreased compared with the controls. These observations suggest that they inhibited the cell growth through a mechanism associated with preventing progression through the G2–M phase of the cell cycle. Further investigation demonstrated that these compounds (<b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b>) strongly inhibited cell-matrix adhesion, migration, and invasion in U87-MG cells in a dose-dependent manner. The careful evaluation of pharmacokinetics and pharmacodynamics <i>in vivo</i> will be required to fully understand the role of FAK inhibition in the regulation of tumorigenesis and metastatic progression. These compounds may provide useful tools to assess the role of adhesion signaling in the regulation of cellular proliferation and migration and may have important therapeutic applications in the prevention or treatment of cancer. More importantly, they will offer possible alternative therapeutic approaches for the currently difficult treatment of distant metastases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercial materials were used without further purification. Microwave irradiation was carried out with a microwave monomode reactor (infrared detector for temperature). Melting points were determined on a Kofler apparatus as uncorrected values. Analytical thin-layer chromatography was performed on precoated 250 μm layer thickness silica gel 60 F254 plates and visualized with UV light. Column chromatography was performed using silica gel 60 (40–63 μm). <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were measured on 250 or 500 MHz spectrometer in DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> with chemical shift (δ) given in parts per million (ppm) relative to TMS as internal standard and recorded at 23 °C. MS (ESI) was determined by using a Q-Tof1 spectrometer with Z-spray source. High-resolution mass spectra (HRMS) were performed on Q-TOF Micro micromass positive ESI (CV = 30 V).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Method for the Synthesis of Compounds <b>6</b>–<b>10</b></h3><div class="NLM_p">A solution of the corresponding compound (<b>2</b>–<b>4</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> 0.18 mmol, 1 equiv) with arylamine (0.18 mmol, 1 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (0.27 mmol, 1.5 equiv) was introduced into a 10 mL microwave vial. The mixture was purged with argon before the addition of Pd(OAc)<sub>2</sub> (7.2 nmol, 0.04 equiv) and BINAP (7.2 nmol, 0.04 equiv). The mixture was subjected to microwave irradiation for 10 min at 100 °C using irradiation power of 100 W. The solvent was evaporated under vacuum, and the crude residue was purified by silica gel column chromatography eluted with mixture of dichloromethane and methanol.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Methyl 3-[4-Amino-6-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-ylamino]benzoate (<b>6</b>)</h4><div class="NLM_p last">White solid, mp 150 °C, 124 mg (87%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.25 (s, 1H), 8.97 (s, 1H), 8.33 (dd, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 8.16 (s, 1H), 7.57 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.42 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.16 (s, 2H), 6.68 (s, 2H), 3.85 (s, 3H), 3.74 (s, 6H), 3.64 (s, 3H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Methyl 2-[4-Amino-6-(2-methoxy-4-morpholinophenylamino)-1,3,5-triazin-2-ylamino]benzoate (<b>7</b>)</h4><div class="NLM_p last">Violet solid, mp 174 °C, 132.5 mg (88%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.27 (s, 1H), 7.95 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.85 (s, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.5 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.03 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.72 (bs, 2H), 6.65 (d, <i>J</i> = 2.0 Hz, 1H), 6.50 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 3.88 (s, 3H), 3.81 (s, 3H), 3.77 (t, <i>J</i> = 4.5 Hz, 4H), 3.13 (t, <i>J</i> = 4.5 Hz, 4H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-[4-Amino-6-(4-cyanophenylamino)-1,3,5-triazin-2-ylamino]-<i>N</i>-methylbenzamide (<b>8</b>)</h4><div class="NLM_p last">Pale yellow solid, mp 163 °C, 107 mg (89%).<sup>1</sup>H NMR (250 MHz, DMSO): δ 9.52 (s, 1H), 8.41 (s, 1H), 8.04 (d, <i>J</i> = 4.5 Hz, 1H), 7.96 (d, <i>J</i> = 9.0, 2H), 7.94 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.65 (d, <i>J</i> = 9 Hz, 2H), 7.41 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.35 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.12 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.87 (bs, 2H), 2.65 (d, <i>J</i> = 4.5 Hz, 3H).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-{2-[4-Amino-6-(4-cyanophenylamino)-1,3,5-triazin-2-ylamino]phenyl}methanesulfonamide (<b>9</b>)</h4><div class="NLM_p last">White solid, mp 184 °C, 95 mg (72%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.69 (s, 1H), 8.43 (s, 1H), 8.15 (bs, 1H), 8.0 (d, <i>J</i> = 9.0 Hz, 2H), 7.95 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.66 (d, <i>J</i> = 9 Hz, 2H), 7.35 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.30 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.17 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.93 (bs, 2H), 2.94 (s, 3H).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Methyl 2-{4-Amino-6-[4-((benzyloxycarbonylamino)methyl)phenylamino]-1,3,5-triazin-2-ylamino}benzoate (<b>10</b>)</h4><div class="NLM_p last">White solid, mp 192 °C, 104 mg (69%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.38 (s, 1H), 9.30 (s, 1H), 8.95 (d, <i>J</i> = 7.5 Hz, 1H), 7.98 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.73 (d, <i>J</i> = 7.5 Hz, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 7.57 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.18 (d, <i>J</i> = 8.0 Hz, 2H), 7.06 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.89 (br, 2H), 6.03–5.83 (m, 1H), 5.38–5.13 (m, 2H), 4.51 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.16 (d, <i>J</i> = 6.0 Hz, 2H), 3.89 (s, 3H).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Method for the Synthesis of Compounds <b>11</b>, <b>13</b>, <b>14</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>25</b>, and <b>26</b></h3><div class="NLM_p">A solution of the corresponding compound (<b>5</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>–<b>10</b> and <b>23</b>, 0.25 mmol, 1 equiv) and 2-chloroacetaldehyde (50% in H<sub>2</sub>O, 0.07 mL, 1.05 mmol, 4.2 equiv) in DMSO was stirred at 120 °C for 5–7 h. The solvent was evaporated under vacuum, and the crude residue was treated with NaHCO<sub>3</sub> saturated aqueous solution. This alkaline solution was extracted with dichloromethane. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, reduced to a small volume, and purified by silica gel column chromatography eluted with a mixture of dichloromethane and methanol.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 2-[2-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]benzoate (<b>11a</b>) and Methyl 2-[4-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]benzoate (<b>11b</b>)</h4><div class="NLM_p last">White solid, mp 196 °C, 70 mg (62%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.47 (s, 1H), 9.11 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.94 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.70 (d, <i>J</i> = 1.5 Hz, 1H), 7.5 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.1 (d, <i>J</i> = 1.5 Hz, 1H), 7.01 (br, 2H), 6.95 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.87 (s, 3H), 3.80 (s, 6H), 3.67 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.2, 156.5, 152.3, 151.4, 147.5, 143.6, 133.9, 132.3, 130.5, 129.2, 119.3, 118.9, 112.7, 106.9, 101.0, 60.1, 55.5, 52.0. MS (ESI) <i>m</i>/<i>z</i> 451.2 [M + 1]<sup>+</sup>. White solid, mp 198 °C, 37 mg (33%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.82 (s, 1H), 10.05 (br, 1H), 8.95 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 8.01 (d, <i>J</i> = 1.0 Hz, 1H), 8.0 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.62 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.38 (d, <i>J</i> = 1.0 Hz, 1H), 7.23 (br, 2H), 7.08 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.87 (br, 9H), 3.71 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.4, 157.5, 153.6, 148.9, 141.3, 133.5, 130.2, 128.4, 124.3, 119.7, 107.5, 101.1, 60.2, 55.7, 52.0. MS (ESI) <i>m</i>/<i>z</i> 451.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 3-[2-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]benzoate (<b>13a</b>) and Methyl 3-[4-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]benzoate (<b>13b</b>)</h4><div class="NLM_p last">White solid, mp 154 °C, 65 mg (58%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.9 (br, 1H), 9.64 (s, 1H), 8.38 (d, <i>J</i> = 2.0 Hz, 1H), 8.17 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.93 (s, 1H), 7.56 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.4 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.33 (d, <i>J</i> = 2.0 Hz, 1H), 7.02 (br, 2H), 3.84 (s, 3H), 3.80 (s, 6H), 3.70 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 52.0, 55.5, 55.5, 60.1, 101.0, 101.0, 106.9, 112.7, 118.9, 119.3, 129.2, 129.2, 130.5, 132.3, 133.9, 143.6, 147.5, 151.4, 152.3, 152.3, 156.5, 168.2. MS (ESI) <i>m</i>/<i>z</i> 451.2 [M + 1]<sup>+</sup>. White solid, mp 164 °C, 30 mg (26%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.11 (br, 1H), 9.32 (s, 1H), 8.39 (d, <i>J</i> = 2.0 Hz, 1H), 8.15 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.93 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.75 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.57 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.30 (d, <i>J</i> = 2.0 Hz, 1H), 7.20 (br, 2H), 3.87 (s, 3H), 3.68 (s, 6H), 3.62 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 52.0, 55.7, 55.7, 60.2, 101.1, 101.1, 107.5, 119.7, 119.7, 124.3, 128.4, 130.2, 130.2, 130.2, 133.5, 133.5, 141.3, 148.9, 148.9, 153.6, 157.5, 168.4. MS (ESI) <i>m</i>/<i>z</i> 451.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 2-[2-(2-Methoxy-4-morpholinophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]benzoate (<b>14a</b>) and Methyl 2-[4-(2-Methoxy-4-morpholinophenylamino)-imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]benzoate (<b>14b</b>)</h4><div class="NLM_p last">Violet solid, mp 168 °C, 67 mg (56%).<sup>1</sup>H NMR (250 MHz, DMSO): δ 10.40 (s, 1H), 9.76 (s, 1H), 8.76 (d, <i>J</i> = 8.6 Hz, 1H), 7.97 (d, <i>J</i> = 1.6 Hz, 1H), 7.93 (d, <i>J</i> = 1.6 Hz, 1H), 7.5 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.35 (s, 1H), 7.3 (d, <i>J</i> = 8.5 Hz, 1H), 7.03 (t, <i>J</i> = 8 Hz, 1H), 6.75 (d, <i>J</i> = 2.5 Hz, 1H), 6.63 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 3.86 (s, 3H), 3.84–3.75 (m, 7H), 3.27–3.20 (m, 4H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.7, 157.3, 155.0, 148.8, 148.2, 147.1, 141.5, 131.6, 131.5, 131.3, 124.3, 123.5, 123.2, 122.8, 122.4, 115.4, 107.0, 102.3, 65.5, 56.7, 52.0, 47.3. MS (ESI) <i>m</i>/<i>z</i> 476.2 [M + 1]<sup>+</sup>. Violet solid, mp 152 °C, 33 mg (28%).<sup>1</sup>H NMR (250 MHz, DMSO): δ 10.40 (s, 1H), 9.76 (s, 1H), 8.76 (d, <i>J</i> = 8.6 Hz, 1H), 7.97 (d, <i>J</i> = 1.6 Hz, 1H), 7.93 (d, <i>J</i> = 1.6 Hz, 1H), 7.5 (ddd, <i>J</i> = 8.5, 7.0, 1.6 Hz, 1H), 7.35 (s, 1H), 7.3 (d, <i>J</i> = 8.5 Hz, 1H), 7.03 (t, <i>J</i> = 8 Hz, 1H), 6.75 (d, <i>J</i> = 2.5 Hz, 1H), 6.63 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 3.86 (s, 3H), 3.84–3.75 (m, 7H), 3.27–3.20 (m, 4H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.8, 156.8, 155.0, 148.9, 148.9, 146.9, 141.8, 131.6, 131.5, 131.3, 124.1, 123.9, 123.6, 122.6, 115.1, 107.1, 101.8, 65.6, 56.8, 52.1, 47.3. MS (ESI) <i>m</i>/<i>z</i> 476.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-[2-(4-Cyanophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]-<i>N</i>-methylbenzamide (<b>16a</b>) and 2-[4-(4-Cyanophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]-<i>N</i>-methylbenzamide (<b>16b</b>)</h4><div class="NLM_p last">Gray solid, mp 164 °C, 40 mg (42%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.49 (br, 1H), 10.89 (s, 1H), 10.11 (s, 1H), 8.64 (d, <i>J</i> = 2.0 Hz, 1H), 7.93 (d, <i>J</i> = 9.0 Hz, 2H), 7.85–7.63 (m, 4H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.48 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.19 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 3.06 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 154.6, 148.9, 148.3, 141.1, 140.6, 132.2, 131.6, 130.6, 127.6, 126.9, 124.6, 123.8, 122.6, 119.1, 107.1, 103.3, 26.2. MS (ESI) <i>m</i>/<i>z</i> 385.1 [M + 1]<sup>+</sup>. Gray solid, mp 158 °C, 26 mg (27%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.72 (br, 1H), 9.57 (s, 1H), 8.04 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.95–7.75 (m, 4H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.34 (d, <i>J</i> = 1.5 Hz, 1H), 7.25 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.84 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.01 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 155.0, 148.9, 148.8, 141.1, 132.6, 131.6, 129.7, 129.5, 126.3, 124.8, 124.2, 122.2, 119.1, 107.1, 105.6, 26.2. MS (ESI) <i>m</i>/<i>z</i> 385.1 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-{2-[2-(4-Cyanophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]phenyl}methanesulfonamide (<b>17a</b>) and <i>N</i>-{2-[4-(4-Cyanophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]phenyl}methanesulfonamide (<b>17b</b>)</h4><div class="NLM_p last">Gray solid, mp 166 °C, 46 mg (44%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.77 (s, 1H), 7.92 (d, <i>J</i> = 9.0 Hz, 2H), 7.83 (d, <i>J</i> = 2.0 Hz, 1H), 7.62 (d, <i>J</i> = 9.0 Hz, 2H), 7.56–7.50 (m, 2H), 7.38 (d, <i>J</i> = 2.0 Hz, 1H), 7.30–7.19 (m, 2H), 2.97 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 154.6, 148.9, 148.3, 141.1, 131.6, 131.4, 130.6, 128.9, 127.5, 126.7, 123.8, 122.2, 121.6 119.1, 107.1, 103.3, 42.2. MS (ESI) <i>m</i>/<i>z</i> 421.1 [M + 1]<sup>+</sup>. Gray solid, mp 162 °C, 32 mg (31%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 8.74 (s, 1H), 7.87–7.65 (m, 5H), 7.37 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.34 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.19 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 155.0, 148.9, 148.8, 141.1, 132.5, 131.6, 129.5, 129.0, 128.2, 126.3, 124.8, 122.7, 121.6, 119.3, 107.2, 105.6, 42.3. MS (ESI) <i>m</i>/<i>z</i> 421.1 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-((2-((4-((((Vinyloxy)carbonyl)amino)methyl)phenyl)amino)imidazo[1,2-<i>a</i>][1,3,5]-triazin-4-yl)amino)benzoate (<b>18a</b>) and Methyl 2-((4-((4-((((Vinyloxy)-carbonyl)amino)methyl)phenyl)amino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-yl)amino)benzoate (<b>18b</b>)</h4><div class="NLM_p last">White solid, mp 174 °C, 61 mg (52%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.45 (s, 1H), 9.30 (s, 1H), 8.92 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 8.05–7.95 (m, 4H), 7.55 (d, <i>J</i> = 2.0 Hz, 1H), 7.3 (d, <i>J</i> = 8.0 Hz, 2H), 7.03 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.18 (d, <i>J</i> = 8.0 Hz, 2H), 7.06 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.89 (br, 2H), 6.06–5.82 (m, 1H), 5.39–5.12 (m, 2H), 4.53 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.23 (d, <i>J</i> = 6.0 Hz, 2H), 3.87 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.8, 158.6, 154.6, 148.9, 148.3, 141.6, 138.2, 134.9, 134.1, 131.6, 131.5, 131.3, 128.4, 123.2, 122.9, 122.4, 120.2, 117.4, 107.1, 66.0, 52.1, 43.5. MS (ESI) <i>m</i>/<i>z</i> 474.2 [M + 1]<sup>+</sup>. White solid, mp 166 °C, 37 mg (31%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.37 (s, 1H), 9.26 (s, 1H), 8.14 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.81 (d, <i>J</i> = 2.0 Hz, 1H), 7.67–7.54 (m, 2H), 7.42 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.23 (d, <i>J</i> = 8.0, 1.5 Hz, 2H), 7.20 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.03 (d, <i>J</i> = 8.0, 1.5 Hz, 2H), 6.52 (s, 1H), 5.96–5.77 (m, 1H), 5.29–5.10 (m, 2H), 4.63 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.32 (d, <i>J</i> = 6.0 Hz, 2H), 3.90 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.8, 158.6, 155.0, 148.9, 148.8, 141.8, 137.2, 135.4, 134.1, 131.6, 131.5, 131.3, 128.0, 124.1, 122.6, 121.7, 117.4, 107.1, 66.0, 52.1, 43.5. MS (ESI) <i>m</i>/<i>z</i> 474.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(2-Nitrobenzyl)-<i>N</i>-(3,4,5-trimethoxyphenyl)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-amine (<b>25a</b>) and 2-(2-Nitrobenzyl)-<i>N</i>-(3,4,5-trimethoxyphenyl)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-amine (<b>25b</b>)</h4><div class="NLM_p last">Yellow solid, mp 129 °C, 62 mg (57%). <sup>1</sup>H NMR (250 MHz, DMSO) δ 9.48 (s, 1H), 8.23 (dd, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.85 (td, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.74 (dd, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.69 (td, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.43 (d, <i>J</i> = 2.0 Hz, 1H), 7.21 (br, 2H), 4.89 (s, 2H), 3.70 (s, 6H), 3.62 (s, 3H). Gray solid, mp126 °C, 25 mg (22%).<sup>1</sup>H NMR (250 MHz, DMSO) δ 10.11 (s, 1H), 8.11 (d, <i>J</i> = 2.0 Hz, 1H), 8.05 (dd, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.72 (td, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.62 (dd, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.57 (td, <i>J</i> = 7.5 Hz, 1.5 Hz, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.07 (br, 2H), 4.89 (s, 2H), 3.74 (s, 6H), 3.68 (s, 3H).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 2-((2-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-yl)methyl)-benzoate (<b>26a</b>) and Methyl 2-((4-((3,4,5-Trimethoxyphenyl)amino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-yl)methyl)benzoate (<b>26b</b>)</h4><div class="NLM_p last">White solid, mp 162 °C, 62 mg (55%). <sup>1</sup>H NMR (250 MHz, CDCl3): δ 8.15 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.61 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.51 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.43 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.06 (s, 2H), 4.72 (s, 2H), 3.88 (s, 6H), 3.83 (s, 3H), 3.78 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 167.2, 158.2, 155.0, 153.3, 150.3, 134.8, 134.6, 134.1, 134.0, 132.8, 132.3, 131.4, 129.6, 128.1, 107.0, 97.0, 61.0, 56.2, 52.3, 38.5. MS (ESI) <i>m</i>/<i>z</i> 450.2 [M + 1]<sup>+</sup>. White solid, mp 154 °C, 27 mg (24%). <sup>1</sup>H NMR (250 MHz, CDCl3): δ 10.86 (s, 1H), 7.89 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.63 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.62 (d, <i>J</i> = 2 Hz, 1H), 7.54 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.37 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.34 (d, <i>J</i> = 2.0 Hz, 1H), 6.14 (s, 2H), 4.11 (s, 2H), 3.87 (s, 3H), 3.80 (s, 6H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 175.0, 167.3, 165.1, 152.6, 147.5, 138.4, 134.6, 132.9, 132.8, 132.0, 131.9, 130.1, 130.0, 126.7, 106.9, 100.3, 60.0, 55.8, 51.8, 42.9. MS (ESI) <i>m</i>/<i>z</i> 450.2 [M + 1]<sup>+</sup>.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Method for the Synthesis of Compounds <b>12</b>, <b>15</b>, and <b>19</b></h3><div class="NLM_p">A solution of the corresponding compound (<b>11</b>, <b>14</b>, <b>18</b>, and <b>26a</b>, 0.05 mmol, 1 equiv), methylamine (2 M in MeOH, 10 equiv, 0.5 mmol), and CaCl<sub>2</sub> (0.15 mmol, 3equiv) in MeOH was introduced into a 10 mL microwave vial. The mixture was subjected to microwave irradiation for 20 min at 80 °C using irradiation power of 100 W. The solvent was evaporated under vacuum and the crude residue was purified by silica gel column chromatography eluted with mixture of dichloromethane and methanol.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-Methyl-2-[2-(3,4,5-trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]benzamide (<b>12a</b>)</h4><div class="NLM_p last">White solid, mp 186 °C, 18 mg (82%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.37 (s, 1H), 9.98 (br, 1H), 8.86 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 8.71 (q, <i>J</i> = 4.5 Hz, 1H), 8.03 (d, <i>J</i> = 2.0 Hz, 1H), 7.72 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.5 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.35 (d, <i>J</i> = 2.0 Hz, 1H), 7.27 (br, 2H), 7.05 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.88 (s, 6H), 3.71 (s, 3H), 2.81 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.2, 156.5, 152.3, 151.4, 147.5, 143.6, 133.9, 132.3, 130.5, 129.2, 119.3, 118.9, 112.7, 106.9, 101.0, 60.1, 55.5, 26.2. MS (ESI) <i>m</i>/<i>z</i> 450.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-Methyl-2-[4-(3,4,5-trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]benzamide (<b>12b</b>)</h4><div class="NLM_p last">White solid, mp 172 °C, 17 mg (78%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.32 (s, 1H), 8.87 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 8.71 (q, <i>J</i> = 4.5 Hz, 1H), 7.96 (d, <i>J</i> = 1.5 Hz, 1H), 7.71 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.49 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.33 (d, <i>J</i> = 1.5 Hz, 1H), 7.24 (br, 2H), 7.04 (t, <i>J</i> = 7.5, 1.5 Hz, 1H), 3.88 (s, 6H), 3.71 (s, 3H), 2.81 (d, <i>J</i> = 4.7 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.4, 156.6, 156.7, 155.0, 148.9, 148.8, 141.1, 134.5, 134.4, 132.6, 131.6, 129.7, 126.3, 124.2, 122.2, 107.1, 102.8, 102.9, 60.6, 56.8, 56.9, 26.2. MS (ESI) <i>m</i>/<i>z</i> 450.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-[2-(2-Methoxy-4-morpholinophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino]-<i>N</i>-methylbenzamide (<b>15a</b>)</h4><div class="NLM_p last">White solid, mp 192 °C, 16 mg (68%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.72 (s, 1H), 8.66 (d, <i>J</i> = 8.0 Hz, 1H), 8.61 (q, <i>J</i> = 4.5 Hz, 1H), 7.89 (s, 1H), 7.86 (d, <i>J</i> = 2.0 Hz, 1H), 7.62 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.37 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.29 (s, 1H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 6.99 (td, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.84–3.73 (m, 7H), 3.24 (m, 4H), 2.76 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 157.3, 155.0, 148.9, 148.3, 147.1, 140.6, 132.2, 131.6, 127.6, 126.9, 124.6, 124.3, 123.6, 122.6, 115.5, 107.1, 102.3, 65.6, 56.8, 47.3, 26.2. MS (ESI) <i>m</i>/<i>z</i> 475.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-[4-(2-Methoxy-4-morpholinophenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino]-<i>N</i>-methylbenzamide (<b>15b</b>)</h4><div class="NLM_p last">White solid, mp 187 °C, 17 mg (72%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.06 (s, 1H), 8.76 (q, <i>J</i> = 4.5 Hz, 1H), 8.40 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.72 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.14 (d, <i>J</i> = 2.0 Hz, 1H), 7.10 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.07 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.02 (d, <i>J</i> = 2.0 Hz, 1H), 6.89 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.60 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.05 (s, 1H), 3.86–3.70 (m, 7H), 3.42–3.20 (m, 4H), 2.86 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 156.8, 155.0, 148.9, 148.3, 146.9, 141.1, 132.6, 131.6, 129.7, 126.3, 124.2, 123.9, 123.6, 122.2, 115.1, 107.1, 101.8, 65.6, 56.8. MS (ESI) <i>m</i>/<i>z</i> 475.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Vinyl 4-((4-((2-(Methylcarbamoyl)phenyl)amino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-yl)amino)benzylcarbamate (<b>19a</b>)</h4><div class="NLM_p last">White solid, mp 187 °C, 12 mg (52%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.24 (s, 1H), 9.85 (q, <i>J</i> = 4.5 Hz, 1H), 7.82 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.79 (d, <i>J</i> = 2.0 Hz, 2H), 7.67 (d, <i>J</i> = 2.0 Hz, 2H), 7.47 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.26 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.03 (d, <i>J</i> = 8.0 Hz, 1H), 6,97 (s, 1H), 5.99–5.82 (m, 1H), 5.46–5.16 (m, 2H), 4.73 (d, <i>J</i> = 6.0 Hz, 2H), 4.50 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 2.82 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 158.6, 154.6, 148.9, 148.3, 140.6, 138.2, 134.9, 134.1, 132.2, 131.6, 128.4, 127.6, 126.9, 124.6, 122.6, 120.2, 117.4, 107.1, 66.0, 43.5, 26.2. MS (ESI) <i>m</i>/<i>z</i> 473.5 [M + 1]<sup>+</sup>.</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Vinyl 4-((2-((2-(Methylcarbamoyl)phenyl)amino)-imidazo[1,2-<i>a</i>][1,3,5]triazin-4-yl)amino)benzylcarbamate (<b>19b</b>)</h4><div class="NLM_p last">White solid, mp 179 °C, 11 mg (48%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.76 (q, <i>J</i> = 4.5 Hz, 1H), 8.58 (s, 1H), 7.76 (dd, <i>J</i> = 7.7, 1.4 Hz, 2H), 7.65 (d, <i>J</i> = 7.5 Hz, 2H), 7.34 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 7.28 (d, <i>J</i> = 7.5 Hz, 2H), 7.13 (d, <i>J</i> = 2.2 Hz, 1H), 7.08 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.07 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.01 (d, <i>J</i> = 7.5 Hz, 2H), 6.71 (s, 1H), 6.04 (s, 1H), 5.96–579 (m, 1H), 5.23–5.12 (m, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 2H), 4.33 (s, 2H), 2.79 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 158.6, 155.0, 148.9, 148.8, 141.1, 137.2, 135.4, 134.1, 132.6, 131.6, 129.7, 128.0, 126.3, 124.2, 122.2, 121.7, 117.4, 107.1, 66.0, 43.5, 26.2. MS (ESI) <i>m</i>/<i>z</i> 473.2 [M + 1]<sup>+</sup>.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Method for the Synthesis of Compounds <b>20</b> and <b>21</b></h3><div class="NLM_p">A solution of the corresponding compound (<b>18</b> or <b>19</b>, 0.2 mmol, 1 equiv) with morpholine (1 mmol, 5 equiv), triphenylphosphine (0.04 mmol, 0.2 equiv), and tetrakis(triphenylphosphine)palladium(0) (0.01 mmol, 0.05 equiv) in dichloromethane was stirred at room temperature for 4 h. The solvent was evaporated under vacuum, and the crude residue was purified by silica gel column chromatography eluted with a mixture of dichloromethane and methanol.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 2-{2-[4-(Aminomethyl)phenylamino]imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino}-benzoate (<b>20a</b>)</h4><div class="NLM_p last">White solid, mp 186 °C, 63 mg (82%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.25 (s, 1H), 10.12 (s, 1H), 7.90 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.65 (d, <i>J</i> = 2.0 Hz, 1H), 7.45 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 7.22 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.16 (d, <i>J</i> = 2.0 Hz, 1H), 7.10 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.00 (d, <i>J</i> = 8.0 Hz, 2H), 5.92 (br, 2H), 4.02 (s, 2H), 3.80 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.8, 154.6, 148.9, 148.3, 141.6, 137.0, 136.2, 131.6, 131.5, 131.3, 127.4, 123.2, 122.9, 122.4, 120.2, 107.1, 52.1, 46.2. MS (ESI) <i>m</i>/<i>z</i> 390.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 2-{4-[4-(Aminomethyl)phenylamino]imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino}benzoate (<b>20b</b>)</h4><div class="NLM_p last">White solid, mp 164 °C, 60 mg (77%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.06 (s, 1H), 10.65 (s, 1H), 7.82 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.70 (d, <i>J</i> = 2.0 Hz, 1H), 7.52 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 7.08 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.05 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 2H), 5.75 (br, 2H), 4.00 (s, 2H), 3.88 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 168.8, 155.0, 148.9, 148.8, 141.8, 136.5, 136.2, 131.6, 131.5, 131.3, 127.2, 124.1, 122.6, 121.7, 107.1, 52.1, 46.2. MS (ESI) <i>m</i>/<i>z</i> 390.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-{2-[4-(Aminomethyl)phenylamino]imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylamino}-<i>N</i>-methylbenzamide (<b>21a</b>)</h4><div class="NLM_p last">White solid, mp 171 °C, 63 mg (81%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.60 (s, 1H), 10.05 (s, 1H), 8.82 (q, <i>J</i> = 4.5 Hz, 1H), 7.87 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.60 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.32 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.20 (d, <i>J</i> = 8.0 Hz, 2H), 7.18 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.12 (d, <i>J</i> = 2.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 2H), 5.70 (br, 2H), 3.95 (s, 2H), 2.82 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 154.6, 148.9, 148.3, 140.6, 137.0, 136.2, 132.2, 131.6, 127.6, 127.4, 126.9, 124.6, 122.6, 120.2, 107.1, 46.2, 26.2. MS (ESI) <i>m</i>/<i>z</i> 389.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-{4-[4-(Aminomethyl)phenylamino]imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylamino}-<i>N</i>-methylbenzamide (<b>21b</b>)</h4><div class="NLM_p last">White solid, mp 154 °C, 261.1 mg (82.6%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 12.06 (s, 1H), 11.22 (s, 1H), 8.50 (q, <i>J</i> = 4.5 Hz, 1H), 7.78 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.77 (d, <i>J</i> = 2.0 Hz, 1H), 7.52 (d, <i>J</i> = 2.0 Hz, 1H), 7.41(td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 2H), 7.14 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.09 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.88 (d, <i>J</i> = 8.0 Hz, 2H), 5.87 (br, 2H), 3.90 (s, 2H), 2.77 (d, <i>J</i> = 4.5 Hz, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 171.5, 155.0, 148.9, 148.8, 141.1, 136.5, 136.2, 132.6, 131.6, 129.7, 127.2, 126.3, 124.2, 122.2, 121.7, 107.1, 46.2. MS (ESI) <i>m</i>/<i>z</i> 389.2 [M + 1]<sup>+</sup>.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Method for the Synthesis of Compounds <b>23</b> and <b>24</b></h3><div class="NLM_p">A mixture of sodium methoxide (1.5 mmol, 1.5 equiv) prepared from Na and methanol, 3,4,5-trimethoxyphenylbiguanide chlorohydrate (1 mmol, 1 equiv), and methyl 2-(2-nitrophenyl)acetate or methyl 2-(2-methoxy-2-oxoethyl)benzoate (3 mmol, 3 equiv) in dry THF (3 mL) was introduced into a 50 mL round-bottomed flask equipped with a condenser and a magnetic stirring bar. The flask was placed in the microwave cavity and exposed to microwave irradiation for 20 min at 70 °C using irradiation power of 100 W. On cooling to room temperature, the mixture was evaporated under vacuum, and the residue was subjected to flash chromatography (silica gel, 5% methanol/CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product as a white solid.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-(2-Nitrobenzyl)-<i>N</i>2-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine (<b>23</b>)</h4><div class="NLM_p last">White solid, mp 157 °C, 197 mg (48%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.20 (s, 1H), 8.04 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.71 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.59 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.55 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.12 (br, 2H), 6.99 (br, 2H), 4.22 (s, 2H), 3.70 (s, 6H), 3.59 (s, 3H).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 2-((4-Amino-6-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-yl)methyl)-benzoate (<b>24</b>)</h4><div class="NLM_p last">White solid, mp 168 °C, 234 mg (55%). <sup>1</sup>H NMR (250 MHz, CDCl3): δ 7.97 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.50 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.36 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.35 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.79 (s, 2H), 4.35 (s, 2H), 3.82 (s, 6H), 3.79 (s, 3H).</div></div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-Methyl-2-((2-(3,4,5-trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-4-yl)methyl)benzamide (<b>27a</b>)</h3><div class="NLM_p last">A solution of methylamine (2.5 M in hexane, 0.25 mmol, 1 equiv) and NH<sub>4</sub>OH (28% in H<sub>2</sub>O, 0.25 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> was stirred for 15 min under argon at room temperature, and compound <b>26a</b> (0.25 mmol, 1 equiv) was added. The solvent was evapored under vacuum, the crude residue was extracted with dichloromethane, and the organic phase was purified by silica gel column chromatography eluted with a mixture of dichloromethane and methanol. White solid, mp 152 °C, 72 mg (64%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.52 (s, 1H), 8.29 (q, <i>J</i> = 4.5 Hz, 1H), 7.79 (d, <i>J</i> = 1.5 Hz, 1H), 7.56 (d, <i>J</i> = 7.0 Hz, 1H), 7.50–7.39 (m, 3H), 7.34 (d, <i>J</i> = 1.5 Hz, 1H), 7.26 (s, 2H), 4.60 (s, 2H), 3.74 (s, 6H), 3.63 (s, 3H), 2.63 (d, <i>J</i> = 4.5 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 449.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-(2-Aminobenzyl)-<i>N</i>-(3,4,5-trimethoxyphenyl)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-amine (<b>28a</b>)</h3><div class="NLM_p last">A solution of compound <b>25a</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (0.2 mmol, 1 equiv) in THF (5 mL), water (2.5 mL), and EtOH (5 mL) with sodium dithionite (0.4 mmol, 2 equiv) and sodium bicarbonate (0.4 mmol, 2 equiv) was stirred at room temperature for 24 h. The mixture was evapored under vacuum, and the crude residue was purified by silica gel column chromatography and eluted with a mixture of dichloromethane and methanol to give 44 mg (54%), light-yellow solid, mp 234 °C. <sup>1</sup>H NMR (250 MHz, DMSO): δ 12.80 (s, 1H), 9.59 (s, 1H), 7.18 (d, <i>J</i> = 2.0 Hz, 1H), 7.01 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.96 (d, <i>J</i> = 1.5 Hz, 1H), 6.78–6.66 (m, 4H), 6.52 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 5.98 (t, <i>J</i> = 5 Hz, 2H), 3.76 (s, 6H), 3.63 (s, 3H), 3.22–2.94 (m, 2H).</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(2-Aminobenzyl)-<i>N</i>-(3,4,5-trimethoxyphenyl)-3,4-dihydroimidazo[1,2-<i>a</i>][1,3,5]triazin-2-amine (<b>29a</b>)</h3><div class="NLM_p last">To a solution of compound <b>25a</b> (0.2 mmol, 1 equiv) in methanol (10 mL), 10% platinum oxide (8 mg) is added under a nitrogen atmosphere. The reaction vessel is charged with hydrogen and evacuated three times until the reaction is under a hydrogen atmosphere. The reaction is stirred overnight. The reaction mixture is filtered through a pad of Celite and washed with methanol. The filtrate is concentrated to a small volume and purified by flash chromatography to give 78 mg (96%), light-yellow solid, mp 260 °C. <sup>1</sup>H NMR (250 MHz, DMSO): δ 9.75 (s, 1H), 7.67 (d, <i>J</i> = 2.0 Hz, 1H), 7.51 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.32 (s, 2H), 7.30 (s, 2H), 7.27 (d, <i>J</i> = 2.0 Hz, 1H), 7.13 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.04 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.82 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 4.41 (s, 2H), 3.76 (s, 6H), 3.64 (s, 3H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> General Method for the Synthesis of Compounds <b>30a</b> and <b>31a</b></h3><div class="NLM_p">A solution of the corresponding compound (<b>28a</b> or <b>29a</b>, 0.2 mmol, 1 equiv) in pyridine (2 mL) with acetic anhydride (0.4 mmol, 2 equiv) was stirred at 50 °C for 5 h. The solvent was evapored under vacuum, and the crude residue was purified by silica gel column chromatography eluted with a mixture of dichloromethane and methanol.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-{2-[4-(3,4,5-Trimethoxyphenylamino)imidazo[1,2-<i>a</i>][1,3,5]triazin-2-ylmethyl]phenyl}methanesulfonamide (<b>30a</b>)</h4><div class="NLM_p last">Light yellow solid, mp 204 °C, 76 mg (79%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 11.54 (br, 1H), 9.01 (s, 1H), 8.87 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 8.03 (d, <i>J</i> = 2.0 Hz, 1H), 7.37 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.36 (d, <i>J</i> = 2.0 Hz, 1H), 7.28 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.26 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.16 (s, 2H), 4.30 (s, 2H), 3.68 (s, 9H), 2.97 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 41.0, 56.7, 56.7, 60.5, 101.5, 101.5, 127.8, 130.1, 130.7, 134.3, 134.8, 135.2, 136.3, 148.9, 157.5, 157.5, 161.3, 165.9, 169.6. MS (ESI) <i>m</i>/<i>z</i> 485.2 [M + 1]<sup>+</sup>.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-{2-[2-(3,4,5-Trimethoxyphenylamino)-3,4-dihydro-imidazo[1,2-<i>a</i>][1,3,5]triazin-4-ylmethyl]phenyl}acetamide (<b>31a</b>)</h4><div class="NLM_p last">Yellow solid, mp 187 °C, 60 mg (62%). <sup>1</sup>H NMR (250 MHz, DMSO): δ 10.27 (s, 1H), 9.70 (s, 1H), 7.72 (d, <i>J</i> = 2.0 Hz, 1H), 7.54 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.34 (s, 2H), 7.32 (d, <i>J</i> = 2.0 Hz, 1H), 7.10 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.04 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 6.80 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 4.38 (s, 2H), 3.76 (s, 6H), 3.61 (s, 3H), 3.08 (s, 3H). <sup>13</sup>C NMR (500 MHz, DMSO): δ 161.0, 156.7, 152.5, 139.7, 134.5, 134.2, 132.0, 131.7, 131.2, 126.8, 125.2, 121.3, 110.9, 101.5, 101.0, 61.3, 56.9, 56.6. 42.3, 36.3. MS (ESI) <i>m</i>/<i>z</i> 487.2 [M + 1]<sup>+</sup>.</div></div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Ligand Docking</h3><div class="NLM_p last">Compounds <b>19a</b> and <b>19b</b> were docked into the apo-FAK inactive conformation (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4c7t">4c7t</a>), which is similar to the TAE-226 bound conformation with the “DFG motif” adopting a helical conformation. The kinase receptor was kept rigid, while the flexible ligands were positioned in the binding pocket according to the PHM16 location. A standard protocol using Autodock 4.2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was carried out. In brief, the protein structure was screened within a 50 × 50 × 50 Å<sup>3</sup> cube centered at the “DFG motif” applying a space grid of 0.375 Å. The lowest energy and most populated clusters were selected after 100 cycles of running a Lamarckian genetic algorithm with a population size of 150. A maximum of 2.5 million energy evaluations was applied, and results were clustered using a tolerance of 2.0 Å.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> In Vitro Kinase Assay</h3><div class="NLM_p last">Ten microliters of assay mixture containing 100 nM FAK substrate ULight-poly GT, 0.1 nM FAK, 25 μM ATP, and 1 μL of compounds at desired concentrations in kinase buffer (50 mM Tris HCl, 1 mM EGTA, 10 mM MgCl<sub>2</sub>, 2 mM DTT, 0.01% Tween 20, pH 7.4) was added into a 384-well plate. After incubation at 30 °C for 1.6 h, the kinase reaction was stopped by the addition of 5 μL of 40 mM EDTA in LANCE detection buffer 10× (Perkin Elmer) for 5 min and then 5 μL of the Eu-labeled antibody, 8 nM in detection buffer. The plate was incubated at 30 °C for 1 h, and the TR-FRET signal was detected with an Envision plate reader. For each compound, the IC<sub>50</sub> value was determined from a sigmoid dose–response curve using Graph-Pad Prism (GraphPad Software, San Diego, CA, USA).</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> FACE FAK ELISA Assay</h3><div class="NLM_p last">Cells (U-87MG, HCT-116, MDA-MB-231, and PC-3) were cultured in 96-well plates at 3 × 10<sup>3</sup> cells per well and treated with the compounds at different concentrations. Following treatment, the cells were fixed using 4% formaldehyde in PBS. Each well was then incubated with a primary antibody that recognizes either phosphorylated FAK or total FAK as suggested by the manufacturer. The phospho-FAK antibody recognizes FAK only when it is phosphorylated at Tyr397. The total-FAK antibody recognizes FAK regardless of its phosphorylation state. Subsequent incubation with secondary HRP-conjugated antibody and developing solution provided an easily quantified colorimetric response at 450 nm. The relative cell number in each well is then determined using the provided Crystal Violet solution and quantified at 595 nm. The levels of FAK phosphorylation were normalized by both the levels of total FAK protein and total cell number in each well.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Cell Culture and Reagents</h3><div class="NLM_p last">Human glioma U-87MG (ATCC HTB-14), colorectal carcinoma HCT-116 (ATCC CCL-247), breast adenocarcinoma MDA-MB-231 (ATCC CRM-HTB-26), and prostate adenocarcinoma PC-3 (ATCC CRL-1435) were purchased from American Type Culture Collection (ATCC) and cultured at 37 °C in a 5% CO<sub>2</sub> humidified incubator and maintained in DMEM supplemented with 10% fetal bovine serum and 5% penicillin–streptomycin.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Cell Viability Assay</h3><div class="NLM_p last">Cell viability was determined in 96-well plates by using the 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2<i>H</i>-5-tetrazolio]-1,3-benzene disulfonate (WST-1) (Roche Diagnostics, Penzberg, Germany). The exponentially growing cells were seeded at 5 × 10<sup>3</sup> cells per well in 96-well plates and incubated overnight. The medium was then removed, and the cells were treated for 48 h with 200 μL of medium containing various concentrations of different compounds prepared in DMSO. Then, WST-1 was added to each well, and the cells were further incubated for 2 h. The optical density was analyzed with a microplate reader (Bio-Rad) at 450 nm to determine the cell viability; the reference wavelength was 620 nm. Data were calculated as the ratio of the values obtained for the treated cells to those for the controls (DMSO). The results are expressed as the mean of three independent experiments with three determinations per tested concentration per experiment. For each compound, the IC<sub>50</sub> values were calculated using nonlinear regression model (logarithmic inhibitor vs normalized response-variable slope) in Graph-Pad Prism (GraphPad Software, San Diego, CA, USA).</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Colony Assays</h3><div class="NLM_p last">Cancer cell lines were seeded in 6-well plates at a density of 250 cells per well for HCT-116 and 300 cells per well for U-87MG, MDA-MB-231, and PC-3 and then incubated overnight. The medium was then removed before treatment at various concentrations of different compound for 2 weeks. The colonies were washed with PBS and fixed with 4% paraformaldehyde solution at room temperature for 30 min, stained with 0.1% crystal violet for 10 min, and finally, washed with water. Positive colony formation (more than 50 cells/colony) was counted, and colony formation rate was calculated. For each compound, the IC<sub>50</sub> values were calculated using nonlinear regression model (logarithmic inhibitor vs normalized response-variable slope) in Graph-Pad Prism (GraphPad Software, San Diego, CA, USA).</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Apoptosis Determination</h3><div class="NLM_p last">Cell apoptosis was evaluated on U-87MG and HCT-116 cells using annexin V-PE (BD Pharmingen) in conjunction with the vital dye 7-amino-actinomycin D (7-AAD) to differentiate early apoptosis (annexin V<sup>+</sup> 7-AAD<sup>–</sup>) from late apoptosis/necrosis (annexin V<sup>+</sup> 7-AAD<sup>+</sup>). The cells were seeded in 24-well plates at 5 × 10<sup>4</sup> cells per well and incubated overnight before treatment for 48 h. The treated cells were collected and incubated in annexin V binding buffer with annexin V-PE and 7-AAD for 30 min at room temperature. The cells were then washed, resuspended in annexin V binding buffer, and analyzed by flow cytometry immediately on a BD LSR II (Becton Dickinson, San Jose, CA). Results were analyzed using FlowJo software (Treestar, Ashland, OR).</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Flow Cytometer Analysis of Cell Cycle</h3><div class="NLM_p last">Cell cycle was analysized on U-87MG or HCT-116 cells using propidium iodide. The cells were seeded in 24-well plates at 5 × 10<sup>4</sup> cells per well and incubated overnight before treatment for 48 h. The treated cells were collected, resuspended, and incubated for 15 min at 37 °C with PI/triton buffer. Cells were finally acquired by flow cytometer, and cell cycle was analyzed using Dean–Jett–Fox methods on a FACS calibur (Becton Dickinson, San Jose, CA).</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Cell Adhesion Assay</h3><div class="NLM_p last">Cells cultured in media containing 10% serum were collected by trypsinization and diluted to a concentration of 100 000 cells/mL in media containing 10% serum and then treated for 30 min with DMSO and each of compounds <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> at various concentrations. Next, 200 μL of the treated cells with inhibitor (20 000 cells) was added to a 96-well plate and incubated for 1 h to allow attachment. Cells were fixed with paraformaldehyde 4% for 30 min and then stained by Toluidine Blue 0.1% in PFA 4% for 30 min. After washing with PBS, the optical density was analyzed with a microplate reader (Bio-Rad) at 620 nm to determine the attached cells.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> xCELLigence Real-Time Cell Analysis (RTCA) of Migration and Invasion</h3><div class="NLM_p">Cell migration and invasion experiments were carried out using the xCELLigence RTCA DP instrument (Roche Diagnostics GmbH, Mannheim, Germany), which was placed in a humidified incubator at 37 °C and 5% CO<sub>2</sub>. The experiments were performed using modified 16-well plates (CIM-16, Roche Diagnostics GmbH, Mannheim, Germany) with each well consisting of an upper and a lower chamber separated by a microporous membrane. Microelectrodes were attached to the underside of the membrane for impedance-based detection of migrated cells.</div><div class="NLM_p">Prior to each experiment, U-87MG cells were cultured in 24-well plates at 5 × 10<sup>4</sup> cells per well, incubated overnight, and then exposed to different compounds or DMSO in 3% FBS for 24 h. Initially, 165 and 15 μL of media were added to the lower and upper chambers, respectively, and the CIM-16 plate was locked in the RTCA DP device at 37 °C and 5% CO<sub>2</sub> during 60 min to obtain equilibrium according to the manufacturer’s guidelines. After this incubation period, a measurement step was performed as a background signal, generated by cell-free media. To initiate an experiment, cells were harvested, resuspended in 3% FBS-medium, counted, and seeded in the upper chamber applying 4 × 10<sup>4</sup> cells in 100 μL. After cell addition, CIM-16 plates were incubated during 30 min at room temperature to allow the cells to settle onto the membrane according to the manufacturer’s guidelines, they were locked in the RTCA DP device in the incubator, and the impedance value of each well was automatically monitored by the xCELLigence system and expressed as a cell index value (CI). Lower chambers contained media with 10% FBS in order to assess chemotactic migration when exposed to FBS. Each condition was performed in duplicate with a programmed signal detection schedule of every 5 min during 10 h of incubation.</div><div class="NLM_p last">An identical protocol was performed to follow the invasion, with the application of a layer of collagen on the upper side of the membranes and dynamic process follow-up during 12 hours. All data have been recorded by the supplied RTCA software (vs 1.2.1).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/jm500784e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">In vitro profile of compound <b>19a</b> against a panel of ten kinases, purity data of tested compounds (HPLC), apoptosis in U-87MG and HCT-116 cells assessed by annexin V/7-AAD double staining, cell cycle distribution studied by flow-cytometry, effects of TAE-226 on the cell attachment in U-87MG cell lines, effects of compounds <b>TAE-226</b>, <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> on the migration/invasion in U-87MG cell lines, using Boyden chamber assays, and experimental details. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500784e/suppl_file/jm500784e_si_001.pdf">jm500784e_si_001.pdf (2.92 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500784e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huixiong Chen</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span>; 
    <span class="hlFld-Affiliation affiliation">School of Chemical Engineering and Light
Industry, Guangdong University of Technology, no. 100 Waihuan Xi road, Education
Mega Center, Guangzhou, 510006, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#177f627e6f7e78797039747f7279576776657e64737264747665637264397165"><span class="__cf_email__" data-cfemail="49213c20312026272e672a212c270939283b203a2d2c3a2a283b3d2c3a672f3b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Dao</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikaia Smith</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Tomkiewicz-Raulet</span> - <span class="hlFld-Affiliation affiliation">Toxicologie, Pharmacologie et Signalisation Cellulaire, INSERM, UMR
S 1124, Université Paris Descartes,
PRES Sorbonne Paris Cité, UFR Biomédicale, 45 rue des Saints-Pères, 75270 Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Expédite Yen-Pon</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Camacho-Artacho</span> - <span class="hlFld-Affiliation affiliation">Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernández Almagro
3, Madrid 28029, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Lietha</span> - <span class="hlFld-Affiliation affiliation">Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernández Almagro
3, Madrid 28029, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Phillipe Herbeuval</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Coumoul</span> - <span class="hlFld-Affiliation affiliation">Toxicologie, Pharmacologie et Signalisation Cellulaire, INSERM, UMR
S 1124, Université Paris Descartes,
PRES Sorbonne Paris Cité, UFR Biomédicale, 45 rue des Saints-Pères, 75270 Cedex 06 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christiane Garbay</span> - <span class="hlFld-Affiliation affiliation">Chemistry & Biology, Nucleo(s)tides
& Immunology for Therapy (CBNIT), CNRS UMR8601, Université Paris Descartes, PRES Sorbonne Paris Cité,
UFR Biomédicale, 45 rue des Saints-Pères, 75270
Cedex 06 Paris, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1763e4219-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Agence Nationale Recherche (Grant RNA-NTO5-2_42590) and Visiotac Pharma.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations</h2><tr><td class="NLM_term">FAK</td><td class="NLM_def"><p class="first last">focal adhesion kinase</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cell</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">aspartate-phenylalanine-glycine</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">NOE</td><td class="NLM_def"><p class="first last">nuclear Overhauser effect</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">Pyk2</td><td class="NLM_def"><p class="first last">proline-rich tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">FGFR2</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor 2</p></td></tr><tr><td class="NLM_term">FLT1/VEGFR1</td><td class="NLM_def"><p class="first last">Fms-related tyrosine kinase 1/vascular endothelial growth factor receptor 1</p></td></tr><tr><td class="NLM_term">IGF1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor 1 receptor</p></td></tr><tr><td class="NLM_term">KDR/VEGFR2</td><td class="NLM_def"><p class="first last">kinase insert domain receptor/vascular endothelial growth factor receptor 2</p></td></tr><tr><td class="NLM_term">PDGFRA</td><td class="NLM_def"><p class="first last">α-type platelet-derived growth factor receptor</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol tetraacetic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochwald, S. N.</span><span> </span><span class="NLM_article-title">The Role of FAK in Tumor Metabolism and Therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.pharmthera.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=24333503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2014&pages=154-163&author=J.+Zhangauthor=S.+N.+Hochwald&title=The+Role+of+FAK+in+Tumor+Metabolism+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of FAK in tumor metabolism and therapy</span></div><div class="casAuthors">Zhang, Jianliang; Hochwald, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-163</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Focal adhesion kinase (FAK) plays a vital role in tumor cell proliferation, survival and migration.  Altered metabolic pathways fuel rapid tumor growth by accelerating glucose, lipid and glutamine processing.  Besides the mitogenic effects of FAK, evidence is accumulating supporting the assocn. between hyper-activated FAK and aberrant metab. in tumorigenesis.  FAK can promote glucose consumption, lipogenesis, and glutamine dependency to promote cancer cell proliferation, motility, and survival.  Clin. studies demonstrate that FAK-related alterations of tumor metab. are assocd. with increased risk of developing solid tumors.  Since FAK contributes to the malignant phenotype, small mol. inhibition of FAK-stimulated bioenergetic and biosynthetic processes can provide a novel approach for therapeutic intervention in tumor growth and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcqgT2ywkqbVg90H21EOLACvtfcHk0lgGZDRJbHFc2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFyiuw%253D%253D&md5=9cb0cd034003cf29b4141e9572e02f6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHochwald%26aufirst%3DS.%2BN.%26atitle%3DThe%2520Role%2520of%2520FAK%2520in%2520Tumor%2520Metabolism%2520and%2520Therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D142%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cance, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurenova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlowe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubovskaya, V.</span><span> </span><span class="NLM_article-title">Disrupting the Scaffold to Improve Focal Adhesion Kinase-Targeted Cancer Therapeutics</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">pe10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1126%2Fscisignal.2004021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=23532331" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=W.+G.+Canceauthor=E.+Kurenovaauthor=T.+Marloweauthor=V.+Golubovskaya&title=Disrupting+the+Scaffold+to+Improve+Focal+Adhesion+Kinase-Targeted+Cancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2004021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2004021%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26aulast%3DKurenova%26aufirst%3DE.%26aulast%3DMarlowe%26aufirst%3DT.%26aulast%3DGolubovskaya%26aufirst%3DV.%26atitle%3DDisrupting%2520the%2520Scaffold%2520to%2520Improve%2520Focal%2520Adhesion%2520Kinase-Targeted%2520Cancer%2520Therapeutics%26jtitle%3DSci.%2520Signaling%26date%3D2013%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lechertier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodivala-Dilke, K.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase and Tumour Angiogenesis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fpath.3018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21984450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2012&pages=404-412&author=T.+Lechertierauthor=K.+Hodivala-Dilke&title=Focal+Adhesion+Kinase+and+Tumour+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase and tumor angiogenesis</span></div><div class="casAuthors">Lechertier, Tanguy; Hodivala-Dilke, Kairbaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-412</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for tumor development.  It is initiated and regulated by growth factors via their surface receptors, which activate several intracellular signalling pathways in endothelial cells.  Cell adhesion mols., such as integrins, also regulate angiogenesis.  Despite these facts, inhibitors of endothelial cell growth factor receptors or integrins have not been as effective as initially hoped in the long-term inhibition of angiogenesis in cancer patients.  Signalling downstream of growth factor receptors and integrins converge on the ubiquitously expressed non-receptor tyrosine kinase focal adhesion kinase (FAK).  FAK is involved in endothelial cell proliferation, migration and survival, is up-regulated in many cancers and has recently been shown to control tumor angiogenesis.  Indeed, FAK inhibitors are presently being developed for the treatment of cancer.  However, recent studies have indicated the complexities of understanding the precise role for FAK in angiogenesis.  Here we have summarized some of the key features of FAK, addressed some of the apparently contradictory roles of this mol. in angiogenesis and provided some perspectives for future studies.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgXcP02UjgLVg90H21EOLACvtfcHk0lgO3LUEebIQ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsb3J&md5=605e7ae8bd660cfc04792e904729addf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpath.3018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.3018%26sid%3Dliteratum%253Aachs%26aulast%3DLechertier%26aufirst%3DT.%26aulast%3DHodivala-Dilke%26aufirst%3DK.%26atitle%3DFocal%2520Adhesion%2520Kinase%2520and%2520Tumour%2520Angiogenesis%26jtitle%3DJ.%2520Pathol.%26date%3D2012%26volume%3D226%26spage%3D404%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ma, W. W.</span><span> </span><span class="NLM_article-title">Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.2174%2F187152011796817628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21787276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BC387kt12mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=638-642&author=W.+W.+Ma&title=Development+of+Focal+Adhesion+Kinase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of focal adhesion kinase inhibitors in cancer therapy</span></div><div class="casAuthors">Ma Wen Wee</div><div class="citationInfo"><span class="NLM_cas:title">Anti-cancer agents in medicinal chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">638-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase implicated in cancer progression, and plays a vital role in integrating environmental signals from growth factors, extracellular matrix and mechanical forces.  As a scaffolding protein, FAK interacts and regulates the activity of many signaling kinases including Src, VEGFR-3, p53, PI3k and IGF-1R.  In turn, FAK activity is modulated by a complex network of regulators that presents a number of therapeutic approaches to targeting FAK in cancer therapy.  The ATP competitive inhibitors binds directly to FAK kinase domain to abrogate multiple downstream signaling pathways, and this class of agents lead the way in FAK inhibitor clinical development.  CFAK-C4 and Y15 represents a novel class of non-ATP dependant, allosteric inhibitors that interrupt protein-protein interactions to achieve anti-cancer effects.  The optimal approach to targeting FAK for cancer therapy is currently under investigation.  Preliminary efficacy signals from early-phase trials suggest that FAK inhibitors may be best used in combination therapy.  In addition to determining dosing schedules that is tolerable by patients, future clinical studies should include mechanistic-based pharmacodynamic studies to determine the biological active dose and explore potential predictive markers.  In summary, a rich pipeline of FAK-targeting agents is entering clinical development and has the potential of improving the lives of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmsy2s-WfhkMK3uFsUIZtkfW6udTcc2eZ34y-6B39Phbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387kt12mtw%253D%253D&md5=76a0b408a10e6650305a1fd27dff0799</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F187152011796817628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152011796817628%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26atitle%3DDevelopment%2520of%2520Focal%2520Adhesion%2520Kinase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D638%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">The Direct Effect of Focal Adhesion Kinase (FAK), Dominant-Negative FAK, FAK-CD and FAK siRNA on Gene Expression and Human MCF-7 Breast Cancer Cell Tumorigenesis</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_elocation-id">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&author=V.+M.+Golubovskayaauthor=M.+Zhengauthor=L.+Zhangauthor=J.-L.+Liauthor=W.+G.+Cance&title=The+Direct+Effect+of+Focal+Adhesion+Kinase+%28FAK%29%2C+Dominant-Negative+FAK%2C+FAK-CD+and+FAK+siRNA+on+Gene+Expression+and+Human+MCF-7+Breast+Cancer+Cell+Tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.-L.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Direct%2520Effect%2520of%2520Focal%2520Adhesion%2520Kinase%2520%2528FAK%2529%252C%2520Dominant-Negative%2520FAK%252C%2520FAK-CD%2520and%2520FAK%2520siRNA%2520on%2520Gene%2520Expression%2520and%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cell%2520Tumorigenesis%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturge, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Attenuation of the Expression of the Focal Adhesion Kinase Induces Apoptosis in Tumor Cells</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=9052982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK28XitFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=413-418&author=L.+H.+Xuauthor=L.+V.+Owensauthor=G.+C.+Sturgeauthor=X.+Yangauthor=E.+T.+Liuauthor=R.+J.+Cravenauthor=W.+G.+Cance&title=Attenuation+of+the+Expression+of+the+Focal+Adhesion+Kinase+Induces+Apoptosis+in+Tumor+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span></div><div class="casAuthors">Xu, Li-hui; Owens, Lewis V.; Sturge, Glenn C.; Yang, Xihui; Liu, Edison T.; Craven, Rolf J.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase implicated in integrin-mediated signal transduction pathways, oncogenic transformation by v-src, and the invasion of human tumors.  The overexpression of p125FAK in a variety of human tumors and tumor cell lines in comparison to their non-transformed counterparts suggested that attenuation of p125FaK expression might have an effect on tumor cell proliferation.  In this study, the authors have treated tumor cell lines that expressed high levels of p125FAK with different antisense oligonucleotides to FAK, and have specifically attenuated p125FAK expression.  The cells treated with antisense oligonucleotides not only lost their attachment, but also underwent apoptosis.  Extensive control oligonucleotide expts. suggested that this attenuation was highly FAK specific.  Furthermore, normal human fibroblasts, which did not express high levels of p125FaK, did not lose their attachment or become apoptotic with FAK antisense treatment.  These results suggested that FAK is involved in adhesion-mediated growth in tumor cells and that FAK may be a rational gene-directed target for disrupting tumor cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYz8mKAEF_LVg90H21EOLACvtfcHk0lhfghLt6tJyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFegt78%253D&md5=ea65ebdce50a369ce454259f072a320d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DOwens%26aufirst%3DL.%2BV.%26aulast%3DSturge%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DAttenuation%2520of%2520the%2520Expression%2520of%2520the%2520Focal%2520Adhesion%2520Kinase%2520Induces%2520Apoptosis%2520in%2520Tumor%2520Cells%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1996%26volume%3D7%26spage%3D413%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loftus, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaarde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monia, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">Inhibition of Focal Adhesion Kinase Expression or Activity Disrupts Epidermal Growth Factor-Stimulated Signaling Promoting the Migration of Invasive Human Carcinoma Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7079</span><span class="NLM_x">–</span> <span class="NLM_lpage">7090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7079-7090&author=C.+R.+Hauckauthor=D.+J.+Siegauthor=D.+A.+Hsiaauthor=J.+C.+Loftusauthor=W.+A.+Gaardeauthor=B.+P.+Moniaauthor=D.+D.+Schlaepfer&title=Inhibition+of+Focal+Adhesion+Kinase+Expression+or+Activity+Disrupts+Epidermal+Growth+Factor-Stimulated+Signaling+Promoting+the+Migration+of+Invasive+Human+Carcinoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DSieg%26aufirst%3DD.%2BJ.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DLoftus%26aufirst%3DJ.%2BC.%26aulast%3DGaarde%26aufirst%3DW.%2BA.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DInhibition%2520of%2520Focal%2520Adhesion%2520Kinase%2520Expression%2520or%2520Activity%2520Disrupts%2520Epidermal%2520Growth%2520Factor-Stimulated%2520Signaling%2520Promoting%2520the%2520Migration%2520of%2520Invasive%2520Human%2520Carcinoma%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7079%26epage%3D7090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuckle, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyke, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikkarainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoslahti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">Decreased Focal Adhesion Kinase Suppresses Papilloma Formation during Experimental Mouse Skin Carcinogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8385</span><span class="NLM_x">–</span> <span class="NLM_lpage">8389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8385-8389&author=G.+W.+McLeanauthor=K.+Brownauthor=M.+I.+Arbuckleauthor=A.+W.+Wykeauthor=T.+Pikkarainenauthor=E.+Ruoslahtiauthor=M.+C.+Frame&title=Decreased+Focal+Adhesion+Kinase+Suppresses+Papilloma+Formation+during+Experimental+Mouse+Skin+Carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DArbuckle%26aufirst%3DM.%2BI.%26aulast%3DWyke%26aufirst%3DA.%2BW.%26aulast%3DPikkarainen%26aufirst%3DT.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DDecreased%2520Focal%2520Adhesion%2520Kinase%2520Suppresses%2520Papilloma%2520Formation%2520during%2520Experimental%2520Mouse%2520Skin%2520Carcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8385%26epage%3D8389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Parsons, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack-Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1078-0432.CCR-07-2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=18245520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=627-632&author=J.+T.+Parsonsauthor=J.+Slack-Davisauthor=R.+Tilghmanauthor=W.+G.+Roberts&title=Focal+Adhesion+Kinase%3A+Targeting+Adhesion+Signaling+Pathways+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span></div><div class="casAuthors">Parsons, J. Thomas; Slack-Davis, Jill; Tilghman, Robert; Roberts, W. Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment plays a central role in cancer progression and metastasis.  Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix.  Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWVNxaWCL7Vg90H21EOLACvtfcHk0lhfghLt6tJyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D&md5=0e9b84c9216582b035ed9abd98b42cda</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2220%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DSlack-Davis%26aufirst%3DJ.%26aulast%3DTilghman%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520Adhesion%2520Kinase%253A%2520Targeting%2520Adhesion%2520Signaling%2520Pathways%2520for%2520Therapeutic%2520Intervention%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shen, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, A. Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.-L.</span><span> </span><span class="NLM_article-title">Conditional Knockout of Focal Adhesion Kinase in Endothelial Cells Reveals Its Role in Angiogenesis and Vascular Development in Late Embryogenesis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=941-952&author=T.-L.+Shenauthor=A.+Y.-J.+Parkauthor=A.+Alcarazauthor=X.+Pengauthor=I.+Jangauthor=P.+Koniauthor=R.+A.+Flavellauthor=H.+Guauthor=J.-L.+Guan&title=Conditional+Knockout+of+Focal+Adhesion+Kinase+in+Endothelial+Cells+Reveals+Its+Role+in+Angiogenesis+and+Vascular+Development+in+Late+Embryogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DT.-L.%26aulast%3DPark%26aufirst%3DA.%2BY.-J.%26aulast%3DAlcaraz%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DJang%26aufirst%3DI.%26aulast%3DKoni%26aufirst%3DP.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DJ.-L.%26atitle%3DConditional%2520Knockout%2520of%2520Focal%2520Adhesion%2520Kinase%2520in%2520Endothelial%2520Cells%2520Reveals%2520Its%2520Role%2520in%2520Angiogenesis%2520and%2520Vascular%2520Development%2520in%2520Late%2520Embryogenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D169%26spage%3D941%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Weis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Pathophysiological Consequences of VEGF-Induced Vascular Permeability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=497-504&author=S.+M.+Weisauthor=D.+A.+Cheresh&title=Pathophysiological+Consequences+of+VEGF-Induced+Vascular+Permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DS.%2BM.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DPathophysiological%2520Consequences%2520of%2520VEGF-Induced%2520Vascular%2520Permeability%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Duffy, M. J.</span><span> </span><span class="NLM_article-title">The Urokinase Plasminogen Activator System: Role in Malignancy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.2174%2F1381612043453559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=14754404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=39-49&author=M.+J.+Duffy&title=The+Urokinase+Plasminogen+Activator+System%3A+Role+in+Malignancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The urokinase plasminogen activator system: Role in malignancy</span></div><div class="casAuthors">Duffy, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The urokinase plasminogen activator (uPA) system consists of the serine protease uPA, its glycolipid-anchored receptor, uPAR and its 2 serpin inhibitors, plasminogen activator inhibitor-1 (PAI-1) and plasminogen activator inhibitor-2 (PAI-2).  Recent findings suggest that the uPA system is causally involved at multiple steps in cancer progression.  In particular, uPA has been implicated in remodelling of the extracellular matrix, enhancing both cell proliferation and migration and modulating cell adhesion.  Consistent with its role in cancer progression, multiple groups have shown that high levels of uPA in primary breast cancers are independently assocd. with adverse outcome.  Paradoxically, high levels of PAI-1 also correlate with poor prognosis in patients with breast cancer.  The prognostic value of uPA/PAI-1 in axillary node-neg. breast cancer patients was recently validated using both a prospective randomized trial and a pooled anal., i.e., in 2 different Level 1 Evidence studies.  Assay of uPA and PAI-1 may thus help identify low risk node-neg. patients for whom adjuvant chemotherapy is unnecessary.  Finally, preclin. studies show that either inhibition of uPA catalytic activity or prevention of uPA binding to its receptor reduces tumor growth, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdjdCtREOu7Vg90H21EOLACvtfcHk0lipO2jHZ3yzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVyhsQ%253D%253D&md5=1feff3497e203e4d109a229b760da52f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1381612043453559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043453559%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520Urokinase%2520Plasminogen%2520Activator%2520System%253A%2520Role%2520in%2520Malignancy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Braren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Endothelial FAK Is Essential for Vascular Network Stability, Cell Survival, and Lamellipodial Formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2006&pages=151-162&author=R.+Brarenauthor=H.+Huauthor=Y.+H.+Kimauthor=H.+E.+Beggsauthor=L.+F.+Reichardtauthor=R.+Wang&title=Endothelial+FAK+Is+Essential+for+Vascular+Network+Stability%2C+Cell+Survival%2C+and+Lamellipodial+Formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraren%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DBeggs%26aufirst%3DH.%2BE.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEndothelial%2520FAK%2520Is%2520Essential%2520for%2520Vascular%2520Network%2520Stability%252C%2520Cell%2520Survival%252C%2520and%2520Lamellipodial%2520Formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D172%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokol, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassalli, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.-L.</span><span> </span><span class="NLM_article-title">Overexpression of Focal Adhesion Kinase in Vascular Endothelial Cells Promotes Angiogenesis in Transgenic Mice</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=421-430&author=X.+Pengauthor=H.+Uedaauthor=H.+Zhouauthor=T.+Stokolauthor=T.-L.+Shenauthor=A.+Alcarazauthor=T.+Nagyauthor=J.-D.+Vassalliauthor=J.-L.+Guan&title=Overexpression+of+Focal+Adhesion+Kinase+in+Vascular+Endothelial+Cells+Promotes+Angiogenesis+in+Transgenic+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DUeda%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DStokol%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DT.-L.%26aulast%3DAlcaraz%26aufirst%3DA.%26aulast%3DNagy%26aufirst%3DT.%26aulast%3DVassalli%26aufirst%3DJ.-D.%26aulast%3DGuan%26aufirst%3DJ.-L.%26atitle%3DOverexpression%2520of%2520Focal%2520Adhesion%2520Kinase%2520in%2520Vascular%2520Endothelial%2520Cells%2520Promotes%2520Angiogenesis%2520in%2520Transgenic%2520Mice%26jtitle%3DCardiovasc.%2520Res.%26date%3D2004%26volume%3D64%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tavora, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadeja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostourou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodivala-Dilke, K. M.</span><span> </span><span class="NLM_article-title">Endothelial FAK Is Required for Tumour Angiogenesis</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Femmm.201000106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21154724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=516-528&author=B.+Tavoraauthor=S.+Batistaauthor=L.+E.+Reynoldsauthor=S.+Jadejaauthor=S.+Robinsonauthor=V.+Kostourouauthor=I.+Hartauthor=M.+Fruttigerauthor=M.+Parsonsauthor=K.+M.+Hodivala-Dilke&title=Endothelial+FAK+Is+Required+for+Tumour+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial FAK is required for tumour angiogenesis</span></div><div class="casAuthors">Tavora, Bernardo; Batista, Silvia; Reynolds, Louise E.; Jadeja, Shalini; Robinson, Stephen; Kostourou, Vassiliki; Hart, Ian; Fruttiger, Marcus; Parsons, Maddy; Hodivala-Dilke, Kairbaan M.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">516-528</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays a fundamental role in integrin and growth factor mediated signalling and is an important player in cell migration and proliferation, processes vital for angiogenesis.  However, the role of FAK in adult pathol. angiogenesis is unknown.  We have generated endothelial-specific tamoxifen-inducible FAK knockout mice by crossing FAK-floxed (FAKfl/fl) mice with the platelet derived growth factor b (Pdgfb)-iCreER mice.  Tamoxifen-treatment of Pdgfb-iCreER;FAKfl/fl mice results in FAK deletion in adult endothelial cells (ECs) without any adverse effects.  Importantly however, endothelial FAK-deletion in adult mice inhibited tumor growth and reduced tumor angiogenesis.  Furthermore, in in vivo angiogenic assays FAK deletion impairs vascular endothelial growth factor (VEGF)-induced neovascularization.  In addn., in vitro deletion of FAK in ECs resulted in reduced VEGF-stimulated Akt phosphorylation and correlating reduced cellular proliferation as well as increased cell death.  Our data suggest that FAK is required for adult pathol. angiogenesis and validates FAK as a possible target for anti-angiogenic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7F0jECcbicrVg90H21EOLACvtfcHk0lgRtTxYq1nhyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFehsg%253D%253D&md5=e1727f709428667a487c2dd61ee9ff9a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000106%26sid%3Dliteratum%253Aachs%26aulast%3DTavora%26aufirst%3DB.%26aulast%3DBatista%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DL.%2BE.%26aulast%3DJadeja%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DKostourou%26aufirst%3DV.%26aulast%3DHart%26aufirst%3DI.%26aulast%3DFruttiger%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHodivala-Dilke%26aufirst%3DK.%2BM.%26atitle%3DEndothelial%2520FAK%2520Is%2520Required%2520for%2520Tumour%2520Angiogenesis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D516%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">[Focal adhesion kinase expression and angiogenesis in breast carcinoma]</span> <span class="citation_source-journal">Nan Fang Yi Ke Da Xue Xue Bao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17884781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BD2srmsFegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1370-1373&author=Y.+Huangauthor=S.+Zhang&title=%5BFocal+adhesion+kinase+expression+and+angiogenesis+in+breast+carcinoma%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase expression and angiogenesis in breast carcinoma</span></div><div class="casAuthors">Huang Yu-dian; Zhang Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Nan fang yi ke da xue xue bao = Journal of Southern Medical University</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1370-3</span>
        ISSN:<span class="NLM_cas:issn">1673-4254</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the expression of focal adhesion kinase (FAK) in breast carcinoma tissues and its association with microvessel density (MVD), and explore the relationship between FAK-mediated cell signaling and angiogenesis in breast carcinoma.  METHODS:  FAK and CD34 expressions were examined by immunohistochemistry with SP method in 88 breast carcinoma tissues and 30 tissues of benign breast disease.  The correlations of FAK protein expression with MVD marked with CD34 and clinicopathological parameters were analyzed in breast carcinoma.  RESULTS:  In the 88 breast carcinomas, the positivity rate of FAK was 68.2% (60/88) with MVD of (34.52-/+13.11) /HPE, showing significant differences from those of the benign disease group (P<0.01).  FAK expression and MVD in breast carcinoma tissues were positively related to tumor size, axillary lymph node metastasis and clinical stage (P<0.05), but not to the patients' age or histopathological grade of the tumors (P>0.05).  In breast carcinoma, the expression of FAK was positively related to MVD (P<0.01).  CONCLUSIONS:  FAK protein expression and MVD are closely correlated with the invasion and metastasis of breast carcinoma.  FAK expression can promote angiogenesis of breast carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdNvPM04mXF_3jf77P2BG3fW6udTcc2eYEzGvRwN7aZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmsFegtA%253D%253D&md5=ca8f999567453a8fa7932ca67f09f9ac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3D%255BFocal%2520adhesion%2520kinase%2520expression%2520and%2520angiogenesis%2520in%2520breast%2520carcinoma%255D%26jtitle%3DNan%2520Fang%2520Yi%2520Ke%2520Da%2520Xue%2520Xue%2520Bao%26date%3D2007%26volume%3D27%26spage%3D1370%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Halder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10976</span><span class="NLM_x">–</span> <span class="NLM_lpage">10983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10976-10983&author=J.+Halderauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=W.+A.+Spannuthauthor=A.+M.+Nickauthor=T.+Hondaauthor=A.+A.+Kamatauthor=L.+Y.+Hanauthor=T.+J.+Kimauthor=C.+Luauthor=A.+M.+Tariauthor=W.+Bornmannauthor=A.+Fernandezauthor=G.+Lopez-Beresteinauthor=A.+K.+Sood&title=Therapeutic+Efficacy+of+a+Novel+Focal+Adhesion+Kinase+Inhibitor+TAE226+in+Ovarian+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DNick%26aufirst%3DA.%2BM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DKim%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520a%2520Novel%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%2520TAE226%2520in%2520Ovarian%2520Carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10976%26epage%3D10983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Coq, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loukaci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepelletier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj-Slimane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Synthesis of Novel Diarylamino-1,3,5-Triazine Derivatives as FAK Inhibitors with Anti-Angiogenic Activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4552</span><span class="NLM_x">–</span> <span class="NLM_lpage">4556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4552-4556&author=P.+Daoauthor=R.+Jarrayauthor=J.+Le+Coqauthor=D.+Liethaauthor=A.+Loukaciauthor=Y.+Lepelletierauthor=R.+Hadj-Slimaneauthor=C.+Garbayauthor=F.+Raynaudauthor=H.+Chen&title=Synthesis+of+Novel+Diarylamino-1%2C3%2C5-Triazine+Derivatives+as+FAK+Inhibitors+with+Anti-Angiogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DJarray%26aufirst%3DR.%26aulast%3DLe%2BCoq%26aufirst%3DJ.%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DLoukaci%26aufirst%3DA.%26aulast%3DLepelletier%26aufirst%3DY.%26aulast%3DHadj-Slimane%26aufirst%3DR.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520Novel%2520Diarylamino-1%252C3%252C5-Triazine%2520Derivatives%2520as%2520FAK%2520Inhibitors%2520with%2520Anti-Angiogenic%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4552%26epage%3D4556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepelletier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coq, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj-Slimane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbeuval, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Inhibition of Both Focal Adhesion Kinase and Fibroblast Growth Factor Receptor 2 Pathways Induces Anti-Tumor and Anti-Angiogenic Activities</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.canlet.2014.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=24657306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Chu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=88-99&author=P.+Daoauthor=R.+Jarrayauthor=N.+Smithauthor=Y.+Lepelletierauthor=J.+L.+Coqauthor=D.+Liethaauthor=R.+Hadj-Slimaneauthor=J.-P.+Herbeuvalauthor=C.+Garbayauthor=F.+Raynaudauthor=H.+Chen&title=Inhibition+of+Both+Focal+Adhesion+Kinase+and+Fibroblast+Growth+Factor+Receptor+2+Pathways+Induces+Anti-Tumor+and+Anti-Angiogenic+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities</span></div><div class="casAuthors">Dao, Pascal; Jarray, Rafika; Smith, Nikaia; Lepelletier, Yves; Coq, Johanne Le; Lietha, Daniel; Hadj-Slimane, Reda; Herbeuval, Jean-Philippe; Garbay, Christiane; Raynaud, Francoise; Chen, Huixiong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">88-99</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">FAK and FGFR2 signaling pathways play important roles in cancer development, progression and tumor angiogenesis.  PHM16 is a novel ATP competitive inhibitor of FAK and FGFR2.  To evaluate the therapeutic efficacy of this agent, we examd. its anti-angiogenic effect in HUVEC and its anti-tumor effect in different cancer cell lines.  We showed PHM16 inhibited endothelial cell viability, adherence and tube formation along with the added ability to induce endothelial cell apoptosis.  This compd. significantly delayed tumor cell growth.  Together, these data showed that inhibition of both FAK and FGFR2 signaling pathways can enhance anti-tumor and anti-angiogenic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx2WBLI2q-H7Vg90H21EOLACvtfcHk0lh0MkZWmy-9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Chu7o%253D&md5=cfe4998e1aea0ac67eba6e10170139d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DJarray%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DLepelletier%26aufirst%3DY.%26aulast%3DCoq%26aufirst%3DJ.%2BL.%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DHadj-Slimane%26aufirst%3DR.%26aulast%3DHerbeuval%26aufirst%3DJ.-P.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Both%2520Focal%2520Adhesion%2520Kinase%2520and%2520Fibroblast%2520Growth%2520Factor%2520Receptor%25202%2520Pathways%2520Induces%2520Anti-Tumor%2520and%2520Anti-Angiogenic%2520Activities%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D348%26spage%3D88%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span> </span><span class="NLM_article-title">A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7405</span><span class="NLM_x">–</span> <span class="NLM_lpage">7416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800483v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7405-7416&author=V.+M.+Golubovskaya&title=A+Small+Molecule+Inhibitor%2C+1%2C2%2C4%2C5-Benzenetetraamine+Tetrahydrochloride%2C+Targeting+the+Y397+Site+of+Focal+Adhesion+Kinase+Decreases+Tumor+Growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm800483v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800483v%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26atitle%3DA%2520Small%2520Molecule%2520Inhibitor%252C%25201%252C2%252C4%252C5-Benzenetetraamine%2520Tetrahydrochloride%252C%2520Targeting%2520the%2520Y397%2520Site%2520of%2520Focal%2520Adhesion%2520Kinase%2520Decreases%2520Tumor%2520Growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7405%26epage%3D7416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Roberts, W. G.</span><span> </span><span class="NLM_article-title">Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Roberts&title=Antitumor+Activity+and+Pharmacology+of+a+Selective+Focal+Adhesion+Kinase+Inhibitor%2C+PF-562%2C271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DAntitumor%2520Activity%2520and%2520Pharmacology%2520of%2520a%2520Selective%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sakurama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span> </span><span class="NLM_article-title">Inhibition of Focal Adhesion Kinase as a Potential Therapeutic Strategy for Imatinib-Resistant Gastrointestinal Stromal Tumor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1535-7163.MCT-08-0884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19139121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=127-134&author=K.+Sakuramaauthor=K.+Nomaauthor=M.+Takaokaauthor=Y.+Tomonoauthor=N.+Watanabeauthor=S.+Hatakeyamaauthor=O.+Ohmoriauthor=S.+Hirotaauthor=T.+Motokiauthor=Y.+Shirakawaauthor=T.+Yamatsujiauthor=M.+Haisaauthor=J.+Matsuokaauthor=N.+Tanakaauthor=Y.+Naomoto&title=Inhibition+of+Focal+Adhesion+Kinase+as+a+Potential+Therapeutic+Strategy+for+Imatinib-Resistant+Gastrointestinal+Stromal+Tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor</span></div><div class="casAuthors">Sakurama, Kazufumi; Noma, Kazuhiro; Takaoka, Munenori; Tomono, Yasuko; Watanabe, Nobuyuki; Hatakeyama, Shinji; Ohmori, Osamu; Hirota, Seiichi; Motoki, Takayuki; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Haisa, Minoru; Matsuoka, Junji; Tanaka, Noriaki; Naomoto, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-134</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is often up-regulated in a variety of malignancies, including gastrointestinal stromal tumor (GIST), and its overexpression seems to be assocd. with tumor progressiveness and poor prognosis.  GIST is well known to have a mutation to c-KIT; thus, a specific c-KIT inhibitor (imatinib) is recognized as the first-line chemotherapy for GIST, although a certain type of c-KIT mutation reveals a resistance to imatinib due to as yet uncertain mol. mechanisms.  To assess the c-KIT mutation-related variation of cellular responses to imatinib, murine lymphocyte-derived Ba/F3 cells, which are stably transduced with different types of c-KIT mutation, were treated with either imatinib or a FAK inhibitor (TAE226), and their antitumor effects were detd. in vitro and in vivo.  A mutation at exon 11 (KITdel559-560) displayed a high sensitivity to imatinib, whereas that at exon 17 (KIT820Tyr) showed a significant resistance to imatinib in vitro and in vivo.  KIT820Tyr cells appeared to maintain the activities of FAK and AKT under the imatinib treatment, suggesting that FAK might play a role in cell survival in imatinib-resistant cells.  When FAK activity in those cells was inhibited by TAE226, cell growth was equally suppressed and the cells underwent apoptosis regardless of the c-KIT mutation types.  Oral administration of TAE226 significantly diminished tumor growth in nude mice bearing KIT820Tyr xenografts.  In summary, c-KIT mutation at exon 17 displayed a resistance to imatinib with maintained activations of FAK and subsequent survival signals.  Targeting FAK could be a potential therapeutic strategy for imatinib-resistant GISTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGb6BgvCFVbVg90H21EOLACvtfcHk0lg717ev3qK7kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSmsw%253D%253D&md5=26d759f5592b41d06ee84cde83c6cf39</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0884%26sid%3Dliteratum%253Aachs%26aulast%3DSakurama%26aufirst%3DK.%26aulast%3DNoma%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DTomono%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DMotoki%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DY.%26aulast%3DYamatsuji%26aufirst%3DT.%26aulast%3DHaisa%26aufirst%3DM.%26aulast%3DMatsuoka%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DNaomoto%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Focal%2520Adhesion%2520Kinase%2520as%2520a%2520Potential%2520Therapeutic%2520Strategy%2520for%2520Imatinib-Resistant%2520Gastrointestinal%2520Stromal%2520Tumor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D127%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_elocation-id">e3800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1371%2Fjournal.pone.0003800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19030106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BD1cjmtF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&author=D.+Liethaauthor=M.+J.+Eck&title=Crystal+Structures+of+the+FAK+Kinase+in+Complex+with+TAE226+and+Related+Bis-Anilino+Pyrimidine+Inhibitors+Reveal+a+Helical+DFG+Conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation</span></div><div class="casAuthors">Lietha Daniel; Eck Michael J</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e3800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase required for cell migration, proliferation and survival.  FAK overexpression has been documented in diverse human cancers and is associated with a poor clinical outcome.  Recently, a novel bis-anilino pyrimidine inhibitor, TAE226, was reported to efficiently inhibit FAK signaling, arrest tumor growth and invasion and prolong the life of mice with glioma or ovarian tumor implants.  Here we describe the crystal structures of the FAK kinase bound to TAE226 and three related bis-anilino pyrimidine compounds.  TAE226 induces a conformation of the N-terminal portion of the kinase activation loop that is only observed in FAK, but is distinct from the conformation in both the active and inactive states of the kinase.  This conformation appears to require a glycine immediately N-terminal to the "DFG motif", which adopts a helical conformation stabilized by interactions with TAE226.  The presence of a glycine residue in this position contributes to the specificity of TAE226 and related compounds for FAK.  Our work highlights the fact that kinases can access conformational space that is not necessarily utilized for their native catalytic regulation, and that such conformations can explain and be exploited for inhibitor specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQsjpXJZjhGaWZyxfu64m4ffW6udTcc2ebnfEZXuqwKxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjmtF2muw%253D%253D&md5=60c1f8e0ae9da7c5b6f638afdff195e1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0003800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0003800%26sid%3Dliteratum%253Aachs%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520FAK%2520Kinase%2520in%2520Complex%2520with%2520TAE226%2520and%2520Related%2520Bis-Anilino%2520Pyrimidine%2520Inhibitors%2520Reveal%2520a%2520Helical%2520DFG%2520Conformation%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">A Novel Low-Molecular Weight Inhibitor of Focal Adhesion Kinase, TAE226, Inhibits Glioma Growth</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fmc.20297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17219439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=488-496&author=Q.+Shiauthor=A.+B.+Hjelmelandauthor=S.+T.+Keirauthor=L.+Songauthor=S.+Wickmanauthor=D.+Jacksonauthor=O.+Ohmoriauthor=D.+D.+Bignerauthor=H.+S.+Friedmanauthor=J.+N.+Rich&title=A+Novel+Low-Molecular+Weight+Inhibitor+of+Focal+Adhesion+Kinase%2C+TAE226%2C+Inhibits+Glioma+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span></div><div class="casAuthors">Shi, Qing; Hjelmeland, Anita B.; Keir, Stephen T.; Song, Linhua; Wickman, Sarah; Jackson, Dowdy; Ohmori, Osamu; Bigner, Darell D.; Friedman, Henry S.; Rich, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Glioblastomas are highly lethal cancers that resist current therapies.  Novel therapies under development target mol. mechanisms that promote glioblastoma growth.  In glioblastoma patient specimens, the non-receptor tyrosine kinase focal adhesion kinase (FAK) is overexpressed.  Upon growth factor receptor stimulation or integrin engagement, FAK is activated by phosphorylation on crit. tyrosine residues.  Activated FAK initiates a signal transduction cascade which promotes glioma growth and invasion by increasing cellular adhesion, migration, invasion, and proliferation.  We find that human glioma cell lines express different levels of total FAK protein and activating phosphorylation of tyrosine residues Tyr397, Tyr861, and Tyr925.  As all glioma cell lines examd. expressed phosphorylated FAK, we examd. the efficacy of a novel low-mol. wt. inhibitor of FAK, TAE226, against human glioma cell lines.  TAE226 inhibited the phosphorylation of FAK as well as the downstream effectors AKT, extracellular signal-related kinase, and S6 ribosomal protein in multiple glioma cell lines.  TAE226 induced a concn.-dependent decrease in cellular proliferation with an assocd. G2 cell cycle arrest in every cell line and an increase in apoptosis in a cell-line-specific manner.  TAE226 also decreased glioma cell adhesion, migration, and invasion through an artificial extracellular matrix.  Together, these data demonstrate the potential benefit of TAE226 for glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL0wEDuHo9bVg90H21EOLACvtfcHk0lg717ev3qK7kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D&md5=83711a44fe2472eae4baf568ee4332a4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmc.20297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20297%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWickman%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DA%2520Novel%2520Low-Molecular%2520Weight%2520Inhibitor%2520of%2520Focal%2520Adhesion%2520Kinase%252C%2520TAE226%252C%2520Inhibits%2520Glioma%2520Growth%26jtitle%3DMol.%2520Carcinog.%26date%3D2007%26volume%3D46%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagatsuka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span> </span><span class="NLM_article-title">Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma in Vitro and in Vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4631</span><span class="NLM_x">–</span> <span class="NLM_lpage">4639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1078-0432.CCR-07-4755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=18628478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4631-4639&author=N.+Watanabeauthor=M.+Takaokaauthor=K.+Sakuramaauthor=Y.+Tomonoauthor=S.+Hatakeyamaauthor=O.+Ohmoriauthor=T.+Motokiauthor=Y.+Shirakawaauthor=T.+Yamatsujiauthor=M.+Haisaauthor=J.+Matsuokaauthor=D.+G.+Beerauthor=H.+Nagatsukaauthor=N.+Tanakaauthor=Y.+Naomoto&title=Dual+Tyrosine+Kinase+Inhibitor+for+Focal+Adhesion+Kinase+and+Insulin-like+Growth+Factor-I+Receptor+Exhibits+Anticancer+Effect+in+Esophageal+Adenocarcinoma+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo</span></div><div class="casAuthors">Watanabe, Nobuyuki; Takaoka, Munenori; Sakurama, Kazufumi; Tomono, Yasuko; Hatakeyama, Shinji; Ohmori, Osamu; Motoki, Takayuki; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Haisa, Minoru; Matsuoka, Junji; Beer, David G.; Nagatsuka, Hitoshi; Tanaka, Noriaki; Naomoto, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4631-4639</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) regulates integrin and growth factor-mediated signaling pathways to enhance cell migration, proliferation, and survival, and its up-regulation correlates malignant grade and poor outcome in several types of cancer.  In this study, we aimed to raise a potential therapeutic strategy using a FAK inhibitor for Barrett's esophageal adenocarcinoma.  The expression status of FAK in clin. Barrett's esophageal adenocarcinoma tissues was detd. by immunohistochem.  Cultured esophageal adenocarcinoma cells were treated with TAE226, a specific FAK inhibitor with an addnl. effect of inhibiting insulin-like growth factor-I receptor (IGF-IR), to assess its anticancer effect in vitro.  Western blot was carried out to explore a participating signaling pathway for TAE226-induced cell death.  Furthermore, TAE226 was orally administered to s.c. xenograft animals to investigate its anticancer effect in vivo.  Strong expression of FAK was found in 94.0% of Barrett's esophageal adenocarcinoma compared with 17.9% of Barrett's epithelia, suggesting that FAK might play a crit. role in the progression of Barrett's esophageal adenocarcinoma.  When esophageal adenocarcinoma cells were treated with TAE226, cell proliferation and migration were greatly inhibited with an apparent structural change of actin fiber and a loss of cell adhesion.  The activities of FAK, IGF-IR, and AKT were suppressed by TAE226 and subsequent dephosphorylation of BAD at Ser136 occurred, resulting in caspase-mediated apoptosis.  In vivo tumor vol. was significantly reduced by oral administration of TAE226.  These results suggest that TAE226, a dual tyrosine kinase inhibitor for FAK and IGF-IR, could become a new remedy for Barrett's esophageal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEkfeYenaE0LVg90H21EOLACvtfcHk0ljSie1gYvtx8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGitbc%253D&md5=207088ee3090e557fa05c99a421e4829</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4755%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DSakurama%26aufirst%3DK.%26aulast%3DTomono%26aufirst%3DY.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DMotoki%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DY.%26aulast%3DYamatsuji%26aufirst%3DT.%26aulast%3DHaisa%26aufirst%3DM.%26aulast%3DMatsuoka%26aufirst%3DJ.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DNagatsuka%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DNaomoto%26aufirst%3DY.%26atitle%3DDual%2520Tyrosine%2520Kinase%2520Inhibitor%2520for%2520Focal%2520Adhesion%2520Kinase%2520and%2520Insulin-like%2520Growth%2520Factor-I%2520Receptor%2520Exhibits%2520Anticancer%2520Effect%2520in%2520Esophageal%2520Adenocarcinoma%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4631%26epage%3D4639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kurio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, N. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, A.</span><span> </span><span class="NLM_article-title">Anti-Tumor Effect in Human Breast Cancer by TAE226, a Dual Inhibitor for FAK and IGF-IR in Vitro and in Vivo</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.yexcr.2011.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21338601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=1134-1146&author=N.+Kurioauthor=T.+Shimoauthor=T.+Fukazawaauthor=M.+Takaokaauthor=T.+Okuiauthor=N.+M.+M.+Hassanauthor=T.+Honamiauthor=S.+Hatakeyamaauthor=M.+Ikedaauthor=Y.+Naomotoauthor=A.+Sasaki&title=Anti-Tumor+Effect+in+Human+Breast+Cancer+by+TAE226%2C+a+Dual+Inhibitor+for+FAK+and+IGF-IR+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo</span></div><div class="casAuthors">Kurio, Naito; Shimo, Tsuyoshi; Fukazawa, Takuya; Takaoka, Munenori; Okui, Tatsuo; Hassan, Nur Mohammad Monsur; Honami, Tatsuki; Hatakeyama, Shinji; Ikeda, Masahiko; Naomoto, Yoshio; Sasaki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1134-1146</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a 125-kDa non-receptor type tyrosine kinase that localizes to focal adhesions.  FAK overexpression is frequently found in invasive and metastatic cancers of the breast, colon, thyroid, and prostate, but its role in osteolytic metastasis is not well understood.  In this study, we have analyzed antitumor effects of the novel FAK Tyr397 inhibitor TAE226 against bone metastasis in breast cancer by using TAE226.  Oral administration of TAE226 in mice significantly decreased bone metastasis and osteoclasts involved which were induced by MDA-MB-231 breast cancer cells and increased the survival rate of the mouse models of bone metastasis.  TAE226 also suppressed the growth of s.c. tumors in vivo and the proliferation and migration of MDA-MB-231 cells in vitro.  Significantly, TAE226 inhibited the osteoclast formation in murine pre-osteoclastic RAW264.7 cells, and actin ring and pit formation in mature osteoclasts.  Moreover, TAE226 inhibited the receptor activator for nuclear factor κ B Ligand (RANKL) gene expression induced by parathyroid hormone-related protein (PTHrP) in bone stromal ST2 cells and blood free calcium concn. induced by PTHrP administration in vivo.  These findings suggest that FAK was critically involved in osteolytic metastasis and activated in tumors, pre-osteoclasts, mature osteoclasts, and bone stromal cells and TAE226 can be effectively used for the treatment of cancer induced bone metastasis and other bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr55W5F5GlRfbVg90H21EOLACvtfcHk0ljSie1gYvtx8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ntr0%253D&md5=1083838b4f36a4eaf62504d577b59ae5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2011.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2011.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DKurio%26aufirst%3DN.%26aulast%3DShimo%26aufirst%3DT.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DHassan%26aufirst%3DN.%2BM.%2BM.%26aulast%3DHonami%26aufirst%3DT.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DNaomoto%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DA.%26atitle%3DAnti-Tumor%2520Effect%2520in%2520Human%2520Breast%2520Cancer%2520by%2520TAE226%252C%2520a%2520Dual%2520Inhibitor%2520for%2520FAK%2520and%2520IGF-IR%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2011%26volume%3D317%26spage%3D1134%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Liu, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFortune, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K. A.</span><span> </span><span class="NLM_article-title">Inhibition of Both Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Kinase Suppresses Glioma Proliferation in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1535-7163.MCT-06-0476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17431114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1357-1367&author=T.-J.+Liuauthor=T.+LaFortuneauthor=T.+Hondaauthor=O.+Ohmoriauthor=S.+Hatakeyamaauthor=T.+Meyerauthor=D.+Jacksonauthor=J.+de+Grootauthor=W.+K.+A.+Yung&title=Inhibition+of+Both+Focal+Adhesion+Kinase+and+Insulin-like+Growth+Factor-I+Receptor+Kinase+Suppresses+Glioma+Proliferation+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span></div><div class="casAuthors">Liu, Ta-Jen; LaFortune, Tiffany; Honda, Toshiyuki; Ohmori, Osamu; Hatakeyama, Shinji; Meyer, Thomas; Jackson, Dowdy; de Groot, John; Yung, W. K. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1367</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple genetic aberrations in human gliomas contribute to their highly infiltrative and rapid growth characteristics.  Focal adhesion kinase (FAK) regulates tumor migration and invasion.  Insulin-like growth factor-I receptor (IGF-IR), whose expression correlates with tumor grade, is involved in proliferation and survival.  We hypothesized that inhibiting the phosphorylation of FAK and IGF-IR by NVP-TAE226 (hereafter called TAE226), a novel dual tyrosine kinase inhibitor of FAK and IGF-IR, would suppress the growth and invasion of glioma cells.  In culture, TAE226 inhibited extracellular matrix-induced autophosphorylation of FAK (Tyr397).  TAE226 also inhibited IGF-I-induced phosphorylation of IGF-IR and activity of its downstream target genes such as MAPK and Akt.  TAE226 retarded tumor cell growth as assessed by a cell viability assay and attenuated G2-M cell cycle progression assocd. with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression.  TAE226 treatment inhibited tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay.  Interestingly, TAE226 treatment of tumor cells contg. wild-type p53 mainly exhibited G2-M arrest, whereas tumor cells bearing mutant p53 underwent apoptosis.  Induction of apoptosis by TAE226 was substantiated by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay.  More importantly, TAE226 treatment significantly increased the survival rate of animals in an intracranial glioma xenograft model.  Collectively, these data show that blocking the signaling pathways of FAK and IGF-IR with TAE226 has the potential to be an efficacious treatment for human gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMIquqcQABrVg90H21EOLACvtfcHk0lhSQpsd_wh39A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D&md5=1659c50e987e8bbb24c998e0aae14861</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0476%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.-J.%26aulast%3DLaFortune%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DJ.%26aulast%3DYung%26aufirst%3DW.%2BK.%2BA.%26atitle%3DInhibition%2520of%2520Both%2520Focal%2520Adhesion%2520Kinase%2520and%2520Insulin-like%2520Growth%2520Factor-I%2520Receptor%2520Kinase%2520Suppresses%2520Glioma%2520Proliferation%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1357%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Heinrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seenisamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuvel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bomke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohdich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esdar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grädler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musil, D.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of New Highly Substituted 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]- and 3<i>H</i>-Imidazolo[4,5-<i>b</i>]-pyridines as Focal Adhesion Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3016014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1160-1170&author=T.+Heinrichauthor=J.+Seenisamyauthor=L.+Emmanuvelauthor=S.+S.+Kulkarniauthor=J.+Bomkeauthor=F.+Rohdichauthor=H.+Greinerauthor=C.+Esdarauthor=M.+Krierauthor=U.+Gr%C3%A4dlerauthor=D.+Musil&title=Fragment-Based+Discovery+of+New+Highly+Substituted+1H-Pyrrolo%5B2%2C3-b%5D-+and+3H-Imidazolo%5B4%2C5-b%5D-pyridines+as+Focal+Adhesion+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3016014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016014%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DSeenisamy%26aufirst%3DJ.%26aulast%3DEmmanuvel%26aufirst%3DL.%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DGreiner%26aufirst%3DH.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DGr%25C3%25A4dler%26aufirst%3DU.%26aulast%3DMusil%26aufirst%3DD.%26atitle%3DFragment-Based%2520Discovery%2520of%2520New%2520Highly%2520Substituted%25201H-Pyrrolo%255B2%252C3-b%255D-%2520and%25203H-Imidazolo%255B4%252C5-b%255D-pyridines%2520as%2520Focal%2520Adhesion%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1160%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Regioselective Synthesis of imidazo[1,2-a][1,3,5]triazines and 3,4-dihydroimidazo[1,2-a][1,3,5]triazines from [1,3,5]triazin-2,4-Diamines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3867</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=3867-3871&author=P.+Daoauthor=C.+Garbayauthor=H.+Chen&title=Regioselective+Synthesis+of+imidazo%5B1%2C2-a%5D%5B1%2C3%2C5%5Dtriazines+and+3%2C4-dihydroimidazo%5B1%2C2-a%5D%5B1%2C3%2C5%5Dtriazines+from+%5B1%2C3%2C5%5Dtriazin-2%2C4-Diamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DRegioselective%2520Synthesis%2520of%2520imidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2520and%25203%252C4-dihydroimidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2520from%2520%255B1%252C3%252C5%255Dtriazin-2%252C4-Diamines%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D3867%26epage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canoll, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Protein Tyrosine Kinase PYK2 Involved in Ca(2+)-Induced Regulation of Ion Channel and MAP Kinase Functions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=737-745&author=S.+Levauthor=H.+Morenoauthor=R.+Martinezauthor=P.+Canollauthor=E.+Pelesauthor=J.+M.+Musacchioauthor=G.+D.+Plowmanauthor=B.+Rudyauthor=J.+Schlessinger&title=Protein+Tyrosine+Kinase+PYK2+Involved+in+Ca%282%2B%29-Induced+Regulation+of+Ion+Channel+and+MAP+Kinase+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLev%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DH.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DCanoll%26aufirst%3DP.%26aulast%3DPeles%26aufirst%3DE.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26aulast%3DRudy%26aufirst%3DB.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DProtein%2520Tyrosine%2520Kinase%2520PYK2%2520Involved%2520in%2520Ca%25282%252B%2529-Induced%2520Regulation%2520of%2520Ion%2520Channel%2520and%2520MAP%2520Kinase%2520Functions%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D737%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kath, J. C.; Luzzio, M. J.</span> Composes Pour Traiter Le Developpement Anormal de Cellules. International Patent WO2004056786 A2, July 8,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kath%2C+J.+C.%3B+Luzzio%2C+M.+J.+Composes+Pour+Traiter+Le+Developpement+Anormal+de+Cellules.+International+Patent+WO2004056786+A2%2C+July+8%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKath%26aufirst%3DJ.%2BC.%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Slack-Davis, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">14845</span><span class="NLM_x">–</span> <span class="NLM_lpage">14852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1074%2Fjbc.M606695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17395594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=14845-14852&author=J.+K.+Slack-Davisauthor=K.+H.+Martinauthor=R.+W.+Tilghmanauthor=M.+Iwanickiauthor=E.+J.+Ungauthor=C.+Autryauthor=M.+J.+Luzzioauthor=B.+Cooperauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=J.+T.+Parsons&title=Cellular+Characterization+of+a+Novel+Focal+Adhesion+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span></div><div class="casAuthors">Slack-Davis, Jill K.; Martin, Karen H.; Tilghman, Robert W.; Iwanicki, Marcin; Ung, Ethan J.; Autry, Christopher; Luzzio, Michael J.; Cooper, Beth; Kath, John C.; Roberts, W. Gregory; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14845-14852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a member of a family of non-receptor protein-tyrosine kinases that regulates integrin and growth factor signaling pathways involved in cell migration, proliferation, and survival.  FAK expression is increased in many cancers, including breast and prostate cancer.  Here we describe perturbation of adhesion-mediated signaling with a FAK inhibitor, PF-573,228.  In vitro, this compd. inhibited purified recombinant catalytic fragment of FAK with an IC50 of 4 nM.  In cultured cells, PF-573,228 inhibited FAK phosphorylation on Tyr397 with an IC50 of 30-100 nM.  Treatment of cells with concns. of PF-573,228 that significantly decreased FAK Tyr397 phosphorylation failed to inhibit cell growth or induce apoptosis.  In contrast, treatment with PF-573,228 inhibited both chemotactic and haptotactic migration concomitant with the inhibition of focal adhesion turnover.  These studies show that PF-573,228 serves as a useful tool to dissect the functions of FAK in integrin-dependent signaling pathways in normal and cancer cells and forms the basis for the generation of compds. amenable for preclin. and patient trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_48hzQ-vWhrVg90H21EOLACvtfcHk0lgDi-6nzExSFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D&md5=38e97c67d37fbcbde006e6937ae4e360</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606695200%26sid%3Dliteratum%253Aachs%26aulast%3DSlack-Davis%26aufirst%3DJ.%2BK.%26aulast%3DMartin%26aufirst%3DK.%2BH.%26aulast%3DTilghman%26aufirst%3DR.%2BW.%26aulast%3DIwanicki%26aufirst%3DM.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DCellular%2520Characterization%2520of%2520a%2520Novel%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D14845%26epage%3D14852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gabarra-Niecko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunty, J. M.</span><span> </span><span class="NLM_article-title">FAK Regulates Biological Processes Important for the Pathogenesis of Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1023%2FA%3A1023725029589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=12884911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=359-374&author=V.+Gabarra-Nieckoauthor=M.+D.+Schallerauthor=J.+M.+Dunty&title=FAK+Regulates+Biological+Processes+Important+for+the+Pathogenesis+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">FAK regulates biological processes important for the pathogenesis of cancer</span></div><div class="casAuthors">Gabarra-Niecko, Veronica; Schaller, Michael D.; Dunty, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Since its initial discovery as a substrate and binding partner for the Src oncogene, a role for the focal adhesion kinase (FAK) in cancer has been speculated.  In this review the clin. evidence correlating FAK overexpression with cancer and the exptl. evidence demonstrating that FAK can control some phenotypes assocd. with cancer will be discussed.  In addn., the emerging theme of interactions between the FAK and growth factor signaling pathways will be described.  The evidence presented in this review provides a compelling case for a role for FAK in the pathol. of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPmHTwXobmj7Vg90H21EOLACvtfcHk0lgDi-6nzExSFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiu78%253D&md5=a3b72160edb7f016a6a862fbb61a6a5f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023725029589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023725029589%26sid%3Dliteratum%253Aachs%26aulast%3DGabarra-Niecko%26aufirst%3DV.%26aulast%3DSchaller%26aufirst%3DM.%2BD.%26aulast%3DDunty%26aufirst%3DJ.%2BM.%26atitle%3DFAK%2520Regulates%2520Biological%2520Processes%2520Important%2520for%2520the%2520Pathogenesis%2520of%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Romer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, K.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Activity, Cytoskeletal Organization, and Motility in Human Vascular Endothelial Cells</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1091%2Fmbc.5.3.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=8049526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK2cXktVGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=349-361&author=L.+H.+Romerauthor=N.+McLeanauthor=C.+E.+Turnerauthor=K.+Burridge&title=Tyrosine+Kinase+Activity%2C+Cytoskeletal+Organization%2C+and+Motility+in+Human+Vascular+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells</span></div><div class="casAuthors">Romer, Lewis H.; McLean, Natalie; Turner, Christopher E.; Burridge, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-61</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    </div><div class="casAbstract">Tyrosine phosphorylation of cytoskeletal proteins occurs during integrin-mediated cell adhesion to extracellular matrix proteins.  The authors have investigated the role of tyrosine phosphorylation in the migration and initial spreading of human umbilical vein endothelial cells (HUVEC).  Elevated phosphotyrosine concns. were noted in the focal adhesions of HUVEC migrating into wounds.  Anti-phosphotyrosine Western blots of exts. of wounded HUVEC monolayers demonstrated increased phosphorylation at 120-130 kDa when compared with exts. of intact monolayers.  The pp125FAK immunopptd. from wounded monolayers exhibited increased kinase activity as compared to pp125FAK from intact monolayers.  The time to wound closure in HUVEC monolayers was doubled by tyrphostin AG 213 treatment.  The same concn. of AG 213 interfered with HUVEC focal adhesion and stress fiber formation.  AG 213 inhibited adhesion-assocd. tyrosine phosphorylation of pp125FAK in HUVEC.  Tyrphostins AG 213 and AG 808 inhibited pp125FAK activity in in vitro kinase assays.  Pp125FAK immunoppts. from HUVEC treated with both of these inhibitors also had kinase activity in vitro that was below levels seen in untreated HUVEC.  These findings suggest that tyrosine phosphorylation of cytoskeletal proteins may be important in HUVEC spreading and migration and that pp125FAK may mediate phosphotyrosine formation during these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9oBrR-mke3LVg90H21EOLACvtfcHk0ljt2Ru6zpFcJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVGqsbk%253D&md5=705486b041a7aa99b744dc38cc44585f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1091%2Fmbc.5.3.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.5.3.349%26sid%3Dliteratum%253Aachs%26aulast%3DRomer%26aufirst%3DL.%2BH.%26aulast%3DMcLean%26aufirst%3DN.%26aulast%3DTurner%26aufirst%3DC.%2BE.%26aulast%3DBurridge%26aufirst%3DK.%26atitle%3DTyrosine%2520Kinase%2520Activity%252C%2520Cytoskeletal%2520Organization%252C%2520and%2520Motility%2520in%2520Human%2520Vascular%2520Endothelial%2520Cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1994%26volume%3D5%26spage%3D349%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Gates, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanney, L. B.</span><span> </span><span class="NLM_article-title">Potential Role for Focal Adhesion Kinase in Migrating and Proliferating Keratinocytes near Epidermal Wounds and in Culture</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=7986754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK2cXlsFCksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=891-899&author=R.+E.+Gatesauthor=L.+E.+Kingauthor=S.+K.+Hanksauthor=L.+B.+Nanney&title=Potential+Role+for+Focal+Adhesion+Kinase+in+Migrating+and+Proliferating+Keratinocytes+near+Epidermal+Wounds+and+in+Culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture</span></div><div class="casAuthors">Gates, Ronald E.; King, Lloyd E., Jr.; Hanks, Steven K.; Nanney, Lillian B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">891-9</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    </div><div class="casAbstract">In normal, differentiating skin, hemidesmosomes make the stable attachment of basal epidermal keratinocytes to the dermis by linking the cytoplasmic keratin intermediate filaments to components of the basal lamina.  In contrast, laterally migrating and proliferating basal keratinocytes in culture and presumably in repairing wounds use focal adhesion to form dynamic attachments to the dermis by linking actin microfilaments to the extracellular matrix.  Focal adhesion kinase (FAK), a non-receptor protein tyrosine kinase concd. along with phosphotyrosine-contg. proteins in the focal adhesions of some cultured cells, is activated in vitro when cells attach, form focal adhesions, and spread.  This report finds that FAK is activated, as detd. from its increased phosphotyrosine content and from its increased labeling with [γ-32P]ATP, in immunoppts. from human cultured keratinocytes attached and spreading on fibronectin compared to those attached but not spreading on polylysine.  Furthermore, immunofluorescence shows that both FAK and phosphotyrosine are concd. in the focal adhesions of cultured keratinocytes attached and spreading on extracellular matrix components known to facilitate cellular migration (fibronectin, collagens I or IV, and epiligrin).  Finally, immunohistochem. localizes FAK to the epidermal-dermal junction in repairing partial thickness burn wounds.  FAK is found at the epidermal-dermal junction at sites and times which coincide with actively migrating or rapidly proliferating basal keratinocytes, suggesting that this distribution represents FAK concd. and activated in adhesions analogous to the focal adhesions seen in cultured cells.  Hence, FAK appears to have an important in vivo role in the reepithelialization of human wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodG50m0nDgaLVg90H21EOLACvtfcHk0ljt2Ru6zpFcJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsFCksb8%253D&md5=c0210b60a8d9d41ec0b7ddf4ebb91860</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGates%26aufirst%3DR.%2BE.%26aulast%3DKing%26aufirst%3DL.%2BE.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DNanney%26aufirst%3DL.%2BB.%26atitle%3DPotential%2520Role%2520for%2520Focal%2520Adhesion%2520Kinase%2520in%2520Migrating%2520and%2520Proliferating%2520Keratinocytes%2520near%2520Epidermal%2520Wounds%2520and%2520in%2520Culture%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1994%26volume%3D5%26spage%3D891%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Taylor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1128%2FMCB.21.5.1565-1572.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=11238893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=1565-1572&author=J.+M.+Taylorauthor=C.+P.+Mackauthor=K.+Nolanauthor=C.+P.+Reganauthor=G.+K.+Owensauthor=J.+T.+Parsons&title=Selective+Expression+of+an+Endogenous+Inhibitor+of+FAK+Regulates+Proliferation+and+Migration+of+Vascular+Smooth+Muscle+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells</span></div><div class="casAuthors">Taylor, Joan M.; Mack, Christopher P.; Nolan, Kate; Regan, Christopher P.; Owens, Gary K.; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1565-1572</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Extracellular matrix signaling via integrin receptors is important for smooth muscle cell (SMC) differentiation during vasculogenesis and for phenotypic modulation of SMCs during atherosclerosis.  We previously reported that the noncatalytic carboxyl-terminal protein binding domain of focal adhesion kinase (FAK) is expressed as a sep. protein termed FAK-related nonkinase (FRNK) and that ectopic expression of FRNK can attenuate FAK activity and integrin-dependent signaling.  Herein we report that in contrast to FAK, which is expressed ubiquitously, FRNK is expressed selectively in SMCs, with particularly high levels obsd. in conduit blood vessels.  FRNK expression was low during embryonic development, was significantly upregulated in the postnatal period, and returned to low but detectable levels in adult tissues.  FRNK expression was also dramatically upregulated following balloon-induced carotid artery injury.  In cultured rat aortic smooth muscle cells, overexpression of FRNK attenuated platelet-derived growth factor (PDGF)-BB-induced migration and also dramatically inhibited [3H]thymidine incorporation upon stimulation with PDGF-BB or 10% serum.  These effects were concomitant with a redn. in SMC proliferation.  Taken together, these data indicate that FRNK acts as an endogenous inhibitor of FAK signaling in SMCs.  Furthermore, increased FRNK expression following vascular injury or during development may alter the SMC phenotype by neg. regulating proliferative and migratory signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2n7JEeG0aTLVg90H21EOLACvtfcHk0ljt2Ru6zpFcJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlGhs7s%253D&md5=af822b41c63d77f3e8112e7e990a54cd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.5.1565-1572.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.5.1565-1572.2001%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BM.%26aulast%3DMack%26aufirst%3DC.%2BP.%26aulast%3DNolan%26aufirst%3DK.%26aulast%3DRegan%26aufirst%3DC.%2BP.%26aulast%3DOwens%26aufirst%3DG.%2BK.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DSelective%2520Expression%2520of%2520an%2520Endogenous%2520Inhibitor%2520of%2520FAK%2520Regulates%2520Proliferation%2520and%2520Migration%2520of%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D1565%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ilic, D.</span><span> </span><span class="NLM_article-title">Reduced Cell Motility and Enhanced Focal Adhesion Contact Formation in Cells from FAK-Deficient Mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=539-544&author=D.+Ilic&title=Reduced+Cell+Motility+and+Enhanced+Focal+Adhesion+Contact+Formation+in+Cells+from+FAK-Deficient+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIlic%26aufirst%3DD.%26atitle%3DReduced%2520Cell%2520Motility%2520and%2520Enhanced%2520Focal%2520Adhesion%2520Contact%2520Formation%2520in%2520Cells%2520from%2520FAK-Deficient%2520Mice%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D539%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Brábek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselý, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabry, B.</span><span> </span><span class="NLM_article-title">The Role of the Tissue Microenvironment in the Regulation of Cancer Cell Motility and Invasion</span> <span class="citation_source-journal">Cell Commun. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_elocation-id">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1186%2F1478-811X-8-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=20822526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BC3cfjtlSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&author=J.+Br%C3%A1bekauthor=C.+T.+Mierkeauthor=D.+R%C3%B6selauthor=P.+Vesel%C3%BDauthor=B.+Fabry&title=The+Role+of+the+Tissue+Microenvironment+in+the+Regulation+of+Cancer+Cell+Motility+and+Invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the tissue microenvironment in the regulation of cancer cell motility and invasion</span></div><div class="casAuthors">Brabek Jan; Mierke Claudia T; Rosel Daniel; Vesely Pavel; Fabry Ben</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> During malignant neoplastic progression the cells undergo genetic and epigenetic cancer-specific alterations that finally lead to a loss of tissue homeostasis and restructuring of the microenvironment.  The invasion of cancer cells through connective tissue is a crucial prerequisite for metastasis formation.  Although cell invasion is foremost a mechanical process, cancer research has focused largely on gene regulation and signaling that underlie uncontrolled cell growth.  More recently, the genes and signals involved in the invasion and transendothelial migration of cancer cells, such as the role of adhesion molecules and matrix degrading enzymes, have become the focus of research.  In this review we discuss how the structural and biomechanical properties of extracellular matrix and surrounding cells such as endothelial cells influence cancer cell motility and invasion.  We conclude that the microenvironment is a critical determinant of the migration strategy and the efficiency of cancer cell invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7hE77k6G743qj_yg7twvpfW6udTcc2eaR07I0yuAUKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfjtlSmug%253D%253D&md5=21824816fe0b6a382c6c5ac0e51b80d1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-22%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A1bek%26aufirst%3DJ.%26aulast%3DMierke%26aufirst%3DC.%2BT.%26aulast%3DR%25C3%25B6sel%26aufirst%3DD.%26aulast%3DVesel%25C3%25BD%26aufirst%3DP.%26aulast%3DFabry%26aufirst%3DB.%26atitle%3DThe%2520Role%2520of%2520the%2520Tissue%2520Microenvironment%2520in%2520the%2520Regulation%2520of%2520Cancer%2520Cell%2520Motility%2520and%2520Invasion%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2010%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Beningo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaverina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. L.</span><span> </span><span class="NLM_article-title">Nascent Focal Adhesions Are Responsible for the Generation of Strong Propulsive Forces in Migrating Fibroblasts</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1083%2Fjcb.153.4.881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=11352946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1WgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=881-888&author=K.+A.+Beningoauthor=M.+Demboauthor=I.+Kaverinaauthor=J.+V.+Smallauthor=Y.+L.+Wang&title=Nascent+Focal+Adhesions+Are+Responsible+for+the+Generation+of+Strong+Propulsive+Forces+in+Migrating+Fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts</span></div><div class="casAuthors">Beningo, Karen A.; Dembo, Micah; Kaverina, Irina; Small, J. Victor; Wang, Yu-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-887</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Fibroblast migration involves complex mech. interactions with the underlying substrate.  Although tight substrate contact at focal adhesions has been studied for decades, the role of focal adhesions in force transduction remains unclear.  To address this question, we have mapped traction stress generated by fibroblasts expressing green fluorescent protein (GFP)-zyxin.  Surprisingly, the overall distribution of focal adhesions only partially resembles the distribution of traction stress.  In addn., detailed anal. reveals that the faint, small adhesions near the leading edge transmit strong propulsive tractions, whereas large, bright, mature focal adhesions exert weaker forces.  This inverse relationship is unique to the leading edge of motile cells and is not obsd. in the trailing edge or in stationary cells.  Furthermore, time-lapse anal. indicates that traction forces decrease soon after the appearance of focal adhesions, whereas the size and zyxin concn. increase.  As focal adhesions mature, changes in structure, protein content, or phosphorylation may cause the focal adhesion to change its function from the transmission of strong propulsive forces, to a passive anchorage device for maintaining a spread cell morphol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWa2SjUsdmerVg90H21EOLACvtfcHk0lg3y-QdskDIfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1WgsbY%253D&md5=28380432f0db7a0855265f808aaaf2f3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1083%2Fjcb.153.4.881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.153.4.881%26sid%3Dliteratum%253Aachs%26aulast%3DBeningo%26aufirst%3DK.%2BA.%26aulast%3DDembo%26aufirst%3DM.%26aulast%3DKaverina%26aufirst%3DI.%26aulast%3DSmall%26aufirst%3DJ.%2BV.%26aulast%3DWang%26aufirst%3DY.%2BL.%26atitle%3DNascent%2520Focal%2520Adhesions%2520Are%2520Responsible%2520for%2520the%2520Generation%2520of%2520Strong%2520Propulsive%2520Forces%2520in%2520Migrating%2520Fibroblasts%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D153%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">High Yielding Microwave-Assisted Synthesis of Tri-Substituted 1,3,5-Triazines Using Pd-Catalyzed Aryl and Heteroarylamination</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=3856-3860&author=P.+Daoauthor=C.+Garbayauthor=H.+Chen&title=High+Yielding+Microwave-Assisted+Synthesis+of+Tri-Substituted+1%2C3%2C5-Triazines+Using+Pd-Catalyzed+Aryl+and+Heteroarylamination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DHigh%2520Yielding%2520Microwave-Assisted%2520Synthesis%2520of%2520Tri-Substituted%25201%252C3%252C5-Triazines%2520Using%2520Pd-Catalyzed%2520Aryl%2520and%2520Heteroarylamination%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D3856%26epage%3D3860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lgVQsq1RTXeCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Brian J. Groendyke, Behnam Nabet, Mikaela L. Mohardt, Haisheng Zhang, Ke Peng, Eriko Koide, Calvin R. Coffey, Jianwei Che, David A. Scott, Adam J. Bass, <span class="NLM_string-name hlFld-ContribAuthor">Nathanael S. Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 30-38. <a href="https://doi.org/10.1021/acsmedchemlett.0c00338" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00338%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPyrimidothiazolodiazepinone%252Bas%252Ba%252BPotent%252Band%252BSelective%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252BInhibitor%26aulast%3DGroendyke%26aufirst%3DBrian%2BJ.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18062020%26date%3D18112020%26date%3D14122020%26volume%3D12%26issue%3D1%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yang Lu, <span class="NLM_string-name hlFld-ContribAuthor">Haiying Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14382-14403. <a href="https://doi.org/10.1021/acs.jmedchem.0c01248" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01248%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecular%252BInhibitors%252Bof%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%26aulast%3DLu%26aufirst%3DYang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D15102020%26volume%3D63%26issue%3D23%26spage%3D14382%26epage%3D14403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bo Li, Yongliang Li, Céline Tomkiewicz-Raulet, Pascal Dao, Daniel Lietha, Expédite Yen-Pon, Zhiyun Du, Xavier Coumoul, Christiane Garbay, Mélanie Etheve-Quelquejeu, <span class="NLM_string-name hlFld-ContribAuthor">Huixiong Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12707-12724. <a href="https://doi.org/10.1021/acs.jmedchem.0c01059" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01059%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BCovalent%252BInhibitors%252Bof%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252Bagainst%252BHuman%252BMalignant%252BGlioblastoma%26aulast%3DLi%26aufirst%3DBo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D29102020%26volume%3D63%26issue%3D21%26spage%3D12707%26epage%3D12724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanyi  Tan</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Chaochao  Gong</span>, <span class="hlFld-ContribAuthor ">Jiawei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113670. <a href="https://doi.org/10.1016/j.ejmech.2021.113670" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113670%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252BFAK%252Binhibitors%252Bwith%252Ba%252B5-fluoro-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bscaffold%252Bas%252Banti-hepatocellular%252Bcarcinoma%252Bagents%26aulast%3DTan%26aufirst%3DHanyi%26date%3D2021%26volume%3D223%26spage%3D113670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhamad  Mustafa</span>, <span class="hlFld-ContribAuthor ">Amer Ali  Abd El-Hafeez</span>, <span class="hlFld-ContribAuthor ">Dalia A  Abdelhafeez</span>, <span class="hlFld-ContribAuthor ">Dalia  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Yaser A  Mostafa</span>, <span class="hlFld-ContribAuthor ">Pradipta  Ghosh</span>, <span class="hlFld-ContribAuthor ">Alaa M  Hayallah</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din  A Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">FAK inhibitors as promising anticancer targets: present and future directions. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.4155/fmc-2021-0015" title="DOI URL">https://doi.org/10.4155/fmc-2021-0015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2021-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2021-0015%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DFAK%252Binhibitors%252Bas%252Bpromising%252Banticancer%252Btargets%25253A%252Bpresent%252Band%252Bfuture%252Bdirections%26aulast%3DMustafa%26aufirst%3DMuhamad%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Jing  Pang</span>, <span class="hlFld-ContribAuthor ">Xiu-Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Yin-Ru  Li</span>, <span class="hlFld-ContribAuthor ">Guang-Xi  Yu</span>, <span class="hlFld-ContribAuthor ">Xin-Yi  Tian</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Cheng-Yun  Jin</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (14)
                                     , 4250. <a href="https://doi.org/10.3390/molecules26144250" title="DOI URL">https://doi.org/10.3390/molecules26144250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26144250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26144250%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDrug%252BDiscovery%252BTargeting%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252Bas%252Ba%252BPromising%252BCancer%252BTherapy%26aulast%3DPang%26aufirst%3DXiao-Jing%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D14%26spage%3D4250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farah  Daili</span>, <span class="hlFld-ContribAuthor ">Stéphane  Sengmany</span>, <span class="hlFld-ContribAuthor ">Eric  Léonel</span>. </span><span class="cited-content_cbyCitation_article-title">Amination of Aryl Halides Mediated by Electrogenerated Nickel from Sacrificial Anode. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (17)
                                     , 2462-2469. <a href="https://doi.org/10.1002/ejoc.202100194" title="DOI URL">https://doi.org/10.1002/ejoc.202100194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100194%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAmination%252Bof%252BAryl%252BHalides%252BMediated%252Bby%252BElectrogenerated%252BNickel%252Bfrom%252BSacrificial%252BAnode%26aulast%3DDaili%26aufirst%3DFarah%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D17%26spage%3D2462%26epage%3D2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier R.P.  David</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: Three Extra 1-Heteroatom 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00058-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00058-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00058-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00058-5%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BThree%252BExtra%252B1-Heteroatom%252B1%25253A2%26aulast%3DDavid%26aufirst%3DOlivier%2BR.P.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Teng</span>, <span class="hlFld-ContribAuthor ">Xiang  Lu</span>, <span class="hlFld-ContribAuthor ">Maoxu  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhenbang  Li</span>, <span class="hlFld-ContribAuthor ">Yumei  Zou</span>, <span class="hlFld-ContribAuthor ">Shengnan  Ren</span>, <span class="hlFld-ContribAuthor ">Yu  Cheng</span>, <span class="hlFld-ContribAuthor ">Guoshun  Luo</span>, <span class="hlFld-ContribAuthor ">Hua  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and highly selective covalent inhibitors of Bruton’s tyrosine kinase bearing triazine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112339. <a href="https://doi.org/10.1016/j.ejmech.2020.112339" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112339%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bhighly%252Bselective%252Bcovalent%252Binhibitors%252Bof%252BBruton%2525E2%252580%252599s%252Btyrosine%252Bkinase%252Bbearing%252Btriazine%252Bscaffold%26aulast%3DTeng%26aufirst%3DYu%26date%3D2020%26volume%3D199%26spage%3D112339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Guo</span>, <span class="hlFld-ContribAuthor ">Quan-Ping  Diao</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazine-azole Hybrids and their Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (16)
                                     , 1481-1492. <a href="https://doi.org/10.2174/1568026620666200310122741" title="DOI URL">https://doi.org/10.2174/1568026620666200310122741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200310122741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200310122741%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3%25252C5-Triazine-azole%252BHybrids%252Band%252Btheir%252BAnticancer%252BActivity%26aulast%3DGuo%26aufirst%3DHua%26date%3D2020%26volume%3D20%26issue%3D16%26spage%3D1481%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip Gangadhar  Balwe</span>, <span class="hlFld-ContribAuthor ">Sandip S.  Vagh</span>, <span class="hlFld-ContribAuthor ">Yeon Tae  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of diverse nitrogen fused polycyclic dihydroisoquinoline (DHIQ) derivatives via GBB-based cyclic iminium induced double-annulation cascade. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (28)
                                     , 152101. <a href="https://doi.org/10.1016/j.tetlet.2020.152101" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152101%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bdiverse%252Bnitrogen%252Bfused%252Bpolycyclic%252Bdihydroisoquinoline%252B%252528DHIQ%252529%252Bderivatives%252Bvia%252BGBB-based%252Bcyclic%252Biminium%252Binduced%252Bdouble-annulation%252Bcascade%26aulast%3DBalwe%26aufirst%3DSandip%2BGangadhar%26date%3D2020%26volume%3D61%26issue%3D28%26spage%3D152101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Tingting  Zheng</span>, <span class="hlFld-ContribAuthor ">Jidong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              /K
              2
              S
              2
              O
              8
              Mediated Direct Oxidative Annulation of Alkylazaarenes with Amidines for the Synthesis of Substituted 1,3,5-Triazines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (7)
                                     , 860-865. <a href="https://doi.org/10.1002/ejoc.201901737" title="DOI URL">https://doi.org/10.1002/ejoc.201901737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901737%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DI%252B2%252B%25252FK%252B2%252BS%252B2%252BO%252B8%252BMediated%252BDirect%252BOxidative%252BAnnulation%252Bof%252BAlkylazaarenes%252Bwith%252BAmidines%252Bfor%252Bthe%252BSynthesis%252Bof%252BSubstituted%252B1%25252C3%25252C5-Triazines%26aulast%3DZhang%26aufirst%3DJun%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D7%26spage%3D860%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Su</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Xianling  Ning</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Lin</span>, <span class="hlFld-ContribAuthor ">Xuyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Juntuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Yuxin  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 32-46. <a href="https://doi.org/10.1016/j.ejmech.2019.05.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2%25252C4-diarylaminopyrimidine%252Bderivatives%252Bbearing%252Bdithiocarbamate%252Bmoiety%252Bas%252Bnovel%252BFAK%252Binhibitors%252Bwith%252Bantitumor%252Band%252Banti-angiogenesis%252Bactivities%26aulast%3DSu%26aufirst%3DYue%26date%3D2019%26volume%3D177%26spage%3D32%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Kumar</span>, <span class="hlFld-ContribAuthor ">A.  Kumar</span>, <span class="hlFld-ContribAuthor ">J.  Sindhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2019,</strong> <em>30 </em>
                                    (2)
                                     , 63-80. <a href="https://doi.org/10.1080/1062936X.2018.1564067" title="DOI URL">https://doi.org/10.1080/1062936X.2018.1564067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2018.1564067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2018.1564067%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DDesign%252Band%252Bdevelopment%252Bof%252Bnovel%252Bfocal%252Badhesion%252Bkinase%252B%252528FAK%252529%252Binhibitors%252Busing%252BMonte%252BCarlo%252Bmethod%252Bwith%252Bindex%252Bof%252Bideality%252Bof%252Bcorrelation%252Bto%252Bvalidate%252BQSAR%26aulast%3DKumar%26aufirst%3DP.%26date%3D2019%26date%3D2019%26volume%3D30%26issue%3D2%26spage%3D63%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baskaran  Purushothaman</span>, <span class="hlFld-ContribAuthor ">Parthasarathy  Arumugam</span>, <span class="hlFld-ContribAuthor ">Hee  Ju</span>, <span class="hlFld-ContribAuthor ">Goutam  Kulsi</span>, <span class="hlFld-ContribAuthor ">Annie Agnes Suganya  Samson</span>, <span class="hlFld-ContribAuthor ">Joon Myong  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]2+ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 747-759. <a href="https://doi.org/10.1016/j.ejmech.2018.07.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bruthenium%252528II%252529%252Btriazine%252Bcomplex%252B%25255BRu%252528bdpta%252529%252528tpy%252529%25255D2%25252B%252Bco-targeting%252Bdrug%252Bresistant%252BGRP78%252Band%252Bsubcellular%252Borganelles%252Bin%252Bcancer%252Bstem%252Bcells%26aulast%3DPurushothaman%26aufirst%3DBaskaran%26date%3D2018%26volume%3D156%26spage%3D747%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felicia Phei Lin  Lim</span>, <span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>, <span class="hlFld-ContribAuthor ">Nathan R.  Halcovitch</span>, <span class="hlFld-ContribAuthor ">Edward R.T.  Tiekink</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of 7-(4-methylphenyl)imidazo[1,2-a][1,3,5]triazin-4-amine, C12H11N5. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Kristallographie - New Crystal Structures</span><span> <strong>2018,</strong> <em>233 </em>
                                    (3)
                                     , 489-490. <a href="https://doi.org/10.1515/ncrs-2017-0371" title="DOI URL">https://doi.org/10.1515/ncrs-2017-0371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/ncrs-2017-0371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fncrs-2017-0371%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Kristallographie%2520-%2520New%2520Crystal%2520Structures%26atitle%3DCrystal%252Bstructure%252Bof%252B7-%2525284-methylphenyl%252529imidazo%25255B1%25252C2-a%25255D%25255B1%25252C3%25252C5%25255Dtriazin-4-amine%25252C%252BC12H11N5%26aulast%3DLim%26aufirst%3DFelicia%2BPhei%2BLin%26date%3D2018%26volume%3D233%26issue%3D3%26spage%3D489%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Cheng</span>, <span class="hlFld-ContribAuthor ">Jiaojiao  Li</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Honglin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Investigations of FAK inhibitors: a combination of 3D-QSAR, docking, and molecular dynamics simulations studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (6)
                                     , 1529-1549. <a href="https://doi.org/10.1080/07391102.2017.1329095" title="DOI URL">https://doi.org/10.1080/07391102.2017.1329095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1329095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1329095%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DInvestigations%252Bof%252BFAK%252Binhibitors%25253A%252Ba%252Bcombination%252Bof%252B3D-QSAR%25252C%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bstudies%26aulast%3DCheng%26aufirst%3DPeng%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D6%26spage%3D1529%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Ai-Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Wei-Ming  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">FAK inhibitors in Cancer, a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 139-145. <a href="https://doi.org/10.1080/13543776.2018.1414183" title="DOI URL">https://doi.org/10.1080/13543776.2018.1414183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1414183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1414183%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFAK%252Binhibitors%252Bin%252BCancer%25252C%252Ba%252Bpatent%252Breview%26aulast%3DLv%26aufirst%3DPeng-Cheng%26date%3D2018%26date%3D2017%26volume%3D28%26issue%3D2%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip Gangadhar  Balwe</span>, <span class="hlFld-ContribAuthor ">Yeon Tae  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds
              via
              GBB reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (8)
                                     , 1287-1296. <a href="https://doi.org/10.1039/C7OB02933K" title="DOI URL">https://doi.org/10.1039/C7OB02933K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02933K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02933K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Bapproach%252Btowards%252Bthe%252Bsynthesis%252Bof%252Bnovel%252Bfused%252Bnitrogen%252Btricyclic%252Bheterocyclic%252Bscaffolds%252Bvia%252BGBB%252Breaction%26aulast%3DBalwe%26aufirst%3DSandip%2BGangadhar%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D8%26spage%3D1287%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Dawei  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyu  Xu</span>, <span class="hlFld-ContribAuthor ">Gila  Dava</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xue</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiangshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation,
              in vitro
              and
              in vivo
              evaluation, and molecular dynamics (MD) simulation studies of novel F-18 labeled tumor imaging agents targeting focal adhesion kinase (FAK). </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (19)
                                     , 10333-10345. <a href="https://doi.org/10.1039/C8RA00652K" title="DOI URL">https://doi.org/10.1039/C8RA00652K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA00652K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA00652K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPreparation%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252B%252528MD%252529%252Bsimulation%252Bstudies%252Bof%252Bnovel%252BF-18%252Blabeled%252Btumor%252Bimaging%252Bagents%252Btargeting%252Bfocal%252Badhesion%252Bkinase%252B%252528FAK%252529%26aulast%3DFang%26aufirst%3DYu%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D19%26spage%3D10333%26epage%3D10345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felicia Phei Lin  Lim</span>, <span class="hlFld-ContribAuthor ">Lin Yuing  Tan</span>, <span class="hlFld-ContribAuthor ">Edward R. T.  Tiekink</span>, <span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot, multicomponent reaction for the synthesis of novel 2-alkyl substituted 4-aminoimidazo[1,2-
              a
              ][1,3,5]triazines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (38)
                                     , 21495-21504. <a href="https://doi.org/10.1039/C8RA03703E" title="DOI URL">https://doi.org/10.1039/C8RA03703E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA03703E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA03703E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bone-pot%25252C%252Bmulticomponent%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnovel%252B2-alkyl%252Bsubstituted%252B4-aminoimidazo%25255B1%25252C2-%252Ba%252B%25255D%25255B1%25252C3%25252C5%25255Dtriazines%26aulast%3DLim%26aufirst%3DFelicia%2BPhei%2BLin%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D38%26spage%3D21495%26epage%3D21504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascal  Dao</span>, <span class="hlFld-ContribAuthor ">Daniel  Lietha</span>, <span class="hlFld-ContribAuthor ">Mélanie  Etheve-Quelquejeu</span>, <span class="hlFld-ContribAuthor ">Christiane  Garbay</span>, <span class="hlFld-ContribAuthor ">Huixiong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 1727-1730. <a href="https://doi.org/10.1016/j.bmcl.2017.02.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnovel%252B1%25252C2%25252C4-triazine%252Bscaffold%252Bas%252BFAK%252Binhibitors%252Bwith%252Bantitumor%252Bactivity%26aulast%3DDao%26aufirst%3DPascal%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D1727%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Dawei  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyu  Xu</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Aiqin  Wu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xue</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Hang  Wang</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 493-508. <a href="https://doi.org/10.1016/j.ejmech.2017.01.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252B%252528MD%252529%252Bsimulation%252Bstudies%252Bof%252Bthree%252Bnovel%252BF-18%252Blabeled%252Band%252Bfocal%252Badhesion%252Bkinase%252B%252528FAK%252529%252Btargeted%252B5-bromo%252Bpyrimidines%252Bas%252Bradiotracers%252Bfor%252Btumor%26aulast%3DFang%26aufirst%3DYu%26date%3D2017%26volume%3D127%26spage%3D493%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawei  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Hang  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyu  Xu</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel F-18-labeled pyrimidine derivatives: potential FAK inhibitors and PET imaging agents for cancer detection. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (36)
                                     , 22388-22399. <a href="https://doi.org/10.1039/C6RA28851K" title="DOI URL">https://doi.org/10.1039/C6RA28851K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA28851K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA28851K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252BF-18-labeled%252Bpyrimidine%252Bderivatives%25253A%252Bpotential%252BFAK%252Binhibitors%252Band%2525C2%2525A0PET%252Bimaging%252Bagents%252Bfor%252Bcancer%252Bdetection%26aulast%3DWang%26aufirst%3DDawei%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D36%26spage%3D22388%26epage%3D22399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imran  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammad Nadeem  Lone</span>, <span class="hlFld-ContribAuthor ">Haasan Y.  Aboul-Enein</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazoles as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1742-1773. <a href="https://doi.org/10.1039/C7MD00067G" title="DOI URL">https://doi.org/10.1039/C7MD00067G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00067G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00067G%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DImidazoles%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DAli%26aufirst%3DImran%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D1742%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felicia Phei Lin  Lim</span>, <span class="hlFld-ContribAuthor ">Szy Teng  Low</span>, <span class="hlFld-ContribAuthor ">Elvina Lee King  Ho</span>, <span class="hlFld-ContribAuthor ">Nathan R.  Halcovitch</span>, <span class="hlFld-ContribAuthor ">Edward R. T.  Tiekink</span>, <span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>. </span><span class="cited-content_cbyCitation_article-title">A multicomponent reaction of 2-aminoimidazoles: microwave-assisted synthesis of novel 5-aza-7-deaza-adenines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (81)
                                     , 51062-51068. <a href="https://doi.org/10.1039/C7RA11305F" title="DOI URL">https://doi.org/10.1039/C7RA11305F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA11305F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA11305F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bmulticomponent%252Breaction%252Bof%252B2-aminoimidazoles%25253A%252Bmicrowave-assisted%252Bsynthesis%252Bof%252Bnovel%252B5-aza-7-deaza-adenines%26aulast%3DLim%26aufirst%3DFelicia%2BPhei%2BLin%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D81%26spage%3D51062%26epage%3D51068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Zai-Qun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of imidazo[1,2-a]quinoxalines by double Groebke reactions and inhibitory effects on radicals and DNA oxidation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (15)
                                     , 1850-1859. <a href="https://doi.org/10.1016/j.tet.2016.02.042" title="DOI URL">https://doi.org/10.1016/j.tet.2016.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dquinoxalines%252Bby%252Bdouble%252BGroebke%252Breactions%252Band%252Binhibitory%252Beffects%252Bon%252Bradicals%252Band%252BDNA%252Boxidation%26aulast%3DChen%26aufirst%3DJia-Feng%26date%3D2016%26volume%3D72%26issue%3D15%26spage%3D1850%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Dao</span>, <span class="hlFld-ContribAuthor ">N.  Smith</span>, <span class="hlFld-ContribAuthor ">D.  Scott-Algara</span>, <span class="hlFld-ContribAuthor ">C.  Garbay</span>, <span class="hlFld-ContribAuthor ">J.P.  Herbeuval</span>, <span class="hlFld-ContribAuthor ">H.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2015,</strong> <em>360 </em>
                                    (1)
                                     , 48-59. <a href="https://doi.org/10.1016/j.canlet.2015.02.016" title="DOI URL">https://doi.org/10.1016/j.canlet.2015.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2015.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2015.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DRestoration%252Bof%252BTRAIL-induced%252Bapoptosis%252Bin%252Bresistant%252Bhuman%252Bpancreatic%252Bcancer%252Bcells%252Bby%252Ba%252Bnovel%252BFAK%252Binhibitor%25252C%252BPH11%26aulast%3DDao%26aufirst%3DP.%26date%3D2015%26volume%3D360%26issue%3D1%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Markwell</span>, <span class="hlFld-ContribAuthor ">Scott  Weed</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor and Stromal-Based Contributions to Head and Neck Squamous Cell Carcinoma Invasion. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2015,</strong> <em>7 </em>
                                    (1)
                                     , 382-406. <a href="https://doi.org/10.3390/cancers7010382" title="DOI URL">https://doi.org/10.3390/cancers7010382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers7010382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers7010382%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTumor%252Band%252BStromal-Based%252BContributions%252Bto%252BHead%252Band%252BNeck%252BSquamous%252BCell%252BCarcinoma%252BInvasion%26aulast%3DMarkwell%26aufirst%3DSteven%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D382%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Direct oxidative coupling of amidine hydrochlorides and methylarenes: TBHP-mediated synthesis of substituted 1,3,5-triazines under metal-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (41)
                                     , 10285-10289. <a href="https://doi.org/10.1039/C5OB01799H" title="DOI URL">https://doi.org/10.1039/C5OB01799H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01799H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01799H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDirect%252Boxidative%252Bcoupling%252Bof%252Bamidine%252Bhydrochlorides%252Band%252Bmethylarenes%25253A%252BTBHP-mediated%252Bsynthesis%252Bof%252Bsubstituted%252B1%25252C3%25252C5-triazines%252Bunder%252Bmetal-free%252Bconditions%26aulast%3DGuo%26aufirst%3DWei%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D41%26spage%3D10285%26epage%3D10289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Arylamine/THF/DIEA, −20°C, and NH<sub>3</sub>/THF, TA; (b) arylamine/dioxane/Pd(OAc)<sub>2</sub>/rac-BINAP/Cs<sub>2</sub>CO<sub>3</sub>/MW, 100 °C, 10 min; (c) 2-chloroacetaldehyde/EtOH/reflux; (d) CH<sub>3</sub>NH<sub>2</sub>/CaCl<sub>2</sub>/MW, 100 °C, 20 min; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaBH<sub>4</sub>, THF, TA.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3,4,5-Trimethoxyaniline/dioxane/MW, 90 °C, 15 min; (b) phenylacetate derivatives/MeONa/THF/reflux; (c) 2-chloroacetaldehyde/EtOH, 120 °C; (d) Al(CH<sub>3</sub>)<sub>3</sub>/NH<sub>4</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>, RT, 12 h; (e) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>/NaHCO<sub>3</sub>/THF/EtOH/H<sub>2</sub>O, RT; (f) H<sub>2</sub>/PtO<sub>2</sub>/MeOH/THF; (g) CH<sub>3</sub>SO<sub>2</sub>Cl/pyridine, 50 °C.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cells (U-87MG, HCT-116, MDA-MB-231, and PC-3) were treated for 48 h with 0.1, 1, and 10 μM of compound <b>19a</b> or TAE-226 as control. Data obtained by the Face method are expressed as the fold decrease relative to the control and represent mean of triplicate readings of three independent experiments. A decrease of FAK tyrosine 397 phosphorylation in a dose-dependent manner is shown for <b>19a</b> and for TAE-226.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Two cancer cell lines (U87-MG and HCT-116) were plated at 10<sup>5</sup> cells per well in a 6-well culture dish, incubated overnight, and then cultured with <b>19a</b>, <b>21a</b>, or TAE-226 for 24 h. Cells were stained with annexin V and 7AAD and analyzed by FACS calibur. Cells were then classified as alive with no apoptosis (i.e., 7AAD negative, annexin V negative), dead (i.e., 7AAD positive), or apoptotic (i.e., annexin V positive). (A) U87-MG cells were treated with 3 μM <b>19a</b>, 0.3 μM <b>21a</b>, or 1 μM TAE-226; (B) HCT-116 cells were treated with 0.5 μM <b>19a</b>, 0.4 μM <b>21a</b>, or 0.3 μM TAE-226. One representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell cycle distribution was studied by flow cytometry: cells (U87-MG and HCT-116) were plated at 10<sup>5</sup> per well in a 6-well culture dish, incubated overnight, and then exposed to <b>19a</b>, <b>21a</b>, or TAE-226 along with a vehicle treatment control for 24 h. Cell cycle distribution was represented by histograms. Asterisks denote statistically significant differences (*<i>p</i> < 0.01; **<i>p</i> < 0.001) as determined by unpaired Student’s <i>t</i> test. (A) U87-MG cells were treated with 3 μM <b>19a</b>, 0.3 μM <b>21a</b>, or 1 μM TAE-226; (B) HCT-116 cells were treated with 0.5 μM <b>19a</b>, 0.4 μM <b>21a</b>, or 0.3 μM TAE-226. One representative experiment is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/medium/jm-2014-00784e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compounds <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> on the cell attachment, migration, and invasion in U-87MG cell lines. (A) Cells were treated for 30 min in the presence of <b>12a</b>, <b>15a</b>, <b>19a</b>, <b>21a</b>, or TAE226. The attached cells were removed and counted. (B) Comparative xCELLigence analysis of the effect of different treatments on the migration of U87-MG human cancer cell lines. CI values are plotted on the graph. The slopes (1/<i>h</i>), representing the cell migrating ability, were calculated based on CI values in the time interval indicated on the plots by the boxes. The mean slopes calculated with DMSO (control) were set to 100. The experiment was repeated two times and was consistent. (C) Comparative xCELLigence analysis of the effect of different treatment on the invasion of U87-MG human cancer cell lines. CI values are plotted on the graph. The slopes (1/<i>h</i>), representing the cell invasion ability, were calculated based on CI values in the time interval indicated on the plots by the boxes. The mean slopes calculated with DMSO (control) were set to 100. The experiment was repeated two times and was consistent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500784e/20150106/images/large/jm-2014-00784e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500784e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochwald, S. N.</span><span> </span><span class="NLM_article-title">The Role of FAK in Tumor Metabolism and Therapy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.pharmthera.2013.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=24333503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2014&pages=154-163&author=J.+Zhangauthor=S.+N.+Hochwald&title=The+Role+of+FAK+in+Tumor+Metabolism+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of FAK in tumor metabolism and therapy</span></div><div class="casAuthors">Zhang, Jianliang; Hochwald, Steven N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-163</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Focal adhesion kinase (FAK) plays a vital role in tumor cell proliferation, survival and migration.  Altered metabolic pathways fuel rapid tumor growth by accelerating glucose, lipid and glutamine processing.  Besides the mitogenic effects of FAK, evidence is accumulating supporting the assocn. between hyper-activated FAK and aberrant metab. in tumorigenesis.  FAK can promote glucose consumption, lipogenesis, and glutamine dependency to promote cancer cell proliferation, motility, and survival.  Clin. studies demonstrate that FAK-related alterations of tumor metab. are assocd. with increased risk of developing solid tumors.  Since FAK contributes to the malignant phenotype, small mol. inhibition of FAK-stimulated bioenergetic and biosynthetic processes can provide a novel approach for therapeutic intervention in tumor growth and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcqgT2ywkqbVg90H21EOLACvtfcHk0lh-ASavEi7esA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFyiuw%253D%253D&md5=9cb0cd034003cf29b4141e9572e02f6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHochwald%26aufirst%3DS.%2BN.%26atitle%3DThe%2520Role%2520of%2520FAK%2520in%2520Tumor%2520Metabolism%2520and%2520Therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D142%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cance, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurenova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlowe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubovskaya, V.</span><span> </span><span class="NLM_article-title">Disrupting the Scaffold to Improve Focal Adhesion Kinase-Targeted Cancer Therapeutics</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">pe10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1126%2Fscisignal.2004021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=23532331" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=W.+G.+Canceauthor=E.+Kurenovaauthor=T.+Marloweauthor=V.+Golubovskaya&title=Disrupting+the+Scaffold+to+Improve+Focal+Adhesion+Kinase-Targeted+Cancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2004021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2004021%26sid%3Dliteratum%253Aachs%26aulast%3DCance%26aufirst%3DW.%2BG.%26aulast%3DKurenova%26aufirst%3DE.%26aulast%3DMarlowe%26aufirst%3DT.%26aulast%3DGolubovskaya%26aufirst%3DV.%26atitle%3DDisrupting%2520the%2520Scaffold%2520to%2520Improve%2520Focal%2520Adhesion%2520Kinase-Targeted%2520Cancer%2520Therapeutics%26jtitle%3DSci.%2520Signaling%26date%3D2013%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lechertier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodivala-Dilke, K.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase and Tumour Angiogenesis</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fpath.3018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21984450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2012&pages=404-412&author=T.+Lechertierauthor=K.+Hodivala-Dilke&title=Focal+Adhesion+Kinase+and+Tumour+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase and tumor angiogenesis</span></div><div class="casAuthors">Lechertier, Tanguy; Hodivala-Dilke, Kairbaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-412</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for tumor development.  It is initiated and regulated by growth factors via their surface receptors, which activate several intracellular signalling pathways in endothelial cells.  Cell adhesion mols., such as integrins, also regulate angiogenesis.  Despite these facts, inhibitors of endothelial cell growth factor receptors or integrins have not been as effective as initially hoped in the long-term inhibition of angiogenesis in cancer patients.  Signalling downstream of growth factor receptors and integrins converge on the ubiquitously expressed non-receptor tyrosine kinase focal adhesion kinase (FAK).  FAK is involved in endothelial cell proliferation, migration and survival, is up-regulated in many cancers and has recently been shown to control tumor angiogenesis.  Indeed, FAK inhibitors are presently being developed for the treatment of cancer.  However, recent studies have indicated the complexities of understanding the precise role for FAK in angiogenesis.  Here we have summarized some of the key features of FAK, addressed some of the apparently contradictory roles of this mol. in angiogenesis and provided some perspectives for future studies.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgXcP02UjgLVg90H21EOLACvtfcHk0lh-ASavEi7esA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCqsb3J&md5=605e7ae8bd660cfc04792e904729addf</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpath.3018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.3018%26sid%3Dliteratum%253Aachs%26aulast%3DLechertier%26aufirst%3DT.%26aulast%3DHodivala-Dilke%26aufirst%3DK.%26atitle%3DFocal%2520Adhesion%2520Kinase%2520and%2520Tumour%2520Angiogenesis%26jtitle%3DJ.%2520Pathol.%26date%3D2012%26volume%3D226%26spage%3D404%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ma, W. W.</span><span> </span><span class="NLM_article-title">Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">Anticancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.2174%2F187152011796817628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21787276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BC387kt12mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=638-642&author=W.+W.+Ma&title=Development+of+Focal+Adhesion+Kinase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of focal adhesion kinase inhibitors in cancer therapy</span></div><div class="casAuthors">Ma Wen Wee</div><div class="citationInfo"><span class="NLM_cas:title">Anti-cancer agents in medicinal chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">638-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase implicated in cancer progression, and plays a vital role in integrating environmental signals from growth factors, extracellular matrix and mechanical forces.  As a scaffolding protein, FAK interacts and regulates the activity of many signaling kinases including Src, VEGFR-3, p53, PI3k and IGF-1R.  In turn, FAK activity is modulated by a complex network of regulators that presents a number of therapeutic approaches to targeting FAK in cancer therapy.  The ATP competitive inhibitors binds directly to FAK kinase domain to abrogate multiple downstream signaling pathways, and this class of agents lead the way in FAK inhibitor clinical development.  CFAK-C4 and Y15 represents a novel class of non-ATP dependant, allosteric inhibitors that interrupt protein-protein interactions to achieve anti-cancer effects.  The optimal approach to targeting FAK for cancer therapy is currently under investigation.  Preliminary efficacy signals from early-phase trials suggest that FAK inhibitors may be best used in combination therapy.  In addition to determining dosing schedules that is tolerable by patients, future clinical studies should include mechanistic-based pharmacodynamic studies to determine the biological active dose and explore potential predictive markers.  In summary, a rich pipeline of FAK-targeting agents is entering clinical development and has the potential of improving the lives of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmsy2s-WfhkMK3uFsUIZtkfW6udTcc2ebDNktpCCg8jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387kt12mtw%253D%253D&md5=76a0b408a10e6650305a1fd27dff0799</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F187152011796817628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152011796817628%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26atitle%3DDevelopment%2520of%2520Focal%2520Adhesion%2520Kinase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DAnticancer%2520Agents%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D638%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">The Direct Effect of Focal Adhesion Kinase (FAK), Dominant-Negative FAK, FAK-CD and FAK siRNA on Gene Expression and Human MCF-7 Breast Cancer Cell Tumorigenesis</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_elocation-id">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&author=V.+M.+Golubovskayaauthor=M.+Zhengauthor=L.+Zhangauthor=J.-L.+Liauthor=W.+G.+Cance&title=The+Direct+Effect+of+Focal+Adhesion+Kinase+%28FAK%29%2C+Dominant-Negative+FAK%2C+FAK-CD+and+FAK+siRNA+on+Gene+Expression+and+Human+MCF-7+Breast+Cancer+Cell+Tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.-L.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Direct%2520Effect%2520of%2520Focal%2520Adhesion%2520Kinase%2520%2528FAK%2529%252C%2520Dominant-Negative%2520FAK%252C%2520FAK-CD%2520and%2520FAK%2520siRNA%2520on%2520Gene%2520Expression%2520and%2520Human%2520MCF-7%2520Breast%2520Cancer%2520Cell%2520Tumorigenesis%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Xu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturge, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cance, W. G.</span><span> </span><span class="NLM_article-title">Attenuation of the Expression of the Focal Adhesion Kinase Induces Apoptosis in Tumor Cells</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=9052982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK28XitFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=413-418&author=L.+H.+Xuauthor=L.+V.+Owensauthor=G.+C.+Sturgeauthor=X.+Yangauthor=E.+T.+Liuauthor=R.+J.+Cravenauthor=W.+G.+Cance&title=Attenuation+of+the+Expression+of+the+Focal+Adhesion+Kinase+Induces+Apoptosis+in+Tumor+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells</span></div><div class="casAuthors">Xu, Li-hui; Owens, Lewis V.; Sturge, Glenn C.; Yang, Xihui; Liu, Edison T.; Craven, Rolf J.; Cance, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-18</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase implicated in integrin-mediated signal transduction pathways, oncogenic transformation by v-src, and the invasion of human tumors.  The overexpression of p125FAK in a variety of human tumors and tumor cell lines in comparison to their non-transformed counterparts suggested that attenuation of p125FaK expression might have an effect on tumor cell proliferation.  In this study, the authors have treated tumor cell lines that expressed high levels of p125FAK with different antisense oligonucleotides to FAK, and have specifically attenuated p125FAK expression.  The cells treated with antisense oligonucleotides not only lost their attachment, but also underwent apoptosis.  Extensive control oligonucleotide expts. suggested that this attenuation was highly FAK specific.  Furthermore, normal human fibroblasts, which did not express high levels of p125FaK, did not lose their attachment or become apoptotic with FAK antisense treatment.  These results suggested that FAK is involved in adhesion-mediated growth in tumor cells and that FAK may be a rational gene-directed target for disrupting tumor cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYz8mKAEF_LVg90H21EOLACvtfcHk0lgbJAQLjPtcXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFegt78%253D&md5=ea65ebdce50a369ce454259f072a320d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%2BH.%26aulast%3DOwens%26aufirst%3DL.%2BV.%26aulast%3DSturge%26aufirst%3DG.%2BC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DE.%2BT.%26aulast%3DCraven%26aufirst%3DR.%2BJ.%26aulast%3DCance%26aufirst%3DW.%2BG.%26atitle%3DAttenuation%2520of%2520the%2520Expression%2520of%2520the%2520Focal%2520Adhesion%2520Kinase%2520Induces%2520Apoptosis%2520in%2520Tumor%2520Cells%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1996%26volume%3D7%26spage%3D413%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loftus, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaarde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monia, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">Inhibition of Focal Adhesion Kinase Expression or Activity Disrupts Epidermal Growth Factor-Stimulated Signaling Promoting the Migration of Invasive Human Carcinoma Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7079</span><span class="NLM_x">–</span> <span class="NLM_lpage">7090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7079-7090&author=C.+R.+Hauckauthor=D.+J.+Siegauthor=D.+A.+Hsiaauthor=J.+C.+Loftusauthor=W.+A.+Gaardeauthor=B.+P.+Moniaauthor=D.+D.+Schlaepfer&title=Inhibition+of+Focal+Adhesion+Kinase+Expression+or+Activity+Disrupts+Epidermal+Growth+Factor-Stimulated+Signaling+Promoting+the+Migration+of+Invasive+Human+Carcinoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DSieg%26aufirst%3DD.%2BJ.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DLoftus%26aufirst%3DJ.%2BC.%26aulast%3DGaarde%26aufirst%3DW.%2BA.%26aulast%3DMonia%26aufirst%3DB.%2BP.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DInhibition%2520of%2520Focal%2520Adhesion%2520Kinase%2520Expression%2520or%2520Activity%2520Disrupts%2520Epidermal%2520Growth%2520Factor-Stimulated%2520Signaling%2520Promoting%2520the%2520Migration%2520of%2520Invasive%2520Human%2520Carcinoma%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7079%26epage%3D7090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuckle, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyke, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikkarainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruoslahti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">Decreased Focal Adhesion Kinase Suppresses Papilloma Formation during Experimental Mouse Skin Carcinogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8385</span><span class="NLM_x">–</span> <span class="NLM_lpage">8389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8385-8389&author=G.+W.+McLeanauthor=K.+Brownauthor=M.+I.+Arbuckleauthor=A.+W.+Wykeauthor=T.+Pikkarainenauthor=E.+Ruoslahtiauthor=M.+C.+Frame&title=Decreased+Focal+Adhesion+Kinase+Suppresses+Papilloma+Formation+during+Experimental+Mouse+Skin+Carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DArbuckle%26aufirst%3DM.%2BI.%26aulast%3DWyke%26aufirst%3DA.%2BW.%26aulast%3DPikkarainen%26aufirst%3DT.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DDecreased%2520Focal%2520Adhesion%2520Kinase%2520Suppresses%2520Papilloma%2520Formation%2520during%2520Experimental%2520Mouse%2520Skin%2520Carcinogenesis%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8385%26epage%3D8389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Parsons, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack-Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span> </span><span class="NLM_article-title">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1078-0432.CCR-07-2220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=18245520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=627-632&author=J.+T.+Parsonsauthor=J.+Slack-Davisauthor=R.+Tilghmanauthor=W.+G.+Roberts&title=Focal+Adhesion+Kinase%3A+Targeting+Adhesion+Signaling+Pathways+for+Therapeutic+Intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention</span></div><div class="casAuthors">Parsons, J. Thomas; Slack-Davis, Jill; Tilghman, Robert; Roberts, W. Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-632</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment plays a central role in cancer progression and metastasis.  Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix.  Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWVNxaWCL7Vg90H21EOLACvtfcHk0lggeGvVx1N41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFyksbw%253D&md5=0e9b84c9216582b035ed9abd98b42cda</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2220%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26aulast%3DSlack-Davis%26aufirst%3DJ.%26aulast%3DTilghman%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DFocal%2520Adhesion%2520Kinase%253A%2520Targeting%2520Adhesion%2520Signaling%2520Pathways%2520for%2520Therapeutic%2520Intervention%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shen, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, A. Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flavell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.-L.</span><span> </span><span class="NLM_article-title">Conditional Knockout of Focal Adhesion Kinase in Endothelial Cells Reveals Its Role in Angiogenesis and Vascular Development in Late Embryogenesis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=941-952&author=T.-L.+Shenauthor=A.+Y.-J.+Parkauthor=A.+Alcarazauthor=X.+Pengauthor=I.+Jangauthor=P.+Koniauthor=R.+A.+Flavellauthor=H.+Guauthor=J.-L.+Guan&title=Conditional+Knockout+of+Focal+Adhesion+Kinase+in+Endothelial+Cells+Reveals+Its+Role+in+Angiogenesis+and+Vascular+Development+in+Late+Embryogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DT.-L.%26aulast%3DPark%26aufirst%3DA.%2BY.-J.%26aulast%3DAlcaraz%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DJang%26aufirst%3DI.%26aulast%3DKoni%26aufirst%3DP.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DJ.-L.%26atitle%3DConditional%2520Knockout%2520of%2520Focal%2520Adhesion%2520Kinase%2520in%2520Endothelial%2520Cells%2520Reveals%2520Its%2520Role%2520in%2520Angiogenesis%2520and%2520Vascular%2520Development%2520in%2520Late%2520Embryogenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2005%26volume%3D169%26spage%3D941%26epage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Weis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Pathophysiological Consequences of VEGF-Induced Vascular Permeability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=497-504&author=S.+M.+Weisauthor=D.+A.+Cheresh&title=Pathophysiological+Consequences+of+VEGF-Induced+Vascular+Permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DS.%2BM.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DPathophysiological%2520Consequences%2520of%2520VEGF-Induced%2520Vascular%2520Permeability%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D497%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Duffy, M. J.</span><span> </span><span class="NLM_article-title">The Urokinase Plasminogen Activator System: Role in Malignancy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.2174%2F1381612043453559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=14754404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=39-49&author=M.+J.+Duffy&title=The+Urokinase+Plasminogen+Activator+System%3A+Role+in+Malignancy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The urokinase plasminogen activator system: Role in malignancy</span></div><div class="casAuthors">Duffy, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The urokinase plasminogen activator (uPA) system consists of the serine protease uPA, its glycolipid-anchored receptor, uPAR and its 2 serpin inhibitors, plasminogen activator inhibitor-1 (PAI-1) and plasminogen activator inhibitor-2 (PAI-2).  Recent findings suggest that the uPA system is causally involved at multiple steps in cancer progression.  In particular, uPA has been implicated in remodelling of the extracellular matrix, enhancing both cell proliferation and migration and modulating cell adhesion.  Consistent with its role in cancer progression, multiple groups have shown that high levels of uPA in primary breast cancers are independently assocd. with adverse outcome.  Paradoxically, high levels of PAI-1 also correlate with poor prognosis in patients with breast cancer.  The prognostic value of uPA/PAI-1 in axillary node-neg. breast cancer patients was recently validated using both a prospective randomized trial and a pooled anal., i.e., in 2 different Level 1 Evidence studies.  Assay of uPA and PAI-1 may thus help identify low risk node-neg. patients for whom adjuvant chemotherapy is unnecessary.  Finally, preclin. studies show that either inhibition of uPA catalytic activity or prevention of uPA binding to its receptor reduces tumor growth, angiogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdjdCtREOu7Vg90H21EOLACvtfcHk0lggeGvVx1N41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVyhsQ%253D%253D&md5=1feff3497e203e4d109a229b760da52f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1381612043453559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043453559%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520Urokinase%2520Plasminogen%2520Activator%2520System%253A%2520Role%2520in%2520Malignancy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Braren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Endothelial FAK Is Essential for Vascular Network Stability, Cell Survival, and Lamellipodial Formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2006&pages=151-162&author=R.+Brarenauthor=H.+Huauthor=Y.+H.+Kimauthor=H.+E.+Beggsauthor=L.+F.+Reichardtauthor=R.+Wang&title=Endothelial+FAK+Is+Essential+for+Vascular+Network+Stability%2C+Cell+Survival%2C+and+Lamellipodial+Formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraren%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DBeggs%26aufirst%3DH.%2BE.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEndothelial%2520FAK%2520Is%2520Essential%2520for%2520Vascular%2520Network%2520Stability%252C%2520Cell%2520Survival%252C%2520and%2520Lamellipodial%2520Formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D172%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokol, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassalli, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.-L.</span><span> </span><span class="NLM_article-title">Overexpression of Focal Adhesion Kinase in Vascular Endothelial Cells Promotes Angiogenesis in Transgenic Mice</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=421-430&author=X.+Pengauthor=H.+Uedaauthor=H.+Zhouauthor=T.+Stokolauthor=T.-L.+Shenauthor=A.+Alcarazauthor=T.+Nagyauthor=J.-D.+Vassalliauthor=J.-L.+Guan&title=Overexpression+of+Focal+Adhesion+Kinase+in+Vascular+Endothelial+Cells+Promotes+Angiogenesis+in+Transgenic+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DUeda%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DStokol%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DT.-L.%26aulast%3DAlcaraz%26aufirst%3DA.%26aulast%3DNagy%26aufirst%3DT.%26aulast%3DVassalli%26aufirst%3DJ.-D.%26aulast%3DGuan%26aufirst%3DJ.-L.%26atitle%3DOverexpression%2520of%2520Focal%2520Adhesion%2520Kinase%2520in%2520Vascular%2520Endothelial%2520Cells%2520Promotes%2520Angiogenesis%2520in%2520Transgenic%2520Mice%26jtitle%3DCardiovasc.%2520Res.%26date%3D2004%26volume%3D64%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tavora, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadeja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostourou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodivala-Dilke, K. M.</span><span> </span><span class="NLM_article-title">Endothelial FAK Is Required for Tumour Angiogenesis</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Femmm.201000106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21154724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=516-528&author=B.+Tavoraauthor=S.+Batistaauthor=L.+E.+Reynoldsauthor=S.+Jadejaauthor=S.+Robinsonauthor=V.+Kostourouauthor=I.+Hartauthor=M.+Fruttigerauthor=M.+Parsonsauthor=K.+M.+Hodivala-Dilke&title=Endothelial+FAK+Is+Required+for+Tumour+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial FAK is required for tumour angiogenesis</span></div><div class="casAuthors">Tavora, Bernardo; Batista, Silvia; Reynolds, Louise E.; Jadeja, Shalini; Robinson, Stephen; Kostourou, Vassiliki; Hart, Ian; Fruttiger, Marcus; Parsons, Maddy; Hodivala-Dilke, Kairbaan M.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">516-528</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays a fundamental role in integrin and growth factor mediated signalling and is an important player in cell migration and proliferation, processes vital for angiogenesis.  However, the role of FAK in adult pathol. angiogenesis is unknown.  We have generated endothelial-specific tamoxifen-inducible FAK knockout mice by crossing FAK-floxed (FAKfl/fl) mice with the platelet derived growth factor b (Pdgfb)-iCreER mice.  Tamoxifen-treatment of Pdgfb-iCreER;FAKfl/fl mice results in FAK deletion in adult endothelial cells (ECs) without any adverse effects.  Importantly however, endothelial FAK-deletion in adult mice inhibited tumor growth and reduced tumor angiogenesis.  Furthermore, in in vivo angiogenic assays FAK deletion impairs vascular endothelial growth factor (VEGF)-induced neovascularization.  In addn., in vitro deletion of FAK in ECs resulted in reduced VEGF-stimulated Akt phosphorylation and correlating reduced cellular proliferation as well as increased cell death.  Our data suggest that FAK is required for adult pathol. angiogenesis and validates FAK as a possible target for anti-angiogenic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7F0jECcbicrVg90H21EOLACvtfcHk0lj8-7YfgM8DVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFehsg%253D%253D&md5=e1727f709428667a487c2dd61ee9ff9a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000106%26sid%3Dliteratum%253Aachs%26aulast%3DTavora%26aufirst%3DB.%26aulast%3DBatista%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DL.%2BE.%26aulast%3DJadeja%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DKostourou%26aufirst%3DV.%26aulast%3DHart%26aufirst%3DI.%26aulast%3DFruttiger%26aufirst%3DM.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHodivala-Dilke%26aufirst%3DK.%2BM.%26atitle%3DEndothelial%2520FAK%2520Is%2520Required%2520for%2520Tumour%2520Angiogenesis%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D516%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">[Focal adhesion kinase expression and angiogenesis in breast carcinoma]</span> <span class="citation_source-journal">Nan Fang Yi Ke Da Xue Xue Bao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17884781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BD2srmsFegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1370-1373&author=Y.+Huangauthor=S.+Zhang&title=%5BFocal+adhesion+kinase+expression+and+angiogenesis+in+breast+carcinoma%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Focal adhesion kinase expression and angiogenesis in breast carcinoma</span></div><div class="casAuthors">Huang Yu-dian; Zhang Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Nan fang yi ke da xue xue bao = Journal of Southern Medical University</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1370-3</span>
        ISSN:<span class="NLM_cas:issn">1673-4254</span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the expression of focal adhesion kinase (FAK) in breast carcinoma tissues and its association with microvessel density (MVD), and explore the relationship between FAK-mediated cell signaling and angiogenesis in breast carcinoma.  METHODS:  FAK and CD34 expressions were examined by immunohistochemistry with SP method in 88 breast carcinoma tissues and 30 tissues of benign breast disease.  The correlations of FAK protein expression with MVD marked with CD34 and clinicopathological parameters were analyzed in breast carcinoma.  RESULTS:  In the 88 breast carcinomas, the positivity rate of FAK was 68.2% (60/88) with MVD of (34.52-/+13.11) /HPE, showing significant differences from those of the benign disease group (P<0.01).  FAK expression and MVD in breast carcinoma tissues were positively related to tumor size, axillary lymph node metastasis and clinical stage (P<0.05), but not to the patients' age or histopathological grade of the tumors (P>0.05).  In breast carcinoma, the expression of FAK was positively related to MVD (P<0.01).  CONCLUSIONS:  FAK protein expression and MVD are closely correlated with the invasion and metastasis of breast carcinoma.  FAK expression can promote angiogenesis of breast carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdNvPM04mXF_3jf77P2BG3fW6udTcc2eZVi_cHX3PM5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srmsFegtA%253D%253D&md5=ca8f999567453a8fa7932ca67f09f9ac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3D%255BFocal%2520adhesion%2520kinase%2520expression%2520and%2520angiogenesis%2520in%2520breast%2520carcinoma%255D%26jtitle%3DNan%2520Fang%2520Yi%2520Ke%2520Da%2520Xue%2520Xue%2520Bao%26date%3D2007%26volume%3D27%26spage%3D1370%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Halder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nick, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span> </span><span class="NLM_article-title">Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10976</span><span class="NLM_x">–</span> <span class="NLM_lpage">10983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10976-10983&author=J.+Halderauthor=Y.+G.+Linauthor=W.+M.+Merrittauthor=W.+A.+Spannuthauthor=A.+M.+Nickauthor=T.+Hondaauthor=A.+A.+Kamatauthor=L.+Y.+Hanauthor=T.+J.+Kimauthor=C.+Luauthor=A.+M.+Tariauthor=W.+Bornmannauthor=A.+Fernandezauthor=G.+Lopez-Beresteinauthor=A.+K.+Sood&title=Therapeutic+Efficacy+of+a+Novel+Focal+Adhesion+Kinase+Inhibitor+TAE226+in+Ovarian+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DMerritt%26aufirst%3DW.%2BM.%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DNick%26aufirst%3DA.%2BM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DKamat%26aufirst%3DA.%2BA.%26aulast%3DHan%26aufirst%3DL.%2BY.%26aulast%3DKim%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DFernandez%26aufirst%3DA.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26aulast%3DSood%26aufirst%3DA.%2BK.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520a%2520Novel%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%2520TAE226%2520in%2520Ovarian%2520Carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10976%26epage%3D10983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Coq, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loukaci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepelletier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj-Slimane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Synthesis of Novel Diarylamino-1,3,5-Triazine Derivatives as FAK Inhibitors with Anti-Angiogenic Activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4552</span><span class="NLM_x">–</span> <span class="NLM_lpage">4556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4552-4556&author=P.+Daoauthor=R.+Jarrayauthor=J.+Le+Coqauthor=D.+Liethaauthor=A.+Loukaciauthor=Y.+Lepelletierauthor=R.+Hadj-Slimaneauthor=C.+Garbayauthor=F.+Raynaudauthor=H.+Chen&title=Synthesis+of+Novel+Diarylamino-1%2C3%2C5-Triazine+Derivatives+as+FAK+Inhibitors+with+Anti-Angiogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DJarray%26aufirst%3DR.%26aulast%3DLe%2BCoq%26aufirst%3DJ.%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DLoukaci%26aufirst%3DA.%26aulast%3DLepelletier%26aufirst%3DY.%26aulast%3DHadj-Slimane%26aufirst%3DR.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520Novel%2520Diarylamino-1%252C3%252C5-Triazine%2520Derivatives%2520as%2520FAK%2520Inhibitors%2520with%2520Anti-Angiogenic%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4552%26epage%3D4556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepelletier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coq, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadj-Slimane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbeuval, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Inhibition of Both Focal Adhesion Kinase and Fibroblast Growth Factor Receptor 2 Pathways Induces Anti-Tumor and Anti-Angiogenic Activities</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.canlet.2014.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=24657306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Chu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=88-99&author=P.+Daoauthor=R.+Jarrayauthor=N.+Smithauthor=Y.+Lepelletierauthor=J.+L.+Coqauthor=D.+Liethaauthor=R.+Hadj-Slimaneauthor=J.-P.+Herbeuvalauthor=C.+Garbayauthor=F.+Raynaudauthor=H.+Chen&title=Inhibition+of+Both+Focal+Adhesion+Kinase+and+Fibroblast+Growth+Factor+Receptor+2+Pathways+Induces+Anti-Tumor+and+Anti-Angiogenic+Activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities</span></div><div class="casAuthors">Dao, Pascal; Jarray, Rafika; Smith, Nikaia; Lepelletier, Yves; Coq, Johanne Le; Lietha, Daniel; Hadj-Slimane, Reda; Herbeuval, Jean-Philippe; Garbay, Christiane; Raynaud, Francoise; Chen, Huixiong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">88-99</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">FAK and FGFR2 signaling pathways play important roles in cancer development, progression and tumor angiogenesis.  PHM16 is a novel ATP competitive inhibitor of FAK and FGFR2.  To evaluate the therapeutic efficacy of this agent, we examd. its anti-angiogenic effect in HUVEC and its anti-tumor effect in different cancer cell lines.  We showed PHM16 inhibited endothelial cell viability, adherence and tube formation along with the added ability to induce endothelial cell apoptosis.  This compd. significantly delayed tumor cell growth.  Together, these data showed that inhibition of both FAK and FGFR2 signaling pathways can enhance anti-tumor and anti-angiogenic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx2WBLI2q-H7Vg90H21EOLACvtfcHk0lh8wFB2_G9bqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Chu7o%253D&md5=cfe4998e1aea0ac67eba6e10170139d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DJarray%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DLepelletier%26aufirst%3DY.%26aulast%3DCoq%26aufirst%3DJ.%2BL.%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DHadj-Slimane%26aufirst%3DR.%26aulast%3DHerbeuval%26aufirst%3DJ.-P.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Both%2520Focal%2520Adhesion%2520Kinase%2520and%2520Fibroblast%2520Growth%2520Factor%2520Receptor%25202%2520Pathways%2520Induces%2520Anti-Tumor%2520and%2520Anti-Angiogenic%2520Activities%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D348%26spage%3D88%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Golubovskaya, V. M.</span><span> </span><span class="NLM_article-title">A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7405</span><span class="NLM_x">–</span> <span class="NLM_lpage">7416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800483v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7405-7416&author=V.+M.+Golubovskaya&title=A+Small+Molecule+Inhibitor%2C+1%2C2%2C4%2C5-Benzenetetraamine+Tetrahydrochloride%2C+Targeting+the+Y397+Site+of+Focal+Adhesion+Kinase+Decreases+Tumor+Growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm800483v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800483v%26sid%3Dliteratum%253Aachs%26aulast%3DGolubovskaya%26aufirst%3DV.%2BM.%26atitle%3DA%2520Small%2520Molecule%2520Inhibitor%252C%25201%252C2%252C4%252C5-Benzenetetraamine%2520Tetrahydrochloride%252C%2520Targeting%2520the%2520Y397%2520Site%2520of%2520Focal%2520Adhesion%2520Kinase%2520Decreases%2520Tumor%2520Growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7405%26epage%3D7416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Roberts, W. G.</span><span> </span><span class="NLM_article-title">Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1935-1944&author=W.+G.+Roberts&title=Antitumor+Activity+and+Pharmacology+of+a+Selective+Focal+Adhesion+Kinase+Inhibitor%2C+PF-562%2C271"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26atitle%3DAntitumor%2520Activity%2520and%2520Pharmacology%2520of%2520a%2520Selective%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%252C%2520PF-562%252C271%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1935%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sakurama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span> </span><span class="NLM_article-title">Inhibition of Focal Adhesion Kinase as a Potential Therapeutic Strategy for Imatinib-Resistant Gastrointestinal Stromal Tumor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1535-7163.MCT-08-0884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19139121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=127-134&author=K.+Sakuramaauthor=K.+Nomaauthor=M.+Takaokaauthor=Y.+Tomonoauthor=N.+Watanabeauthor=S.+Hatakeyamaauthor=O.+Ohmoriauthor=S.+Hirotaauthor=T.+Motokiauthor=Y.+Shirakawaauthor=T.+Yamatsujiauthor=M.+Haisaauthor=J.+Matsuokaauthor=N.+Tanakaauthor=Y.+Naomoto&title=Inhibition+of+Focal+Adhesion+Kinase+as+a+Potential+Therapeutic+Strategy+for+Imatinib-Resistant+Gastrointestinal+Stromal+Tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor</span></div><div class="casAuthors">Sakurama, Kazufumi; Noma, Kazuhiro; Takaoka, Munenori; Tomono, Yasuko; Watanabe, Nobuyuki; Hatakeyama, Shinji; Ohmori, Osamu; Hirota, Seiichi; Motoki, Takayuki; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Haisa, Minoru; Matsuoka, Junji; Tanaka, Noriaki; Naomoto, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-134</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is often up-regulated in a variety of malignancies, including gastrointestinal stromal tumor (GIST), and its overexpression seems to be assocd. with tumor progressiveness and poor prognosis.  GIST is well known to have a mutation to c-KIT; thus, a specific c-KIT inhibitor (imatinib) is recognized as the first-line chemotherapy for GIST, although a certain type of c-KIT mutation reveals a resistance to imatinib due to as yet uncertain mol. mechanisms.  To assess the c-KIT mutation-related variation of cellular responses to imatinib, murine lymphocyte-derived Ba/F3 cells, which are stably transduced with different types of c-KIT mutation, were treated with either imatinib or a FAK inhibitor (TAE226), and their antitumor effects were detd. in vitro and in vivo.  A mutation at exon 11 (KITdel559-560) displayed a high sensitivity to imatinib, whereas that at exon 17 (KIT820Tyr) showed a significant resistance to imatinib in vitro and in vivo.  KIT820Tyr cells appeared to maintain the activities of FAK and AKT under the imatinib treatment, suggesting that FAK might play a role in cell survival in imatinib-resistant cells.  When FAK activity in those cells was inhibited by TAE226, cell growth was equally suppressed and the cells underwent apoptosis regardless of the c-KIT mutation types.  Oral administration of TAE226 significantly diminished tumor growth in nude mice bearing KIT820Tyr xenografts.  In summary, c-KIT mutation at exon 17 displayed a resistance to imatinib with maintained activations of FAK and subsequent survival signals.  Targeting FAK could be a potential therapeutic strategy for imatinib-resistant GISTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGb6BgvCFVbVg90H21EOLACvtfcHk0ljZFduXEc5bWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSmsw%253D%253D&md5=26d759f5592b41d06ee84cde83c6cf39</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0884%26sid%3Dliteratum%253Aachs%26aulast%3DSakurama%26aufirst%3DK.%26aulast%3DNoma%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DTomono%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DMotoki%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DY.%26aulast%3DYamatsuji%26aufirst%3DT.%26aulast%3DHaisa%26aufirst%3DM.%26aulast%3DMatsuoka%26aufirst%3DJ.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DNaomoto%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Focal%2520Adhesion%2520Kinase%2520as%2520a%2520Potential%2520Therapeutic%2520Strategy%2520for%2520Imatinib-Resistant%2520Gastrointestinal%2520Stromal%2520Tumor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D127%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lietha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_elocation-id">e3800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1371%2Fjournal.pone.0003800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19030106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BD1cjmtF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&author=D.+Liethaauthor=M.+J.+Eck&title=Crystal+Structures+of+the+FAK+Kinase+in+Complex+with+TAE226+and+Related+Bis-Anilino+Pyrimidine+Inhibitors+Reveal+a+Helical+DFG+Conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation</span></div><div class="casAuthors">Lietha Daniel; Eck Michael J</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e3800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase required for cell migration, proliferation and survival.  FAK overexpression has been documented in diverse human cancers and is associated with a poor clinical outcome.  Recently, a novel bis-anilino pyrimidine inhibitor, TAE226, was reported to efficiently inhibit FAK signaling, arrest tumor growth and invasion and prolong the life of mice with glioma or ovarian tumor implants.  Here we describe the crystal structures of the FAK kinase bound to TAE226 and three related bis-anilino pyrimidine compounds.  TAE226 induces a conformation of the N-terminal portion of the kinase activation loop that is only observed in FAK, but is distinct from the conformation in both the active and inactive states of the kinase.  This conformation appears to require a glycine immediately N-terminal to the "DFG motif", which adopts a helical conformation stabilized by interactions with TAE226.  The presence of a glycine residue in this position contributes to the specificity of TAE226 and related compounds for FAK.  Our work highlights the fact that kinases can access conformational space that is not necessarily utilized for their native catalytic regulation, and that such conformations can explain and be exploited for inhibitor specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQsjpXJZjhGaWZyxfu64m4ffW6udTcc2eYf9sH5UV-RHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjmtF2muw%253D%253D&md5=60c1f8e0ae9da7c5b6f638afdff195e1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0003800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0003800%26sid%3Dliteratum%253Aachs%26aulast%3DLietha%26aufirst%3DD.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520FAK%2520Kinase%2520in%2520Complex%2520with%2520TAE226%2520and%2520Related%2520Bis-Anilino%2520Pyrimidine%2520Inhibitors%2520Reveal%2520a%2520Helical%2520DFG%2520Conformation%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">A Novel Low-Molecular Weight Inhibitor of Focal Adhesion Kinase, TAE226, Inhibits Glioma Growth</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fmc.20297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17219439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=488-496&author=Q.+Shiauthor=A.+B.+Hjelmelandauthor=S.+T.+Keirauthor=L.+Songauthor=S.+Wickmanauthor=D.+Jacksonauthor=O.+Ohmoriauthor=D.+D.+Bignerauthor=H.+S.+Friedmanauthor=J.+N.+Rich&title=A+Novel+Low-Molecular+Weight+Inhibitor+of+Focal+Adhesion+Kinase%2C+TAE226%2C+Inhibits+Glioma+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth</span></div><div class="casAuthors">Shi, Qing; Hjelmeland, Anita B.; Keir, Stephen T.; Song, Linhua; Wickman, Sarah; Jackson, Dowdy; Ohmori, Osamu; Bigner, Darell D.; Friedman, Henry S.; Rich, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Glioblastomas are highly lethal cancers that resist current therapies.  Novel therapies under development target mol. mechanisms that promote glioblastoma growth.  In glioblastoma patient specimens, the non-receptor tyrosine kinase focal adhesion kinase (FAK) is overexpressed.  Upon growth factor receptor stimulation or integrin engagement, FAK is activated by phosphorylation on crit. tyrosine residues.  Activated FAK initiates a signal transduction cascade which promotes glioma growth and invasion by increasing cellular adhesion, migration, invasion, and proliferation.  We find that human glioma cell lines express different levels of total FAK protein and activating phosphorylation of tyrosine residues Tyr397, Tyr861, and Tyr925.  As all glioma cell lines examd. expressed phosphorylated FAK, we examd. the efficacy of a novel low-mol. wt. inhibitor of FAK, TAE226, against human glioma cell lines.  TAE226 inhibited the phosphorylation of FAK as well as the downstream effectors AKT, extracellular signal-related kinase, and S6 ribosomal protein in multiple glioma cell lines.  TAE226 induced a concn.-dependent decrease in cellular proliferation with an assocd. G2 cell cycle arrest in every cell line and an increase in apoptosis in a cell-line-specific manner.  TAE226 also decreased glioma cell adhesion, migration, and invasion through an artificial extracellular matrix.  Together, these data demonstrate the potential benefit of TAE226 for glioma therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXL0wEDuHo9bVg90H21EOLACvtfcHk0ljZFduXEc5bWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Olsrg%253D&md5=83711a44fe2472eae4baf568ee4332a4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmc.20297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20297%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWickman%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DA%2520Novel%2520Low-Molecular%2520Weight%2520Inhibitor%2520of%2520Focal%2520Adhesion%2520Kinase%252C%2520TAE226%252C%2520Inhibits%2520Glioma%2520Growth%26jtitle%3DMol.%2520Carcinog.%26date%3D2007%26volume%3D46%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagatsuka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span> </span><span class="NLM_article-title">Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma in Vitro and in Vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4631</span><span class="NLM_x">–</span> <span class="NLM_lpage">4639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1078-0432.CCR-07-4755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=18628478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFGitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4631-4639&author=N.+Watanabeauthor=M.+Takaokaauthor=K.+Sakuramaauthor=Y.+Tomonoauthor=S.+Hatakeyamaauthor=O.+Ohmoriauthor=T.+Motokiauthor=Y.+Shirakawaauthor=T.+Yamatsujiauthor=M.+Haisaauthor=J.+Matsuokaauthor=D.+G.+Beerauthor=H.+Nagatsukaauthor=N.+Tanakaauthor=Y.+Naomoto&title=Dual+Tyrosine+Kinase+Inhibitor+for+Focal+Adhesion+Kinase+and+Insulin-like+Growth+Factor-I+Receptor+Exhibits+Anticancer+Effect+in+Esophageal+Adenocarcinoma+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo</span></div><div class="casAuthors">Watanabe, Nobuyuki; Takaoka, Munenori; Sakurama, Kazufumi; Tomono, Yasuko; Hatakeyama, Shinji; Ohmori, Osamu; Motoki, Takayuki; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Haisa, Minoru; Matsuoka, Junji; Beer, David G.; Nagatsuka, Hitoshi; Tanaka, Noriaki; Naomoto, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4631-4639</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) regulates integrin and growth factor-mediated signaling pathways to enhance cell migration, proliferation, and survival, and its up-regulation correlates malignant grade and poor outcome in several types of cancer.  In this study, we aimed to raise a potential therapeutic strategy using a FAK inhibitor for Barrett's esophageal adenocarcinoma.  The expression status of FAK in clin. Barrett's esophageal adenocarcinoma tissues was detd. by immunohistochem.  Cultured esophageal adenocarcinoma cells were treated with TAE226, a specific FAK inhibitor with an addnl. effect of inhibiting insulin-like growth factor-I receptor (IGF-IR), to assess its anticancer effect in vitro.  Western blot was carried out to explore a participating signaling pathway for TAE226-induced cell death.  Furthermore, TAE226 was orally administered to s.c. xenograft animals to investigate its anticancer effect in vivo.  Strong expression of FAK was found in 94.0% of Barrett's esophageal adenocarcinoma compared with 17.9% of Barrett's epithelia, suggesting that FAK might play a crit. role in the progression of Barrett's esophageal adenocarcinoma.  When esophageal adenocarcinoma cells were treated with TAE226, cell proliferation and migration were greatly inhibited with an apparent structural change of actin fiber and a loss of cell adhesion.  The activities of FAK, IGF-IR, and AKT were suppressed by TAE226 and subsequent dephosphorylation of BAD at Ser136 occurred, resulting in caspase-mediated apoptosis.  In vivo tumor vol. was significantly reduced by oral administration of TAE226.  These results suggest that TAE226, a dual tyrosine kinase inhibitor for FAK and IGF-IR, could become a new remedy for Barrett's esophageal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEkfeYenaE0LVg90H21EOLACvtfcHk0lgfBN63c36JpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFGitbc%253D&md5=207088ee3090e557fa05c99a421e4829</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4755%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DSakurama%26aufirst%3DK.%26aulast%3DTomono%26aufirst%3DY.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DMotoki%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DY.%26aulast%3DYamatsuji%26aufirst%3DT.%26aulast%3DHaisa%26aufirst%3DM.%26aulast%3DMatsuoka%26aufirst%3DJ.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DNagatsuka%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DNaomoto%26aufirst%3DY.%26atitle%3DDual%2520Tyrosine%2520Kinase%2520Inhibitor%2520for%2520Focal%2520Adhesion%2520Kinase%2520and%2520Insulin-like%2520Growth%2520Factor-I%2520Receptor%2520Exhibits%2520Anticancer%2520Effect%2520in%2520Esophageal%2520Adenocarcinoma%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4631%26epage%3D4639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kurio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, N. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naomoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, A.</span><span> </span><span class="NLM_article-title">Anti-Tumor Effect in Human Breast Cancer by TAE226, a Dual Inhibitor for FAK and IGF-IR in Vitro and in Vivo</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1016%2Fj.yexcr.2011.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=21338601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=1134-1146&author=N.+Kurioauthor=T.+Shimoauthor=T.+Fukazawaauthor=M.+Takaokaauthor=T.+Okuiauthor=N.+M.+M.+Hassanauthor=T.+Honamiauthor=S.+Hatakeyamaauthor=M.+Ikedaauthor=Y.+Naomotoauthor=A.+Sasaki&title=Anti-Tumor+Effect+in+Human+Breast+Cancer+by+TAE226%2C+a+Dual+Inhibitor+for+FAK+and+IGF-IR+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo</span></div><div class="casAuthors">Kurio, Naito; Shimo, Tsuyoshi; Fukazawa, Takuya; Takaoka, Munenori; Okui, Tatsuo; Hassan, Nur Mohammad Monsur; Honami, Tatsuki; Hatakeyama, Shinji; Ikeda, Masahiko; Naomoto, Yoshio; Sasaki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1134-1146</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a 125-kDa non-receptor type tyrosine kinase that localizes to focal adhesions.  FAK overexpression is frequently found in invasive and metastatic cancers of the breast, colon, thyroid, and prostate, but its role in osteolytic metastasis is not well understood.  In this study, we have analyzed antitumor effects of the novel FAK Tyr397 inhibitor TAE226 against bone metastasis in breast cancer by using TAE226.  Oral administration of TAE226 in mice significantly decreased bone metastasis and osteoclasts involved which were induced by MDA-MB-231 breast cancer cells and increased the survival rate of the mouse models of bone metastasis.  TAE226 also suppressed the growth of s.c. tumors in vivo and the proliferation and migration of MDA-MB-231 cells in vitro.  Significantly, TAE226 inhibited the osteoclast formation in murine pre-osteoclastic RAW264.7 cells, and actin ring and pit formation in mature osteoclasts.  Moreover, TAE226 inhibited the receptor activator for nuclear factor κ B Ligand (RANKL) gene expression induced by parathyroid hormone-related protein (PTHrP) in bone stromal ST2 cells and blood free calcium concn. induced by PTHrP administration in vivo.  These findings suggest that FAK was critically involved in osteolytic metastasis and activated in tumors, pre-osteoclasts, mature osteoclasts, and bone stromal cells and TAE226 can be effectively used for the treatment of cancer induced bone metastasis and other bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr55W5F5GlRfbVg90H21EOLACvtfcHk0lgfBN63c36JpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ntr0%253D&md5=1083838b4f36a4eaf62504d577b59ae5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2011.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2011.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DKurio%26aufirst%3DN.%26aulast%3DShimo%26aufirst%3DT.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DTakaoka%26aufirst%3DM.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DHassan%26aufirst%3DN.%2BM.%2BM.%26aulast%3DHonami%26aufirst%3DT.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DNaomoto%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DA.%26atitle%3DAnti-Tumor%2520Effect%2520in%2520Human%2520Breast%2520Cancer%2520by%2520TAE226%252C%2520a%2520Dual%2520Inhibitor%2520for%2520FAK%2520and%2520IGF-IR%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2011%26volume%3D317%26spage%3D1134%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Liu, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFortune, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, W. K. A.</span><span> </span><span class="NLM_article-title">Inhibition of Both Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Kinase Suppresses Glioma Proliferation in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1357</span><span class="NLM_x">–</span> <span class="NLM_lpage">1367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1158%2F1535-7163.MCT-06-0476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17431114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1357-1367&author=T.-J.+Liuauthor=T.+LaFortuneauthor=T.+Hondaauthor=O.+Ohmoriauthor=S.+Hatakeyamaauthor=T.+Meyerauthor=D.+Jacksonauthor=J.+de+Grootauthor=W.+K.+A.+Yung&title=Inhibition+of+Both+Focal+Adhesion+Kinase+and+Insulin-like+Growth+Factor-I+Receptor+Kinase+Suppresses+Glioma+Proliferation+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo</span></div><div class="casAuthors">Liu, Ta-Jen; LaFortune, Tiffany; Honda, Toshiyuki; Ohmori, Osamu; Hatakeyama, Shinji; Meyer, Thomas; Jackson, Dowdy; de Groot, John; Yung, W. K. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1357-1367</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple genetic aberrations in human gliomas contribute to their highly infiltrative and rapid growth characteristics.  Focal adhesion kinase (FAK) regulates tumor migration and invasion.  Insulin-like growth factor-I receptor (IGF-IR), whose expression correlates with tumor grade, is involved in proliferation and survival.  We hypothesized that inhibiting the phosphorylation of FAK and IGF-IR by NVP-TAE226 (hereafter called TAE226), a novel dual tyrosine kinase inhibitor of FAK and IGF-IR, would suppress the growth and invasion of glioma cells.  In culture, TAE226 inhibited extracellular matrix-induced autophosphorylation of FAK (Tyr397).  TAE226 also inhibited IGF-I-induced phosphorylation of IGF-IR and activity of its downstream target genes such as MAPK and Akt.  TAE226 retarded tumor cell growth as assessed by a cell viability assay and attenuated G2-M cell cycle progression assocd. with a decrease in cyclin B1 and phosphorylated cdc2 (Tyr15) protein expression.  TAE226 treatment inhibited tumor cell invasion by at least 50% compared with the control in an in vitro Matrigel invasion assay.  Interestingly, TAE226 treatment of tumor cells contg. wild-type p53 mainly exhibited G2-M arrest, whereas tumor cells bearing mutant p53 underwent apoptosis.  Induction of apoptosis by TAE226 was substantiated by detection of caspase-3/7 activation and poly(ADP-ribose) polymerase cleavage and by an Annexin V apoptosis assay.  More importantly, TAE226 treatment significantly increased the survival rate of animals in an intracranial glioma xenograft model.  Collectively, these data show that blocking the signaling pathways of FAK and IGF-IR with TAE226 has the potential to be an efficacious treatment for human gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMIquqcQABrVg90H21EOLACvtfcHk0lhzj4m8QedqBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFams7o%253D&md5=1659c50e987e8bbb24c998e0aae14861</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0476%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.-J.%26aulast%3DLaFortune%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DJ.%26aulast%3DYung%26aufirst%3DW.%2BK.%2BA.%26atitle%3DInhibition%2520of%2520Both%2520Focal%2520Adhesion%2520Kinase%2520and%2520Insulin-like%2520Growth%2520Factor-I%2520Receptor%2520Kinase%2520Suppresses%2520Glioma%2520Proliferation%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1357%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Heinrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seenisamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmanuvel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bomke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohdich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esdar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grädler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musil, D.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of New Highly Substituted 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]- and 3<i>H</i>-Imidazolo[4,5-<i>b</i>]-pyridines as Focal Adhesion Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3016014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1160-1170&author=T.+Heinrichauthor=J.+Seenisamyauthor=L.+Emmanuvelauthor=S.+S.+Kulkarniauthor=J.+Bomkeauthor=F.+Rohdichauthor=H.+Greinerauthor=C.+Esdarauthor=M.+Krierauthor=U.+Gr%C3%A4dlerauthor=D.+Musil&title=Fragment-Based+Discovery+of+New+Highly+Substituted+1H-Pyrrolo%5B2%2C3-b%5D-+and+3H-Imidazolo%5B4%2C5-b%5D-pyridines+as+Focal+Adhesion+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3016014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016014%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DSeenisamy%26aufirst%3DJ.%26aulast%3DEmmanuvel%26aufirst%3DL.%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DGreiner%26aufirst%3DH.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DGr%25C3%25A4dler%26aufirst%3DU.%26aulast%3DMusil%26aufirst%3DD.%26atitle%3DFragment-Based%2520Discovery%2520of%2520New%2520Highly%2520Substituted%25201H-Pyrrolo%255B2%252C3-b%255D-%2520and%25203H-Imidazolo%255B4%252C5-b%255D-pyridines%2520as%2520Focal%2520Adhesion%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1160%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Regioselective Synthesis of imidazo[1,2-a][1,3,5]triazines and 3,4-dihydroimidazo[1,2-a][1,3,5]triazines from [1,3,5]triazin-2,4-Diamines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3867</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=3867-3871&author=P.+Daoauthor=C.+Garbayauthor=H.+Chen&title=Regioselective+Synthesis+of+imidazo%5B1%2C2-a%5D%5B1%2C3%2C5%5Dtriazines+and+3%2C4-dihydroimidazo%5B1%2C2-a%5D%5B1%2C3%2C5%5Dtriazines+from+%5B1%2C3%2C5%5Dtriazin-2%2C4-Diamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DRegioselective%2520Synthesis%2520of%2520imidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2520and%25203%252C4-dihydroimidazo%255B1%252C2-a%255D%255B1%252C3%252C5%255Dtriazines%2520from%2520%255B1%252C3%252C5%255Dtriazin-2%252C4-Diamines%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D3867%26epage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canoll, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Protein Tyrosine Kinase PYK2 Involved in Ca(2+)-Induced Regulation of Ion Channel and MAP Kinase Functions</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=737-745&author=S.+Levauthor=H.+Morenoauthor=R.+Martinezauthor=P.+Canollauthor=E.+Pelesauthor=J.+M.+Musacchioauthor=G.+D.+Plowmanauthor=B.+Rudyauthor=J.+Schlessinger&title=Protein+Tyrosine+Kinase+PYK2+Involved+in+Ca%282%2B%29-Induced+Regulation+of+Ion+Channel+and+MAP+Kinase+Functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLev%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DH.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DCanoll%26aufirst%3DP.%26aulast%3DPeles%26aufirst%3DE.%26aulast%3DMusacchio%26aufirst%3DJ.%2BM.%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26aulast%3DRudy%26aufirst%3DB.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DProtein%2520Tyrosine%2520Kinase%2520PYK2%2520Involved%2520in%2520Ca%25282%252B%2529-Induced%2520Regulation%2520of%2520Ion%2520Channel%2520and%2520MAP%2520Kinase%2520Functions%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D737%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kath, J. C.; Luzzio, M. J.</span> Composes Pour Traiter Le Developpement Anormal de Cellules. International Patent WO2004056786 A2, July 8,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kath%2C+J.+C.%3B+Luzzio%2C+M.+J.+Composes+Pour+Traiter+Le+Developpement+Anormal+de+Cellules.+International+Patent+WO2004056786+A2%2C+July+8%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKath%26aufirst%3DJ.%2BC.%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Slack-Davis, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilghman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanicki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">14845</span><span class="NLM_x">–</span> <span class="NLM_lpage">14852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1074%2Fjbc.M606695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=17395594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=14845-14852&author=J.+K.+Slack-Davisauthor=K.+H.+Martinauthor=R.+W.+Tilghmanauthor=M.+Iwanickiauthor=E.+J.+Ungauthor=C.+Autryauthor=M.+J.+Luzzioauthor=B.+Cooperauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=J.+T.+Parsons&title=Cellular+Characterization+of+a+Novel+Focal+Adhesion+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor</span></div><div class="casAuthors">Slack-Davis, Jill K.; Martin, Karen H.; Tilghman, Robert W.; Iwanicki, Marcin; Ung, Ethan J.; Autry, Christopher; Luzzio, Michael J.; Cooper, Beth; Kath, John C.; Roberts, W. Gregory; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14845-14852</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Focal adhesion kinase (FAK) is a member of a family of non-receptor protein-tyrosine kinases that regulates integrin and growth factor signaling pathways involved in cell migration, proliferation, and survival.  FAK expression is increased in many cancers, including breast and prostate cancer.  Here we describe perturbation of adhesion-mediated signaling with a FAK inhibitor, PF-573,228.  In vitro, this compd. inhibited purified recombinant catalytic fragment of FAK with an IC50 of 4 nM.  In cultured cells, PF-573,228 inhibited FAK phosphorylation on Tyr397 with an IC50 of 30-100 nM.  Treatment of cells with concns. of PF-573,228 that significantly decreased FAK Tyr397 phosphorylation failed to inhibit cell growth or induce apoptosis.  In contrast, treatment with PF-573,228 inhibited both chemotactic and haptotactic migration concomitant with the inhibition of focal adhesion turnover.  These studies show that PF-573,228 serves as a useful tool to dissect the functions of FAK in integrin-dependent signaling pathways in normal and cancer cells and forms the basis for the generation of compds. amenable for preclin. and patient trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_48hzQ-vWhrVg90H21EOLACvtfcHk0lgHnslGL8YHHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFemtbY%253D&md5=38e97c67d37fbcbde006e6937ae4e360</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M606695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M606695200%26sid%3Dliteratum%253Aachs%26aulast%3DSlack-Davis%26aufirst%3DJ.%2BK.%26aulast%3DMartin%26aufirst%3DK.%2BH.%26aulast%3DTilghman%26aufirst%3DR.%2BW.%26aulast%3DIwanicki%26aufirst%3DM.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DAutry%26aufirst%3DC.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DCellular%2520Characterization%2520of%2520a%2520Novel%2520Focal%2520Adhesion%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D14845%26epage%3D14852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gabarra-Niecko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunty, J. M.</span><span> </span><span class="NLM_article-title">FAK Regulates Biological Processes Important for the Pathogenesis of Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1023%2FA%3A1023725029589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=12884911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=359-374&author=V.+Gabarra-Nieckoauthor=M.+D.+Schallerauthor=J.+M.+Dunty&title=FAK+Regulates+Biological+Processes+Important+for+the+Pathogenesis+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">FAK regulates biological processes important for the pathogenesis of cancer</span></div><div class="casAuthors">Gabarra-Niecko, Veronica; Schaller, Michael D.; Dunty, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-374</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Since its initial discovery as a substrate and binding partner for the Src oncogene, a role for the focal adhesion kinase (FAK) in cancer has been speculated.  In this review the clin. evidence correlating FAK overexpression with cancer and the exptl. evidence demonstrating that FAK can control some phenotypes assocd. with cancer will be discussed.  In addn., the emerging theme of interactions between the FAK and growth factor signaling pathways will be described.  The evidence presented in this review provides a compelling case for a role for FAK in the pathol. of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPmHTwXobmj7Vg90H21EOLACvtfcHk0lgHnslGL8YHHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiu78%253D&md5=a3b72160edb7f016a6a862fbb61a6a5f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023725029589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023725029589%26sid%3Dliteratum%253Aachs%26aulast%3DGabarra-Niecko%26aufirst%3DV.%26aulast%3DSchaller%26aufirst%3DM.%2BD.%26aulast%3DDunty%26aufirst%3DJ.%2BM.%26atitle%3DFAK%2520Regulates%2520Biological%2520Processes%2520Important%2520for%2520the%2520Pathogenesis%2520of%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2003%26volume%3D22%26spage%3D359%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Romer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, K.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Activity, Cytoskeletal Organization, and Motility in Human Vascular Endothelial Cells</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1091%2Fmbc.5.3.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=8049526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK2cXktVGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=349-361&author=L.+H.+Romerauthor=N.+McLeanauthor=C.+E.+Turnerauthor=K.+Burridge&title=Tyrosine+Kinase+Activity%2C+Cytoskeletal+Organization%2C+and+Motility+in+Human+Vascular+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells</span></div><div class="casAuthors">Romer, Lewis H.; McLean, Natalie; Turner, Christopher E.; Burridge, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-61</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    </div><div class="casAbstract">Tyrosine phosphorylation of cytoskeletal proteins occurs during integrin-mediated cell adhesion to extracellular matrix proteins.  The authors have investigated the role of tyrosine phosphorylation in the migration and initial spreading of human umbilical vein endothelial cells (HUVEC).  Elevated phosphotyrosine concns. were noted in the focal adhesions of HUVEC migrating into wounds.  Anti-phosphotyrosine Western blots of exts. of wounded HUVEC monolayers demonstrated increased phosphorylation at 120-130 kDa when compared with exts. of intact monolayers.  The pp125FAK immunopptd. from wounded monolayers exhibited increased kinase activity as compared to pp125FAK from intact monolayers.  The time to wound closure in HUVEC monolayers was doubled by tyrphostin AG 213 treatment.  The same concn. of AG 213 interfered with HUVEC focal adhesion and stress fiber formation.  AG 213 inhibited adhesion-assocd. tyrosine phosphorylation of pp125FAK in HUVEC.  Tyrphostins AG 213 and AG 808 inhibited pp125FAK activity in in vitro kinase assays.  Pp125FAK immunoppts. from HUVEC treated with both of these inhibitors also had kinase activity in vitro that was below levels seen in untreated HUVEC.  These findings suggest that tyrosine phosphorylation of cytoskeletal proteins may be important in HUVEC spreading and migration and that pp125FAK may mediate phosphotyrosine formation during these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9oBrR-mke3LVg90H21EOLACvtfcHk0lgHnslGL8YHHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVGqsbk%253D&md5=705486b041a7aa99b744dc38cc44585f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1091%2Fmbc.5.3.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.5.3.349%26sid%3Dliteratum%253Aachs%26aulast%3DRomer%26aufirst%3DL.%2BH.%26aulast%3DMcLean%26aufirst%3DN.%26aulast%3DTurner%26aufirst%3DC.%2BE.%26aulast%3DBurridge%26aufirst%3DK.%26atitle%3DTyrosine%2520Kinase%2520Activity%252C%2520Cytoskeletal%2520Organization%252C%2520and%2520Motility%2520in%2520Human%2520Vascular%2520Endothelial%2520Cells%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1994%26volume%3D5%26spage%3D349%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Gates, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, L. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanney, L. B.</span><span> </span><span class="NLM_article-title">Potential Role for Focal Adhesion Kinase in Migrating and Proliferating Keratinocytes near Epidermal Wounds and in Culture</span> <span class="citation_source-journal">Cell Growth Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=7986754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADyaK2cXlsFCksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=891-899&author=R.+E.+Gatesauthor=L.+E.+Kingauthor=S.+K.+Hanksauthor=L.+B.+Nanney&title=Potential+Role+for+Focal+Adhesion+Kinase+in+Migrating+and+Proliferating+Keratinocytes+near+Epidermal+Wounds+and+in+Culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture</span></div><div class="casAuthors">Gates, Ronald E.; King, Lloyd E., Jr.; Hanks, Steven K.; Nanney, Lillian B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">891-9</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    </div><div class="casAbstract">In normal, differentiating skin, hemidesmosomes make the stable attachment of basal epidermal keratinocytes to the dermis by linking the cytoplasmic keratin intermediate filaments to components of the basal lamina.  In contrast, laterally migrating and proliferating basal keratinocytes in culture and presumably in repairing wounds use focal adhesion to form dynamic attachments to the dermis by linking actin microfilaments to the extracellular matrix.  Focal adhesion kinase (FAK), a non-receptor protein tyrosine kinase concd. along with phosphotyrosine-contg. proteins in the focal adhesions of some cultured cells, is activated in vitro when cells attach, form focal adhesions, and spread.  This report finds that FAK is activated, as detd. from its increased phosphotyrosine content and from its increased labeling with [γ-32P]ATP, in immunoppts. from human cultured keratinocytes attached and spreading on fibronectin compared to those attached but not spreading on polylysine.  Furthermore, immunofluorescence shows that both FAK and phosphotyrosine are concd. in the focal adhesions of cultured keratinocytes attached and spreading on extracellular matrix components known to facilitate cellular migration (fibronectin, collagens I or IV, and epiligrin).  Finally, immunohistochem. localizes FAK to the epidermal-dermal junction in repairing partial thickness burn wounds.  FAK is found at the epidermal-dermal junction at sites and times which coincide with actively migrating or rapidly proliferating basal keratinocytes, suggesting that this distribution represents FAK concd. and activated in adhesions analogous to the focal adhesions seen in cultured cells.  Hence, FAK appears to have an important in vivo role in the reepithelialization of human wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodG50m0nDgaLVg90H21EOLACvtfcHk0lj8Cn_W8RtWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsFCksb8%253D&md5=c0210b60a8d9d41ec0b7ddf4ebb91860</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGates%26aufirst%3DR.%2BE.%26aulast%3DKing%26aufirst%3DL.%2BE.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DNanney%26aufirst%3DL.%2BB.%26atitle%3DPotential%2520Role%2520for%2520Focal%2520Adhesion%2520Kinase%2520in%2520Migrating%2520and%2520Proliferating%2520Keratinocytes%2520near%2520Epidermal%2520Wounds%2520and%2520in%2520Culture%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D1994%26volume%3D5%26spage%3D891%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Taylor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. T.</span><span> </span><span class="NLM_article-title">Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1128%2FMCB.21.5.1565-1572.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=11238893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=1565-1572&author=J.+M.+Taylorauthor=C.+P.+Mackauthor=K.+Nolanauthor=C.+P.+Reganauthor=G.+K.+Owensauthor=J.+T.+Parsons&title=Selective+Expression+of+an+Endogenous+Inhibitor+of+FAK+Regulates+Proliferation+and+Migration+of+Vascular+Smooth+Muscle+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells</span></div><div class="casAuthors">Taylor, Joan M.; Mack, Christopher P.; Nolan, Kate; Regan, Christopher P.; Owens, Gary K.; Parsons, J. Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1565-1572</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Extracellular matrix signaling via integrin receptors is important for smooth muscle cell (SMC) differentiation during vasculogenesis and for phenotypic modulation of SMCs during atherosclerosis.  We previously reported that the noncatalytic carboxyl-terminal protein binding domain of focal adhesion kinase (FAK) is expressed as a sep. protein termed FAK-related nonkinase (FRNK) and that ectopic expression of FRNK can attenuate FAK activity and integrin-dependent signaling.  Herein we report that in contrast to FAK, which is expressed ubiquitously, FRNK is expressed selectively in SMCs, with particularly high levels obsd. in conduit blood vessels.  FRNK expression was low during embryonic development, was significantly upregulated in the postnatal period, and returned to low but detectable levels in adult tissues.  FRNK expression was also dramatically upregulated following balloon-induced carotid artery injury.  In cultured rat aortic smooth muscle cells, overexpression of FRNK attenuated platelet-derived growth factor (PDGF)-BB-induced migration and also dramatically inhibited [3H]thymidine incorporation upon stimulation with PDGF-BB or 10% serum.  These effects were concomitant with a redn. in SMC proliferation.  Taken together, these data indicate that FRNK acts as an endogenous inhibitor of FAK signaling in SMCs.  Furthermore, increased FRNK expression following vascular injury or during development may alter the SMC phenotype by neg. regulating proliferative and migratory signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2n7JEeG0aTLVg90H21EOLACvtfcHk0lj8Cn_W8RtWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlGhs7s%253D&md5=af822b41c63d77f3e8112e7e990a54cd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.5.1565-1572.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.5.1565-1572.2001%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BM.%26aulast%3DMack%26aufirst%3DC.%2BP.%26aulast%3DNolan%26aufirst%3DK.%26aulast%3DRegan%26aufirst%3DC.%2BP.%26aulast%3DOwens%26aufirst%3DG.%2BK.%26aulast%3DParsons%26aufirst%3DJ.%2BT.%26atitle%3DSelective%2520Expression%2520of%2520an%2520Endogenous%2520Inhibitor%2520of%2520FAK%2520Regulates%2520Proliferation%2520and%2520Migration%2520of%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D1565%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ilic, D.</span><span> </span><span class="NLM_article-title">Reduced Cell Motility and Enhanced Focal Adhesion Contact Formation in Cells from FAK-Deficient Mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=539-544&author=D.+Ilic&title=Reduced+Cell+Motility+and+Enhanced+Focal+Adhesion+Contact+Formation+in+Cells+from+FAK-Deficient+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIlic%26aufirst%3DD.%26atitle%3DReduced%2520Cell%2520Motility%2520and%2520Enhanced%2520Focal%2520Adhesion%2520Contact%2520Formation%2520in%2520Cells%2520from%2520FAK-Deficient%2520Mice%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D539%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Brábek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselý, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabry, B.</span><span> </span><span class="NLM_article-title">The Role of the Tissue Microenvironment in the Regulation of Cancer Cell Motility and Invasion</span> <span class="citation_source-journal">Cell Commun. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_elocation-id">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1186%2F1478-811X-8-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=20822526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A280%3ADC%252BC3cfjtlSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&author=J.+Br%C3%A1bekauthor=C.+T.+Mierkeauthor=D.+R%C3%B6selauthor=P.+Vesel%C3%BDauthor=B.+Fabry&title=The+Role+of+the+Tissue+Microenvironment+in+the+Regulation+of+Cancer+Cell+Motility+and+Invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the tissue microenvironment in the regulation of cancer cell motility and invasion</span></div><div class="casAuthors">Brabek Jan; Mierke Claudia T; Rosel Daniel; Vesely Pavel; Fabry Ben</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> During malignant neoplastic progression the cells undergo genetic and epigenetic cancer-specific alterations that finally lead to a loss of tissue homeostasis and restructuring of the microenvironment.  The invasion of cancer cells through connective tissue is a crucial prerequisite for metastasis formation.  Although cell invasion is foremost a mechanical process, cancer research has focused largely on gene regulation and signaling that underlie uncontrolled cell growth.  More recently, the genes and signals involved in the invasion and transendothelial migration of cancer cells, such as the role of adhesion molecules and matrix degrading enzymes, have become the focus of research.  In this review we discuss how the structural and biomechanical properties of extracellular matrix and surrounding cells such as endothelial cells influence cancer cell motility and invasion.  We conclude that the microenvironment is a critical determinant of the migration strategy and the efficiency of cancer cell invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7hE77k6G743qj_yg7twvpfW6udTcc2eaTm3_5lUaKMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfjtlSmug%253D%253D&md5=21824816fe0b6a382c6c5ac0e51b80d1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-22%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25A1bek%26aufirst%3DJ.%26aulast%3DMierke%26aufirst%3DC.%2BT.%26aulast%3DR%25C3%25B6sel%26aufirst%3DD.%26aulast%3DVesel%25C3%25BD%26aufirst%3DP.%26aulast%3DFabry%26aufirst%3DB.%26atitle%3DThe%2520Role%2520of%2520the%2520Tissue%2520Microenvironment%2520in%2520the%2520Regulation%2520of%2520Cancer%2520Cell%2520Motility%2520and%2520Invasion%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2010%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Beningo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaverina, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. L.</span><span> </span><span class="NLM_article-title">Nascent Focal Adhesions Are Responsible for the Generation of Strong Propulsive Forces in Migrating Fibroblasts</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1083%2Fjcb.153.4.881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=11352946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1WgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=881-888&author=K.+A.+Beningoauthor=M.+Demboauthor=I.+Kaverinaauthor=J.+V.+Smallauthor=Y.+L.+Wang&title=Nascent+Focal+Adhesions+Are+Responsible+for+the+Generation+of+Strong+Propulsive+Forces+in+Migrating+Fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts</span></div><div class="casAuthors">Beningo, Karen A.; Dembo, Micah; Kaverina, Irina; Small, J. Victor; Wang, Yu-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-887</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Fibroblast migration involves complex mech. interactions with the underlying substrate.  Although tight substrate contact at focal adhesions has been studied for decades, the role of focal adhesions in force transduction remains unclear.  To address this question, we have mapped traction stress generated by fibroblasts expressing green fluorescent protein (GFP)-zyxin.  Surprisingly, the overall distribution of focal adhesions only partially resembles the distribution of traction stress.  In addn., detailed anal. reveals that the faint, small adhesions near the leading edge transmit strong propulsive tractions, whereas large, bright, mature focal adhesions exert weaker forces.  This inverse relationship is unique to the leading edge of motile cells and is not obsd. in the trailing edge or in stationary cells.  Furthermore, time-lapse anal. indicates that traction forces decrease soon after the appearance of focal adhesions, whereas the size and zyxin concn. increase.  As focal adhesions mature, changes in structure, protein content, or phosphorylation may cause the focal adhesion to change its function from the transmission of strong propulsive forces, to a passive anchorage device for maintaining a spread cell morphol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWa2SjUsdmerVg90H21EOLACvtfcHk0lgOrQ7k1VZGPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1WgsbY%253D&md5=28380432f0db7a0855265f808aaaf2f3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1083%2Fjcb.153.4.881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.153.4.881%26sid%3Dliteratum%253Aachs%26aulast%3DBeningo%26aufirst%3DK.%2BA.%26aulast%3DDembo%26aufirst%3DM.%26aulast%3DKaverina%26aufirst%3DI.%26aulast%3DSmall%26aufirst%3DJ.%2BV.%26aulast%3DWang%26aufirst%3DY.%2BL.%26atitle%3DNascent%2520Focal%2520Adhesions%2520Are%2520Responsible%2520for%2520the%2520Generation%2520of%2520Strong%2520Propulsive%2520Forces%2520in%2520Migrating%2520Fibroblasts%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D153%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">High Yielding Microwave-Assisted Synthesis of Tri-Substituted 1,3,5-Triazines Using Pd-Catalyzed Aryl and Heteroarylamination</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">–</span> <span class="NLM_lpage">3860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=3856-3860&author=P.+Daoauthor=C.+Garbayauthor=H.+Chen&title=High+Yielding+Microwave-Assisted+Synthesis+of+Tri-Substituted+1%2C3%2C5-Triazines+Using+Pd-Catalyzed+Aryl+and+Heteroarylamination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDao%26aufirst%3DP.%26aulast%3DGarbay%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DHigh%2520Yielding%2520Microwave-Assisted%2520Synthesis%2520of%2520Tri-Substituted%25201%252C3%252C5-Triazines%2520Using%2520Pd-Catalyzed%2520Aryl%2520and%2520Heteroarylamination%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D3856%26epage%3D3860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500784e&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500784e&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500784e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+with+Selective+Receptor+Flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0liHmLCCi-snyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520with%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4c7t" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4c7t','PDB','4c7t'); return false;">PDB: 4c7t</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/jm500784e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58758"></div></div></div></div></div><hr /></hr><p class="last">In vitro profile of compound <b>19a</b> against a panel of ten kinases, purity data of tested compounds (HPLC), apoptosis in U-87MG and HCT-116 cells assessed by annexin V/7-AAD double staining, cell cycle distribution studied by flow-cytometry, effects of TAE-226 on the cell attachment in U-87MG cell lines, effects of compounds <b>TAE-226</b>, <b>12a</b>, <b>15a</b>, <b>19a</b>, and <b>21a</b> on the migration/invasion in U-87MG cell lines, using Boyden chamber assays, and experimental details. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500784e/suppl_file/jm500784e_si_001.pdf">jm500784e_si_001.pdf (2.92 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500784e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm500784e" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500784e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679948a6aca83da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
